Ethanol exposure during synaptogenesis in a mouse model of fetal alcohol spectrum disorders: acute and long-term effects on gene expression and behaviour by Kleiber, Morgan L
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
11-16-2015 12:00 AM 
Ethanol exposure during synaptogenesis in a mouse model of 
fetal alcohol spectrum disorders: acute and long-term effects on 
gene expression and behaviour 
Morgan L. Kleiber 
The University of Western Ontario 
Supervisor 
Shiva M. Singh 
The University of Western Ontario 
Graduate Program in Biology 
A thesis submitted in partial fulfillment of the requirements for the degree in Doctor of 
Philosophy 
© Morgan L. Kleiber 2015 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Developmental Neuroscience Commons, and the Genetics and Genomics Commons 
Recommended Citation 
Kleiber, Morgan L., "Ethanol exposure during synaptogenesis in a mouse model of fetal alcohol spectrum 
disorders: acute and long-term effects on gene expression and behaviour" (2015). Electronic Thesis and 
Dissertation Repository. 3343. 
https://ir.lib.uwo.ca/etd/3343 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
  
Ethanol exposure during synaptogenesis in a mouse model  
of fetal alcohol spectrum disorders: acute and long-term effects 
on gene expression and behaviour 
 
 
(Thesis format: Monograph) 
 
 
by 
 
Morgan L. Kleiber 
 
 
 
Graduate Program in Biology 
 
Submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
© Morgan L. Kleiber 2015 
 ii 
 
Abstract 
 
Alcohol is a neuroactive molecule that is able to exert variable and often detrimental 
effects on the developing brain, resulting in a broad range of physiological, 
behavioural, and cognitive phenotypes that characterize ‘fetal alcohol spectrum 
disorders’ (FASD).   Factors affecting the manifestation of these phenotypes include 
alcohol dosage, timing of exposure, and pattern of maternal alcohol consumption; 
however, the biological processes that are vulnerable to ethanol at any given 
neurodevelopmental stage are unclear, as is how their disruption results in the 
emergence of specific pathological phenotypes later in life.   
The research included in this thesis utilizes a C57BL/6J (B6) mouse model to examine 
the changes to gene expression and behaviour following a binge-like exposure to 
ethanol during synaptogenesis, a period of neurodevelopment characterized by the 
rapid formation and pruning of synaptic connectivity that correlates to brain 
development during the human third trimester.  B6 pups were treated with a high 
dose (5 g/kg over 2 hours) of ethanol at postnatal day 4 (P4), P7, or on both days 
(P4+7).  Mice were evaluated using a battery of behavioural tests designed to assess 
FASD-relevant phenotypes, and showed delayed achievement of neuromuscular 
coordination, hyperactivity, increased anxiety-related traits, and impaired spatial 
learning and memory.   
Gene expression analysis identified 315 transcripts that were altered acutely (4 
hours) following ethanol exposure.  Up-regulated transcripts were associated with 
cellular stress response, including both pro- and anti-apoptotic molecules, as well as 
maintenance of cell structural integrity.  Down-regulated transcripts were associated 
with energetically costly processes such as ribosome biogenesis and cell cycle 
progression.  Genes critical to synapse formation were also affected, as well as genes 
important for the appropriate development of the hypothalamic-pituitary-adrenal 
axis. 
 iii 
 
Additionally, gene expression changes within the adult brain of mice treated with 
ethanol at P4+7 were examined to evaluate the long-term effects of 
neurodevelopmental alcohol exposure.  Array analysis identified 376 altered mRNA 
transcripts with roles in synaptic function, plasticity, and stability, as well as 
epigenetic processes such as folate metabolism and chromatin remodeling.  
MicroRNA analyses identified changes in the levels of 33 microRNA species, 
suggesting that that long-term changes to gene expression following may be 
maintained (at least in part) via epigenetic mechanisms.  
Taken together, these analyses illustrate the sensitivity of synaptogenesis to ethanol 
exposure, leading to a ‘molecular footprint’ of gene expression changes that persists 
into adulthood and may contribute to the emergence of long-term behavioural and 
cognitive phenotypes associated with FASD.   
 
 
 
 
 
 
 
 
Keywords   
fetal alcohol spectrum disorder, brain, development, gene expression, ethanol, 
mouse model, microarray, behaviour  
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Chapter 1 
INTRODUCTION 
 
 
 
1.1 Fetal alcohol exposure and the developmental origins of   
health and disease 
Development is guided by the interaction between the code inherited as one’s 
genomic DNA and the dynamic systems that regulate its control.  The development of 
the mammalian brain is acutely sensitive to this interplay:  dependent on precise 
spatial and temporal gene regulation but highly responsive to the developmental 
environment, including the decisions a woman may make regarding her own health 
and her child’s while pregnant.   
Neurodevelopmental gene expression can be affected by maternal stress, diet, and 
the consumption of drugs or alcohol.  How the prenatal environment influences the 
emergence of later-life physiological or psychological disorders forms the basis of the 
“developmental origins of health and disease” hypothesis (BARKER 2004, GILLMAN 
2005), which has been applied to psychopathologies such as autism, schizophrenia, 
attention-deficit hyperactivity disorder, and anxiety and mood disorders (SCHLOTZ 
and PHILLIPS 2009, BALE et al. 2010, DUFOUR-RAINFRAY et al. 2011, KIRAN KUMAR et al. 
2013, UHER 2014).  Few disorders, however, have such a clear developmental etiology 
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as fetal alcohol spectrum disorders (FASD).  Caused by prenatal alcohol exposure, 
FASD is one of the most prevalent examples of how disrupting the developmental 
environment can lead to a broad range of negative later-life physiological, 
behavioural, and cognitive outcomes.   
 
1.2 Fetal alcohol spectrum disorders 
Fetal alcohol spectrum disorders (FASD) is a non-diagnostic umbrella term that 
encompasses the physiological, neurological, behavioural, and cognitive features 
displayed by individuals exposed to alcohol by maternal consumption during 
pregnancy.   Historically, very little attention was given to the relationship between 
alcohol and birth defects and much medical literature condoned moderate alcohol use 
during pregnancy until as recently as the middle of the 20th century (ABEL 2012).  In 
1968, French researchers described delayed growth and distinctive physiological 
characteristics in children of alcoholic mothers (LEMOINE et al. 1968), suggesting that 
prenatal alcohol exposure was harmful to the development of a fetus.  This study 
remained largely ignored until 1973 when Jones and Smith reported similar findings 
(JONES et al. 1973), describing an array of physiological and intellectual abnormalities 
among children they defined as having ‘fetal alcohol syndrome’. 
It is remarkable that such a common substance, consumed for centuries, was so 
recently acknowledged as a health hazard and a cause of detrimental effects on a 
developing child.  However, since the publication of these seminal studies, the effects 
of prenatal alcohol exposure have received increasing attention.  Even so, the 
recognition of fetal alcohol-related disorders remains complicated, with variable 
diagnostic criteria and significant phenotypic heterogeneity.  Recently, the term 
“neurodevelopmental disorder-prenatal alcohol exposed” achieved a code under the 
category “otherwise specified neurodevelopmental disorder” within the most recent 
American Psychiatric Association’s Diagnostic and Statistical Manual (DSM-5) as a 
condition requiring further study (AMERICAN PSYCHIATRIC ASSOCIATION 2013).  Some 
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classification terms have, however, been established within Canada and the United 
States to define the differences in the severity of physiological and behavioural 
features that are nonetheless consistent with prenatal alcohol exposure (BERTRAND et 
al. 2005, CHUDLEY et al. 2005) .    
At its most severe, individuals exposed to heavy alcohol exposure during early 
gestation display prenatal and postnatal growth deficiencies, distinctive craniofacial 
features, physiological and central nervous system abnormalities, and significant 
cognitive impairment that define Fetal Alcohol Syndrome (FAS) (ASTLEY et al. 1999, 
ARCHIBALD et al. 2001, BERTRAND et al. 2005, LIPINSKI et al. 2012).  More commonly, 
prenatal alcohol exposure results in less severe clinical phenotypes that include 
partial fetal alcohol syndrome (PFAS), in which individuals may present partial 
physiological features of FAS while remaining severely cognitively impaired.   Other 
categories include static encephalopathy/alcohol exposed (SE/AE), meaning 
permanent or unchanging neurological damage that may or may not present 
physiologically as well as neurobehaviourally, and neurodevelopmental 
disorder/alcohol exposed (ND/AE) that may present solely as cognitive and 
behavioural changes in the absence of gross physiological abnormalities (ASTLEY and 
CLARREN 2000).  Importantly, the latter categories most likely comprise the majority 
of FASD cases, making identification and diagnosis extremely difficult.  Further, there 
is no necessary correlation between detectable neurophysiological abnormalities and 
severity of cognitive impairment (MATTSON et al. 1998).    
 
1.2.1 Behavioural and cognitive phenotypes associated with FASD 
Part of the difficulty with diagnosing FASD in the absence of confirmed prenatal 
alcohol exposure relates to the phenotypic heterogeneity associated with FASD.  Also, 
the physical, cognitive, and behavioural impairments associated with prenatal 
alcohol exposure (PAE) may not be clearly “normal” or “abnormal”; indeed, 
individuals with PAE fall within a broad continuum that ranges from a normal 
spectrum of behaviours to distinctively impaired (MATTSON and RILEY 1998, ASTLEY et 
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al. 2009, KODITUWAKKU 2009).  Many of these behaviours are also not specific to 
prenatal alcohol exposure and may manifest differently across the life of an affected 
individual.   
The vulnerability of the developing brain to ethanol translates to risk for a broad 
range of later-life outcomes.  Infants and young children with PAE often show 
impaired motor coordination, balance, and reflex responses that may persist into 
adulthood (COLES et al. 1985, CONNOR et al. 2006, LUCAS et al. 2014).  Also, children with 
FAS and FASD typically have lower IQs than non-exposed children though there is 
considerable variability, with most individuals with (non-severe) prenatal alcohol 
exposure falling within a normal IQ range (MATTSON and RILEY 1998).   Regardless, 
children with FASD exhibit increased rates of learning disabilities and, as a result, 
poor academic achievement (HOWELL et al. 2006).   This may be due to impaired verbal 
and non-verbal learning, as well as deficits in verbal information encoding and 
visuospatial processing (MATTSON et al. 1996, ROEBUCK-SPENCER and MATTSON 2004, 
WILLFORD et al. 2004).   Poor academic performance may also be attributable to 
inattention and activity levels (GREEN et al. 2009, ALVIK et al. 2013); indeed, attention-
deficit/hyperactivity disorders (ADHD) is the most common psychiatric comorbidity 
of children with FASD, with three to nine times higher prevalence than the general 
population (BHATARA et al. 2006, HERMAN et al. 2008).  Further compounding these 
disadvantages are associations with PAE and disruptive, impulsive, and delinquent 
behaviour, impaired social and adaptive functioning, and tendency to engage in 
dangerous or risk-taking behaviour (RASMUSSEN 2005, RASMUSSEN and WYPER 2007, 
JIRIKOWIC et al. 2008a, CROCKER et al. 2009, WARE et al. 2014). Additionally, recent 
associations have been made between prenatal alcohol exposure and circadian 
dysfunction, impacting adaptive function, mood, concentration and cognitive function 
(EARNEST et al. 2001, WENGEL et al. 2011, CHEN et al. 2012).  Many of these phenotypes 
persist into adulthood and result in secondary psychiatric and psychosocial 
manifestations such as increased risk for depression, anxiety and oppositional 
defiance-related disorders, as well as an increased risk for alcohol and drug abu se, 
impairments in moral and social development, and failure to learn from experience 
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(STREISSGUTH and O'MALLEY 2000, STEINHAUSEN et al. 2003, BHATARA et al. 2006, NICCOLS 
2007).   This often leads to increased difficulty with the legal system, either as 
offenders or victims, and an increased prevalence within the correctional system 
(FAST and CONRY 2004, STREISSGUTH et al. 2004). Comprehensive medical and social 
programs are imperative to identify and improve the prognosis of individuals born 
with FASD; however, we still have little understanding of how alcohol exposure 
during neurodevelopment, including factors such as timing, dose, and pattern of 
exposure, induces such a broad and variable range of neurobehavioural phenotypes. 
 
1.2.2 Epidemiology of fetal alcohol spectrum disorders 
Given the inconsistencies with diagnostic criteria, variability of phenotypic 
presentation, and unlikelihood of accurately ascertaining the nature of gestational 
alcohol exposure, there are large discrepancies in estimates of FASD incidence and 
prevalence.  It is, however, recognized that maternal alcohol consumption during 
pregnancy is the most common preventable cause of neurodevelopmental disabilities 
in Western cultures.  The estimated prevalence of FAS is between 0.5 and 3 per 1,000 
births; however, the estimated incidence of conditions falling within the FASD 
spectrum in Canada is approximately 9 in 1000 births (PUBLIC HEALTH AGENCY OF 
CANADA 2003).  More recent studies have suggested that the prevalence is 
underestimated and may be as high as 2-5% (MAY et al. 2009, MAY et al. 2011).  These 
numbers are considerably concentrated within low socio-economic communities, in 
children within the child care system, the Canadian correctional system, and in 
certain remote, rural or indigenous populations, where estimates of FAS and FASD 
rise to approximately 6.0% and 16.9%, respectively (WILLIAMS et al. 1999, MASOTTI et 
al. 2006, LANGE et al. 2013, POPOVA et al. 2015).   In a comprehensive analysis by Stade 
et al. (2009) using a conservative estimate of 3 per 1000 births and including 
individuals from 0-53 years of age, the annual estimated cost in 2007 for health care, 
educational and social services, and other indirect costs associated with FASD was 
$5.3 billion (95% confidence interval: $4.12 - $6.4 billion) at the population level 
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(STADE et al. 2009).  These numbers indicate that FASD is a pressing concern 
economically, medically, and sociologically, and research into the biological etiology 
of these disorders may aid in developing better diagnostic tools and improve the 
ultimate quality of life for individuals prenatally exposed to alcohol.   
 
1.2.3 Maternal drinking patterns and associations with FASD 
The number of individuals diagnosed with prenatal alcohol exposure-related 
disabilities has increased significantly over the last few decades.   Part of this increase 
is due to improvements in social and medical awareness of these disorders (CHUDLEY 
et al. 2005, GOH et al. 2008, ASTLEY 2013).  Regardless of this, in North America as 
many as 30% of women continue to drink during pregnancy, with approximately 5% 
engaging in “binge” drinking (ETHEN et al. 2009).  This may occur for varied reasons: 
naïveté of potential consequences, addiction, or unawareness of pregnancy.   Further, 
changes in social attitudes and drinking patterns among women of childbearing age 
also may contribute to these growing numbers.   
Binge drinking is defined as the consumption of alcohol that raises one’s blood alcohol 
concentration (BAC) to approximately 0.08% or above (NATIONAL INSTITUTE OF 
ALCOHOL ABUSE AND ALCOHOLISM 2004).  For an average woman, this equates to 
approximately 4 standard drinks in two hours or less.  According to a recent study 
conducted by the United States Center for Disease Control, binge drinking prevalence, 
frequency, and intensity was found to be highest in women aged 18-24 years of age 
(CENTER FOR DISEASE CONTROL 2012).   This is troubling, given that binge drinking in the 
months prior to pregnancy considerably elevates the risk of drinking (and binge 
drinking) during pregnancy (ETHEN et al. 2009).  Generally, mothers of individuals 
that fall with the SE/AE and ND/AE categories engage in drinking during the first 
trimester, but cut down substantially upon recognition of the pregnancy; however, 
when they do drink, they are likely to do so in a binge-type fashion.   This is important 
given that a binge pattern of drinking, even infrequently, results in higher and 
prolonged BACs, which are strongly correlated with increased neurological and 
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cognitive damage, regardless of the trimester in which the binge episode occurred 
(MAY et al. 2013). 
 
1.2.4 Effect of prenatal alcohol exposure on brain structure  
Ethanol is a small molecule that easily crosses the placental and blood-brain barrier 
(IDANPAAN-HEIKKILA et al. 1972).  One to two hours after maternal alcohol ingestion, 
blood alcohol levels of the fetus reaches an approximately equivalent level as 
maternal BAC; however, ethanol elimination by the fetus does not occur at the same 
level of metabolic efficiency, resulting in prolonged exposure time and reliance on 
maternal ethanol metabolism to eliminate alcohol from the bloodstream and the 
amniotic fluid (BURD et al. 2012).  There is a dose-response relationship between 
maternal BAC levels, the duration of a high BAC, and the severity of neurological 
damage in the developing fetus (MAIER and WEST 2001).  Consequently, binge drinking 
is more detrimental to the developing brain than drinking patterns that produce low 
or moderate BACs (MAIER and WEST 2001).   
Much of the neuropathological data regarding how ethanol physiologically impacts 
the developing brain in humans has been obtained using neuroimaging techniques.   
Studies involving FAS and FASD patients have shown a wide array of morphological 
changes and a general reduction in brain volume.  There seem to be few areas (if any) 
that are not susceptible to ethanol-induced damage, depending on timing of exposure.  
Fairly consistently, magnetic resonance imaging studies have found abnormal 
cortical thickness and diminution of white matter, the corpus callosum, the prefrontal 
cortex, the cerebellum, and the hippocampus (ARCHIBALD et al. 2001, BOOKSTEIN et al. 
2002, SOWELL et al. 2002, RILEY et al. 2004, CORTESE et al. 2006). Given the critical roles 
in learning, memory, sensory information processing, and cognitive function played 
by these brain regions, these results are consistent with the kinds of deficits seen in 
FASD.  At the same time, many individuals that have abnormalities in brain 
functioning show no gross anatomical abnormalities upon brain imaging (MATTSON 
and RILEY 1998, SPADONI et al. 2007). Further, alcohol-exposed children both with and 
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without physiological abnormalities are similarly impaired on tests of language, 
memory, fine-motor speed, and visual-motor integration, suggesting that the degree 
of behavioural and cognitive deficits may be independent of physical features 
(MATTSON et al. 1998). These findings suggest that reduced brain volume in particular 
regions cannot account for all the neurological phenotypes associated with FASD.  
 
1.3 Animal models in FASD research 
Understanding the biological mechanisms through which alcohol affects the 
developing brain and leads to behavioural and cognitive abnormalities is a complex 
and difficult challenge.  The problem lies in the variability of phenotypes associated 
with FASD: there is no checklist of behaviours that can confirm prenatal alcohol 
exposure.  Rarely, if ever, do researchers have information regarding the exact timing, 
dosage, or pattern of maternal alcohol consumption, nor can they determine the 
impact of potentially deleterious socioeconomic factors that may exacerbate FASD-
associated traits.  In order to better understand how prenatal alcohol exposure may 
result in FASD in human populations requires the development and use of effective 
animal models.   Animal models are crucial to elucidating the biological mechanisms 
that initiate or underlie human psychiatric disorders in ways not possible in humans; 
additionally, these results can be effectively translated to improve human phenotypes 
(BALE et al. 2010, NESTLER and HYMAN 2010a).   Animal models also allow for the 
control of genetic and environmental factors that confound the manifestation of FASD 
in humans, such as ethanol dosage, timing of exposure, pattern of exposure (acute or 
chronic), maternal nutrition, comorbid drug exposure, and genetic background.   
Creating a model for FASD in animals seems straight-forward given that these 
disorders have a very discrete etiology: prenatal alcohol exposure.  However, to 
effectively model a human disorder, the model must provide a conserved biological 
basis that can replicate similar anatomical, molecular, and phenotypic features of the 
disorder. 
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1.3.1 A multi-species approach to understanding FASD 
Animal models have played a critical role in FASD research since the late 1970s to 
establish that alcohol was indeed a teratogen and prenatal exposure was able to cause 
adverse physiological and behavioural effects (BOND and DI GIUSTO 1976, CHERNOFF 
1977, HENDERSON and SCHENKER 1977, RANDALL and TAYLOR 1979).  Also, these early 
studies determined that there was a relationship between dose of ethanol (ie, 
maternal BAC levels) and severity of offspring abnormalities (CHERNOFF 1977, 
RANDALL and TAYLOR 1979).  In an important study conducted by Sulik et al. (1981), it 
was demonstrated that the distinctive facial features of FAS could be replicated in 
mice and that the appearance of these craniofacial abnormalities were dependent on 
the timing of exposure (SULIK et al. 1981).  This study demonstrated that there were 
critical windows of vulnerability for certain physiological and neurological 
abnormalities.   Since these pivotal studies, many different animal models have been 
developed and utilized over the last few decades, each lending itself more 
appropriately to certain research goals depending on the nature and complexity of 
the question.  Fundamental biological questions regarding the effect of ethanol on 
evolutionarily-conserved developmental mechanisms have been addressed using 
organisms such as Caenorhabditis elegans, Drosophila, and zebrafish (DAVIS et al. 
2008, MCCLURE et al. 2011, COLE et al. 2012).  By far the most common model, however, 
are rodent species such as mice, rats, and guinea pigs.  While each model may mimic 
one or several features of FASD, certainly none are entirely comprehensive.  However, 
together they effectively contribute to our understanding of genetic and cellular 
mechanisms involved in prenatal alcohol exposure and how those mechanisms may 
lead to physiological changes, neuro-functional alterations, and behavioural and 
cognitive impairments in humans with FASD.   
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1.3.2 Modeling FASD in mice 
Mouse models are extremely useful for evaluating the genetic and cellular impact of 
alcohol in vivo in a complex neurological system.  In general, mice are often used for 
health-related research due to their short generation time, their ease of care, and 
basic genetic, developmental and physiological similarity to humans.  There is 
considerable literature describing their physiology, behaviour, susceptibility to 
ethanol teratology, and developmental timeline with relation to the human timeline .  
They are also particularly amenable to genomic studies given the availability of tools 
such as DNA sequence and gene expression data (including spatial and temp oral 
expression of genes during development), well-established behavioural assays, and 
availability of arrays and transgenic tools.    
Mouse models, and in particular the C57BL/6 (B6) inbred strain, have been widely 
used in FASD research since the demonstration that they could be used to recapitulate 
strikingly similar physiological and craniofacial abnormalities to those observed in 
humans with FAS (SULIK et al. 1981).  Since then, numerous mouse models have been 
developed using various ethanol dosages, treatments at different developmental 
stages, and multiple methods of ethanol administration.  These models are used to 
examine the behavioural, physiological, cellular, and genetic consequences of ethanol 
exposure.   
Mouse models of FASD generally fall within one of two categories: chronic moderate 
exposure throughout gestation or punctuated acute treatments at specific 
neurodevelopmental stages.  The former often utilizes inbred strains with a high 
ethanol preference, such as B6, to model voluntary maternal ethanol consumption 
throughout gestation (ALLAN et al. 2003, BOEHM et al. 2008, KLEIBER et al. 2011, BRADY 
et al. 2012).   Pregnant B6 females continue to consume approximately 70% of their 
total liquid intake in the form of a 10% ethanol solution when given a choice between 
the ethanol solution and water, exposing the developing fetus to low-to-moderate 
levels of ethanol (BACs reach approximately 80 – 200 mg/dl) throughout gestation.  
The resulting offspring show subtle but consistent behavioural phenotypes relevant 
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to FASD, such as delays in the development of neuromuscular reflexes and 
coordination, increases in novelty-induced anxiety, decreased sensitivity to ethanol 
during adolescence, and deficits in spatial learning and hippocampal-dependent 
learning tasks (BOEHM et al. 2008, KLEIBER et al. 2011, BRADY et al. 2012).  Models using 
voluntary consumption throughout gestation have face validity in that they likely 
represent a common pattern of alcohol consumption in humans that choose to drink 
while pregnant; however, they can make it difficult to ascertain the effects of ethanol 
on processes that occur at specific neurodevelopmental stages.  To address this, other 
models use an exposure paradigm where a punctuated high-dose or “binge”-like 
treatment is administered at a specific developmental time, either through oral 
intubation, injection, or inhalation (PARSON and SOJITRA 1995, IKONOMIDOU et al. 2000, 
HEATON et al. 2002b, BAKE et al. 2012, LIPINSKI et al. 2012, WAGNER et al. 2014).  These 
“binge” paradigms results in higher BACs, usually above 200 mg/dl, and as is the case 
in humans, more severe neurological damage.  In B6 mice, the threshold of 200 mg/dl 
is sufficient to induce significant apoptotic neurodegeneration in the developing 
brain, with the severity of damage proportional to the length of time BACs remain 
above this level (IKONOMIDOU et al. 2000).  These binge models are also useful in 
making associations between the timing of exposure and specific physiological and 
behavioural phenotypes, as ethanol can be administered both during specific 
pregnancy trimester-equivalents, and in specific dosages  (GOODLETT and JOHNSON 
1997, MAIER et al. 1997, WOZNIAK et al. 2004, HUNT et al. 2009, LIPINSKI et al. 2012, 
MANTHA et al. 2013).  The variability of these studies, however, in terms of the dosage 
administered and timing of exposure, make comparisons between different models 
difficult.  A consistent ethanol administration paradigm across different 
developmental stages (and trimester-equivalents) would be useful to assess windows 
of vulnerability of developing brain regions, behavioural changes associated with 
these windows, and the effect of alcohol on molecular processes that may underlie 
these changes.   Our laboratory has developed a treatment paradigm in B6 mice that 
represents a binge-like exposure, with a consistent dose, which we have administered 
via subcutaneous injection during the first, second, or third human trimester 
equivalent (KLEIBER et al. 2013, MANTHA et al. 2013).  The results presented in this 
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thesis examine the effects of ethanol on developing brain during the third trimester-
equivalent, an exceptionally sensitive period to the teratogenic effects of alcohol.  
However, results from multiple studies support that there is no safe time during 
pregnancy in which it is safe to consume alcohol and not risk the proper 
neurodevelopment of the fetus.  
  
1.4 Biological mechanisms implicated in the 
neurodevelopmental effects of alcohol 
Alcohol’s adverse effects are likely due to a combination of direct and indirect 
interactions with biological processes occurring in the developing brain at the time 
of exposure.  Part of the difficulty in assessing the etiology of FASD is the pleiotropic 
nature of ethanol’s actions within the brain , as well as our incomplete understanding 
of the exact cellular and molecular processes involved in brain development.  There 
are a number of studies, however, that have implicated specific biological 
mechanisms that consistently seem to be adversely affected by ethanol, all of which 
likely contribute to the heterogeneous physiological and behavioural phenotypes 
associated with prenatal alcohol exposure.  Some of these processes are discussed 
below.   
 
1.4.1 Alcohol metabolism 
Genes involved in the metabolism of alcohol and its metabolic intermediates possess 
polymorphisms in human populations that affect gene functioning, making them 
natural targets for research examining susceptibility to the effects of alcohol (GOEDDE 
et al. 1983, CRABBE et al. 1999).  The primary pathway for the metabolism of alcohol 
involves alcohol dehydrogenase (ADH), which converts alcohol into the toxic 
intermediate metabolite acetaldehyde, which is then metabolized by acetaldehyde 
dehydrogenase (ALDH) into acetate (ZAKHARI 2006).   Both ethanol and acetaldehyde 
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easily cross the placental barrier and are readily accessible by the developing fetus 
very shortly after maternal consumption (BLAKLEY and SCOTT 1984).  Studies have 
examined the association of different alleles of enzymes within the alcohol 
metabolism pathway, such as those within the alcohol dehydrogenase ADH1B gene, 
with the severity or frequency of FAS and FASD in various populations (STOLER et al. 
2002, JACOBSON et al. 2006, GREEN and STOLER 2007).   Inefficient ADH proteins limit 
the conversion of ethanol to the toxic metabolite acetaldehyde prolonging higher 
BACs; similarly, inefficient ALDH isozymes result in longer exposure to acetaldehyde.  
Further, ethanol may competitively inhibit the role of ADH in the catalyzation of 
retinol to retinoic acid, a potent mediator of embryogenesis and cellular 
differentiation, leading to retinoic acid deficiency (CHAMBON 1996, DUESTER 1996, 
ZACHMAN and GRUMMER 1998). While these studies point to genes that may mitigate 
the severity of ethanol neurotoxicity between individuals (WARREN and LI 2005), they 
do not explain the mechanisms that trigger ethanol’s neurotoxic effects. More 
important, polymorphisms in genes related to alcohol metabolism are not sufficient 
to explain the full range of alcohol’s effects on the developing brain.  
 
1.4.2 Oxidative stress 
Numerous studies have demonstrated that prenatal alcohol exposure results in 
increased reactive oxygen species (ROS) and oxidative stress in multiple brain 
regions (RAMACHANDRAN et al. 2001, RAMACHANDRAN et al. 2003, GREEN et al. 2006, CHU 
et al. 2007, HILL et al. 2014).  This increase in ROS can cause damage to cell 
membranes, DNA, and proteins, and trigger the release of apoptosis-inducing factors 
from the mitochondria (REGO and OLIVEIRA 2003).  Changes in ROS levels can also 
affect mitochondrial function, leading to altered intracellular and extracellular 
calcium concentrations.  Given the need to tightly regulate calcium-mediated 
neuronal signaling when establishing appropriate synaptic connections, altered 
calcium concentrations could be detrimental during synaptogenesis.  
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The developing brain is vulnerable to ethanol-induced ROS damage for multiple 
reasons, including a high oxygen metabolic rate, the high concentration of fatty acids 
that can be used as substrates for ROS, and the relatively low concentration of 
endogenous antioxidant enzymes as compared to the adult brain (FLOYD and CARNEY 
1992, HALLIWELL 1992, HENDERSON et al. 1999, SOKOLOFF 1999).  Indeed, there is 
substantial evidence that supplementation with exogenous antioxidants  can prevent 
certain ethanol-induced neurodevelopmental damage (HEATON et al. 2003, MARINO et 
al. 2004, KUMRAL et al. 2005).   As with other mechanisms, certain regions show 
windows of vulnerability.  Studies in rodents have demonstrated that the cerebellum, 
hippocampus, and hypothalamus, and striatum are all vulnerable to increases in ROS 
following alcohol exposure during the third trimester equivalent (HEATON et al. 
2002b, HEATON et al. 2003, MARINO et al. 2004, DEMBELE et al. 2006).  Further, oxidative 
stress has been shown to have a long-lasting impact on the function of these regions.  
For example, early neonatal ethanol exposure increases mitochondrial antioxidant 
manganese superoxide dismutase levels within the hypothalamus at P7 in rats 
(DEMBELE et al. 2006).  This is associated with decreased expression of pro-
opiomelanocortin that persists into adulthood, affecting hypothalamic-pituitary-
adrenal signaling, endocrine function (DEMBELE et al. 2006) and anxiety and 
depressive-like behaviours (BROCARDO et al. 2012).   While oxidative stress can 
certainly trigger cell death, these studies demonstrate that it can also affect long-term 
gene expression and cellular function, which then may contribute to FASD -associated 
phenotypes.   
 
1.4.3 Growth factor and neurotrophic factor signaling 
Growth factors are secreted, diffusible proteins essential for neuronal survival, 
proliferation, and maturation.  Depending on the balance of mitogenic or anti-
proliferative trophic signals, developing cells make decisions regarding progression 
or rate of mitosis, the initiation of programmed cell death, cell shape and size, and 
dendritic arborization (BIBEL and BARDE 2000).  Many growth factors that are critical 
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to normal brain development such as the neurotrophins nerve growth factor (NGF), 
brain derived neurotrophic factor (BDNF), neurotrophins 3, 4, and 5 (NT-3, NT-4, and 
NT-5), as well as transforming growth factor-β (TGFβ) and insulin-like growth factors 
(IGFs), are disrupted by neurodevelopmental ethanol exposure(HEATON et al. 1995, 
HEATON et al. 2000b, MILLER 2003, PARKS et al. 2008, DE LA MONTE et al. 2011).  This 
disruption may be direct, with ethanol acting as an agonist or antagonist on the 
growth factor receptor  or within its signaling pathway, or indirect, inducing changes 
to the expression of genes involved in growth factor signaling or expression of the  
growth factor itself (RESNICOFF et al. 1993, ZHANG et al. 1998, MAIER et al. 1999, HEATON 
et al. 2000b, MOORE et al. 2004).  By whatever mechanism, it seems that ethanol acts 
to reduce signaling of neurotrophic factors, encouraging the cell to undergo 
apoptosis.  Supplementation of cells (in vitro and in vivo) with specific neurotrophins 
can reduce ethanol-induced neurotoxicity (LUO et al. 1997, JAURENA et al. 2011).  
Transgenic studies have demonstrated that the deletion of BDNF can increase 
ethanol-induced cell death in specific regions, while NGF overexpression can 
ameliorate ethanol neurotoxicity (HEATON et al. 2000a, HEATON et al. 2002a).  This may 
be achieved via the up-regulation of anti-apoptotic and down-regulation of pro-
apoptotic genes (ALOYZ et al. 1998, PEREZ-NAVARRO et al. 2005, CHIOU et al. 2007).  
Other growth factors, however, such as TGFβ, can promote cell death following 
ethanol exposure by up-regulating the expression of genes involved in apoptotic 
pathways (HICKS and MILLER 2011).  Given that growth factors play such essential 
roles in brain development, altering their availability or signaling at critical 
neurodevelopmental times or in vulnerable regions likely contributes to both short 
and long-term ethanol effects.     
 
1.4.4 Cell adhesion and interaction 
During neurodevelopment, cell-cell recognition and adhesion are required for 
numerous processes including neuron survival, migration, and, during 
synaptogenesis, synaptic formation, maturation, and plasticity (RUTISHAUSER 1984, 
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YANG et al. 2014).  Cell adhesion molecules (CAMs) establish synapse specificity by 
mediating protein interactions to properly align the pre- and post-synaptic neurons, 
recruit proteins integral to synaptic membranes such as neurotransmitter receptors 
and scaffolding proteins, facilitate vesicle reuptake and neurotransmitter release , and 
control the formation and balance of excitatory and inhibitory synapses  
(WASHBOURNE et al. 2004, WILLIAMS et al. 2010).  Further, disruption of neural cell 
adhesion molecules leads to neurodevelopmental disorders resembling the 
physiological and behavioural phenotypes of FAS (CREMER et al. 1994, KAMIGUCHI et al. 
1998).  Ethanol has been shown to interact with neural cell adhesion molecule 
(NCAM) and L1-NCAM to affect neurodevelopmental cell adhesion (MINANA et al. 
2000, AREVALO et al. 2008, LITTNER et al. 2013).  The impact of this is likely substantial, 
but the effect of ethanol on other cell adhesion molecules remains relatively 
unexplored.  However, given their pivotal role in synaptogenesis, any disruption of 
cell adhesion molecules have the potential to strongly contribute to the phenotypes 
associated with FASD that rely on synaptic maintenance and plasticity such as 
learning, memory, stress response, and motor function.   
 
1.4.5 Neurotransmitter signaling 
Synaptogenesis, the process by which cells establish synaptic connectivity, relies 
heavily on intercellular communication.  Excitatory and inhibitory signals between 
synapses and dendrites are formed, maintained, and deleted by neurotransmission 
between pre- and post-synaptic neurons.  John Olney and colleagues have 
demonstrated the profound effect of ethanol on neurotransmitter signaling during 
synaptogenesis, showing that ethanol interferes with NMDA and GABA receptors to 
trigger widespread neurodegeneration within the mouse brain  (IKONOMIDOU et al. 
2000, OLNEY et al. 2000, OLNEY et al. 2002c).  Cell death, however, is not the singular 
mechanism by which ethanol acts through developing neurotransmitter systems. 
Ethanol is a unique drug in that it interferes with multiple neuronal signaling 
mechanisms, including ligand-gated ion channels such as those associated with γ-
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aminobutyric acid (GABA), N-methyl-D-aspartate (NMDA), serotonin, dopamine, 
catecholamines, opioids, and steroids (HARRIS et al. 2008).   Brain regions implicated 
in the phenotypic effects of prenatal alcohol exposure including the cerebellum, 
hippocampus, and neocortex show changes such as altered expression of GABA and 
NMDA receptor subunits, delayed developmental maturation of GABAergic and 
glutamatergic neurons, altered receptor functionality, or impaired plasticity (HSIAO et 
al. 2004, TOSO et al. 2006a, SERVAIS et al. 2007, INCERTI et al. 2010, PUGLIA and 
VALENZUELA 2010).  Additionally, impairments in serotonergic and dopaminergic 
function result in reduced serotonin neuron innervation, alterations to hypothalamic-
pituitary-adrenal axis function, circadian rhythm abnormalities, and altered reward 
pathway signaling (SHER 2004, ZHOU et al. 2005, HOFMANN et al. 2007, FERNANDES et al. 
2015).  The effects of neurodevelopmental disruption of neurotransmitter systems 
have been shown to persist into adulthood (IZUMI et al. 2005, TOSO et al. 2005, TOSO et 
al. 2006b), and as such have received much attention as contributors to the long-term 
phenotypic changes associated with fetal alcohol exposure.   Certainly, even subtle 
changes to these major neurotransmitter systems during synaptogenesis likely has 
significant implications for the formation and refinement of neural circuits and 
contribute to learning and memory deficits, motor abnormalities, changes to stress 
responsiveness, and other FASD-associated phenotypes.  However, while ethanol 
may act directly on neurotransmitter function during exposure, the persistent effects 
of neurodevelopmental alcohol exposure may be attributed to more long-lasting 
mechanisms, including changes to the expression of genes that facilitate and support 
interneuron communication.   
 
1.5 Gene expression and epigenetic patterning as targets of 
neurodevelopmental alcohol exposure 
Among the many biological mechanisms vulnerable to ethanol is the regulation of 
gene expression.  As such, prenatal ethanol exposure is particularly troubling given 
that neurodevelopment is a carefully-orchestrated genetic process, involving precise 
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spatial and temporal coordination of the transcriptome.  This includes the epigenetic 
patterning that is established during neurodevelopment and critical to appropriate 
gene expression in differentiated cells.  The previously-mentioned biological 
mechanisms rely, at least in part, by ethanol-induced changes to the expression of 
genes involved in those processes.  Alcohol acts pleiotropically in the adult brain, and 
so may interfere with the transcriptional regulation of a number of developmental 
pathways.  Consequently, many of the studies examining ethanol-induced changes to 
neurodevelopmental gene expression have focused on candidate genes chosen based 
on evidence from these processes, including genes involved in cell survival, apoptosis, 
migration, oxidative stress, and neurotransmission (CLIMENT et al. 2002, TOSO et al. 
2005, CHEN et al. 2006a, DEMBELE et al. 2006, TOSO et al. 2006b, CAMARILLO and MIRANDA 
2008, BEKDASH et al. 2014, TYLER and ALLAN 2014).  The genes examined by these 
studies include regulators of neurogenesis, NMDA and GABA receptor subunits, HPA 
and circadian-associated transcripts, and neurotrophic molecules and their 
receptors.  However, a candidate approach does not fully account for the broad range 
of neurological phenotypes characteristic of a multifactorial spectrum disorder , nor 
does it capture the interactions between genes and biological pathways that support 
the involvement of specific developmental mechanisms.   
 
1.5.1 The necessity of genome-wide strategies 
Given that ethanol is a well-established instigator of gene expression changes in the 
adult brain (TREADWELL and SINGH 2004, MULLIGAN et al. 2006, CONTET 2012), it is 
surprising that few studies have examined the effect of alcohol exposure on genome-
wide changes to neurodevelopmental mRNA expression.  The studies that have 
examined the effect of ethanol on the developing brain using expression arrays 
typically focus on early neurodevelopmental exposure (ie, during the first trimester 
equivalent) (HARD et al. 2005, GREEN et al. 2007, DOWNING et al. 2012), providing 
insight into mechanisms that may produce physiological and neurological 
abnormalities associated with FAS but not the mechanisms that may underlie the 
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cognitive and behavioural changes in individuals as a consequence of later gestational 
exposure.  Further, research has indicated that neurodevelopmental processes have 
windows of vulnerability to ethanol, suggesting that the genes affected during the 
first trimester equivalent are likely very different from those affected during later 
brain development.  Given the amount of physiological and behavioural research that 
has focused on the third trimester equivalent as a critical period of brain 
development, the lack of data exploring the genetic mechanisms that may underlie 
these findings is surprising.  FASD is a complex disorder, affecting multiple brain 
regions and associated with a broad range of phenotypic abnormalities.  Therefore, a 
candidate gene approach may be insufficient to fully appreciate the range of effects 
that prenatal alcohol exposure induces on normal gene regulation and expression.  
Genome-wide expression studies also cannot focus on a single stage of development; 
understanding the effects of ethanol on late-gestation neurodevelopmental processes 
are essential to understanding why the third trimester-equivalent is so critically 
vulnerable to ethanol and why exposure during this period is sufficient to produce 
profound behavioural deficits.     
Microarray data and subsequent gene set enrichment analyses can be useful when 
distilling the biological underpinnings of complex phenotypes and to identify major 
pathways involved in its cause or maintenance (BUNNEY et al. 2003, MIRNICS and 
PEVSNER 2004).  This is particularly critical to FASD; ethanol exerts an initial cellular 
response within the developing brain, but it has also been shown to interfere with 
mechanisms, including epigenetic patterning, which may affect long-term gene 
expression and cellular function.  While multiple studies have focused on the 
immediate effects of neurodevelopmental ethanol exposure, fewer have evaluated 
how exposure translates to mature brain dysfunction that contributes to the 
persistent phenotypes associated with FASD.  Evaluation of the mechanisms that 
contribute to these long-term effects are perhaps more critical and beneficial to those 
prenatally exposed to alcohol, particularly if they may lead to potential diagnostic or 
therapeutic strategies.  Further, studies examining the relationship between the acute 
effects of ethanol on gene expression at specific developmental stages, the persistent 
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changes it induces within the mature brain, and the manifestation of these neural 
changes as phenotypic characteristics would provide a more comprehensive picture 
of FASD as a neurodevelopmental disorder with life-long psychiatric consequences.    
 
1.5.2 MicroRNA expression as a contributing mechanism 
Alcohol-induced changes to developmental epigenetic patterning has recently been 
suggested as a mechanism of long-term maintenance of altered gene expression in 
the brain.  Non-coding RNAs (ncRNAs) are abundantly expressed, some exclusively, 
in the mammalian brain (MEHLER and MATTICK 2007).  They have demonstrated roles 
in mature brain function, including long and short-term memory formation, 
neuroprotective mechanisms, and in controlling the malleability and plasticity of 
neural networks (MEHLER and MATTICK 2007, MERCER et al. 2008, QURESHI and MEHLER 
2012, JIMENEZ-MATEOS 2015).  MicroRNAs (miRNAs) are able to fine-tune protein 
expression by interfering with mRNA translation (LAGOS-QUINTANA et al. 2001). Also, 
miRNAs have important roles in normal neurodevelopment, including mitigating the 
levels of gene expression that control cell proliferation, apoptosis, differentiation, and 
synapse formation and remodeling (MEHLER and MATTICK 2007, COOLEN et al. 2013, 
NOWAK and MICHLEWSKI 2013, HU et al. 2014).   
In 2007, Sathyan et al. (2007) first explored the role of regulatory miRNAs in the 
teratogenic effects of ethanol on the developing brain.  This study reported the 
potential interplay of miR-9, miR-21, miR-153, and miR-355 and their target mRNAs, 
illustrating the sensitive balance of antagonistic biological cues that may ultimately 
determine cellular death or survival and adaptation following ethanol insult (SATHYAN 
et al. 2007).  Importantly, Sathyan and colleagues identified that miRNAs serve as an 
effective intermediary between an environmental teratogen and cellular response  
given their ability to rapidly affect the expression of multiple genes.  
Not only are miRNAs involved in the immediate response of developing cells to 
ethanol, but PAE may alter the epigenetic patterning that regulates miRNA 
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expression, in turn changing the balance of mRNA regulation within the adult brain 
(MIRANDA 2007, BALARAMAN et al. 2013, LAUFER et al. 2013).  Few studies have yet to 
explore the long-term dysregulation of miRNA expression as a potential mechanism 
underlying the phenotypic changes associated with FASD, but work in has identified 
a number of altered miRNAs in the adult brain of mice exposed to ethanol during 
neurodevelopment (BALARAMAN et al. 2013, LAUFER et al. 2013, MANTHA et al. 2014a).  
A number of the miRNAs identified in the adult brain of PAE mice have previously 
been implicated by studies exploring the acute effects of ethanol exposure .  These 
include miR-335, which was found to be suppressed following high ethanol levels but 
upregulated following more moderate exposures, affecting neural stem cell 
differentiation (SATHYAN et al. 2007).   Also found to be ethanol responsive during 
neurodevelopment was miR-10b (WANG et al. 2009), which was found to be down-
regulated in the adult brain (MANTHA et al. 2014a).  This miRNA is a regulator of the 
Hox gene family, which play key roles in neuronal migration (GEISEN et al. 2008).  The 
relationship or significance between the alterations in miRNA expression acutely 
following ethanol exposure as well as in the adult brain of mice prenatally exposed to 
alcohol has yet to be determined.  However, it is clear that miRNAs are powerful 
modulators of gene expression with the ability to affect numerous mRNA targets.  
Further, a given biological pathway or process may be affected from multiple 
vantages simultaneously in an antagonistic or synergistic manner.  Given that recent 
results suggest a significant role for miRNAs in the etiology of FASD and that changes 
to their expression may persist long after alcohol exposure, it appears critical to 
evaluate their altered expression in the adult brain and their relationship to altered 
mRNAs and associated biological pathways to more fully understand the scope of 
changes that prenatal alcohol exposure may exert over the life of an affected 
individual.   
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1.6 Developmental timing and ethanol vulnerability  
Mouse models have been invaluable in establishing that the structure of the 
developing brain, the extent of neurological damage, and the resulting phenotypic 
changes are highly dependent on the timing of alcohol exposure.   The normal 
maturation of regions of the rodent brain follow a similar pattern as in humans, with 
caudal regions such as the hindbrain developing earlier than more rostral areas and 
a somewhat parallel sequence of processes in each region (RICE and BARONE 2000).   
There are important differences, however, in the timeline of mouse and human 
neurodevelopment that need to be acknowledged.  In humans, neurodevelopmental 
processes occur at the scale of months, with stages defined by three trimesters of 
gestational development.  In mice, these processes occur on a scale of days (BAYER et 
al. 1993a).   Further, while the processes that occur during the first and second 
trimester in humans (the first to sixth month of pregnancy) also occur gestationally 
in mice, they equate to gestational day (G) 0 – 11 and G12-21, respectively. Given that 
parturition in mice occurs at 21-22 days post-conception, the neurodevelopmental 
processes associated with the third trimester in humans occur postnatally in mice 
(postnatal day 0 to 14, approximately).  This means that third trimester-equivalent 
exposures must be modeled by neonate ethanol treatment, eliminating the kinetics of 
maternal ethanol metabolism and transfer through the bloodstream and placenta 
that certainly impact the effect of alcohol exposure during this period in humans.  
Regardless, mouse models have been instrumental in establishing that the brain is 
vulnerable to the teratogenic effects of alcohol throughout its development, as well as 
in determining specific neurodevelopmental processes and brain regions that may be 
vulnerable to ethanol exposure at various times.   
 
1.6.1 The vulnerability of synaptogenesis to ethanol exposure 
During the third trimester of pregnancy in humans and the first three postnatal weeks 
in mice, the brain undergoes a rapid period of growth and development during which 
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much of the physiological and molecular basis of neural connections are established 
(DOBBING and SANDS 1979, BAYER et al. 1993b, COHEN-CORY 2002). This process of 
synaptogenesis includes an overproduction of dendritic arborization and synapse 
formation, greatly increasing synaptic density and brain mass, lending this period  the 
designation the “brain growth spurt” (CHANGEUX and DANCHIN 1976, DOBBING and 
SANDS 1979).  This is followed by extensive apoptotic pruning and refinement of 
synaptic connectivity hypothesized to maximize transmission efficiency (PURVES and 
LICHTMAN 1980).  This process is a fundamental developmental strategy and occurs in 
multiple brain regions across mammalian species (ANDERSEN 2003).   
The formation, maintenance, and deletion of synapses requires the careful regulation 
of molecular cues such as neurotrophic factor expression, cell adhesion protein 
regulation, and neurotransmitter signaling (JUNG and BENNETT 1996, KNOLL and 
DRESCHER 2002, TAKASU et al. 2002, HERLENIUS and LAGERCRANTZ 2004, ZAGREBELSKY and 
KORTE 2014).   These processes are essential to establish mature excitatory synaptic 
connectivity and required for the development of neuronal structure in an intact, 
adult brain (CLINE and HAAS 2008, WANG and KRIEGSTEIN 2008, WONDOLOWSKI and 
DICKMAN 2013).  The importance of interneuron communication during this stage of 
development, however, also makes it attune to environmental cues including 
teratogens; indeed, synaptogenesis may be one of the most exquisitely ethanol-
sensitive periods of brain development (IKONOMIDOU et al. 2000, OLNEY et al. 2002b).   
Even transient increases in blood alcohol at postnatal day 7 (P7), a peak period of 
synaptogenesis in mice, can lead to widespread cell death in multiple brain regions 
(WOZNIAK et al. 2004).  This is associated with ethanol’s ability to act as an N-methyl-
D-aspartate (NMDA) receptor antagonist and a γ-aminobutyric acid (GABA) agonist, 
which can suppress the intensity of action potentials that are required to establish 
synaptic connectivity leading to the inappropriate apoptosis of developing neurons 
(IKONOMIDOU et al. 2000, OLNEY et al. 2002c).  The regions that suffer a significant 
deletion of developing neurons following ethanol exposure during this ‘brain growth 
spurt’ are consistent with many of the behavioural abnormalities observed in FASD, 
including the hippocampus, cerebellum, cortex, amygdala, hypothalamus, and corpus 
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callosum (IKONOMIDOU et al. 2000, OLNEY et al. 2002a, DIKRANIAN et al. 2005).  Further, 
early neonatal ethanol treatment (during synaptogenesis) is sufficient to produce 
multiple FASD-related behavioural traits in adolescent and adult mice, including 
spatial learning impairment, motor deficits, increased anxiety- and depression-like 
behaviours, and  alterations to circadian regulation (SAKATA-HAGA et al. 2006, 
BROCARDO et al. 2012, VOLGIN and KUBIN 2012, DIAZ et al. 2014a, DIAZ et al. 2014b, 
WAGNER et al. 2014).  However, not all cells exposed to ethanol during synaptogenesis 
undergo apoptosis.  Many are exposed to ethanol – even within vulnerable regions – 
and survive to comprise the developmental basis of adult neural architecture.  Also, 
it has been shown that alcohol-induced neurodegeneration is dependent on the 
transcription and translation of new molecules, including the caspase activator Blc2-
associated X protein (Bax) (NOWOSLAWSKI et al. 2005).  As such, the period of 
synaptogenesis becomes an intriguing period of development in terms of how ethanol 
may trigger a genetic or cellular response in developing neurons that initiates 
programmed cell death, how cells may balance pro- and anti-apoptotic signals, and 
what biological processes are affected in non-apoptotic cells by this 
neurodevelopmental disruption and in the mature brain, long after the cessation of 
alcohol, but while the phenotypes associated with FASD have manifested.   
 
1.7 Summary and research rationale 
It is apparent that FASD is an extremely socially and economically costly set of 
disorders, despite its preventability.  While research examining the complex array of 
behavioural, physiological, and biological mechanisms that initiate or maintain the 
features of these disorders continues to progress, there appears to be a gap in our 
understanding of how disruptions to genetic processes may be involved.  Further, the 
variability of ethanol dosage, timing of exposure, animal model, and analytic assay 
used prohibits any comparison between many FASD-associated studies, making the 
identification of underlying mechanisms extremely difficult.   
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Although our understanding of neurodevelopment is certainly incomplete, we a re 
aware that the development of the brain is not uniform and that certain periods of 
vulnerability exist for specific regions.  The work included in this thesis seeks to 
examine the effects of alcohol exposure on synaptogenesis, or the third trimester -
equivalent in humans, as a known period of exceptional sensitivity to ethanol and a 
period important for the development of multiple behavioural and cognitive 
processes. This requires the development of an effective animal (mouse) model that 
can recapitulate a number of phenotypes associated with FASD across ontogeny.  
Also, evaluating the changes in gene expression only acutely following ethanol 
exposure, while important, will not be sufficient to predict how those changes will 
affect genetic processes in the adult brain.  This work seeks to examine not only the 
acute genetic response, but those genes that exhibit altered expression in the adult 
brain that may contribute to the maintenance of FASD-related phenotypes. 
Finally, this work is part of a more comprehensive, genome-wide analysis of 
transcripts disrupted at specific neurodevelopmental times, including all trimester 
equivalents, using a consistent dosage regimen and a consistent evaluation strategy.    
I feel this approach will provide a better understanding of the relationship between 
timing of exposure, vulnerable neurodevelopmental pathways, and phenotypes 
resulting from that treatment.  This approach may facilitate a non-reductionist 
(systems) approach to understanding the etiology of FASD features and aid in the 
identification of molecular targets as diagnostic markers or for ameliorative 
therapeutics.   
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1.8 Hypothesis and research objectives 
The primary goal of the research included in this thesis is to investigate, at a genome -
wide level, the effect of alcohol on neurodevelopmental gene expression and how the 
disrupted genetic pathways may correlate with neurobehavioural changes consistent 
with human FASD.   
I hypothesize that a binge-like exposure to ethanol during synaptogenesis induces 
alterations in behavioural and cognitive phenotypes relevant to FASD.  These changes 
are associated with acute changes to gene expression that occur at the time of exposure 
as well as long-term changes that persist into adulthood.  The genes affected by ethanol 
exposure during synaptogenesis will have relevance to molecular pathways important 
during the third trimester-equivalent as well as the behavioural changes observed in 
ethanol-treated mice.   
This thesis focuses on several objectives to address this hypothesis: 
1. Develop a behavioural battery appropriate to evaluate mouse models for a 
variety of FASD-relevant behavioural and cognitive phenotypes. 
2. Evaluate behavioural changes resulting from a binge-like dose of ethanol 
during synaptogenesis as a model for FASD.  Included in this are the effects of 
timing and the cumulative effect of a multi-day treatment. 
3. Establish if a binge-like dose of ethanol during synaptogenesis results in 
acute changes to the transcriptome of the developing brain. 
4. Determine if ethanol treatment during synaptogenesis results in long-term 
changes to mRNA and miRNA expression in the adult brain. 
5. Perform gene set analysis of the genes identified in (3) and (4) to evaluate 
associations with biological pathways and relevance to brain development 
and behaviour.  
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Chapter 2 
MATERIALS AND METHODS 
 
 
 
2.1  Animal care 
All animal protocols were approved by the Animal Use Subcommittee at the 
University of Western Ontario (London, ON) and complied with the ethical standards 
established by the Canadian Council on Animal Care.  Male and female C57BL/6J (B6) 
mice were originally obtained from Jackson Laboratories (Bar Harbor, ME, USA) and 
subsequently bred and maintained in the Health Sciences Animal Care Facility at the 
University of Western Ontario.  Prior to breeding, mice were housed in same-sex 
colonies of two to four mice with ad libitum access to water and food.  Environmental 
factors (such as cage type and size, colony size, bedding, nestlets, and environmental 
enrichment) were standardized between cages.  Colony rooms were maintained in a 
controlled environment on a 14/10-hour light/dark cycle (2000 h to 0600 h dark) 
with 40% to 60% humidity and a temperature range of 21°C to 24°C.  
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2.2 Breeding and ethanol treatments 
Nulliparous female B6 mice of approximately 8 weeks of age were individually 
housed and mated overnight with 8 to 12-week old B6 males.  Males were removed 
the subsequent morning and, during gestation, females were housed individually in 
standard caging.  Towards the end of gestation (gestational days 17-22) cages were 
checked each evening at 5pm and each morning at 10am for the presence of pups.  
Day of birth was noted as postnatal day (P) 0.  Litters were culled to contain a 
maximum of 10 pups and litters containing less than 4 pups were excluded from 
further study.  At P0, pups from each litter were assigned to one of three treatment 
groups, each designed to mimic a binge-like ethanol exposure within the human third 
trimester-equivalent (T3) of neurodevelopment: early T3 at P4, mid T3 at P7, or both 
early and mid T3 (P4 and P7).   On treatment days, dams were temporarily removed 
from the cage and pups were divided into control and ethanol treatment groups as 
equally as possible by sex and weight to account for litter effects.  Treatments 
consisted of two subcutaneous injections spaced two hours apart (0 h and 2 h) of 2.5 
g/kg ethanol in 0.15 M saline.  This paradigm results in peak blood alcohol 
concentrations of over 0.3 g/dl for 4 to 5 hours following the initial injection 
(IKONOMIDOU et al. 2000, WOZNIAK et al. 2004).  Control mice were injected with an 
equivalent amount of 0.15 M saline only.  Following injection, the tail of each pup was 
marked with non-toxic ink to allow for identification. Once the injections for all pups 
were completed, the dam was returned to the cage.  Pups remained with their 
biological dams until weaning at P25, when they were re-housed into same-sex in 
colonies of 2-4 littermate mice.   
 
2.3 Behavioural phenotyping 
When developing a behavioral battery for the assessment of FASD-relevant 
behavioural phenotypes, I considered several criteria: 
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1. The assay measured phenotypes in mice that had been consistently observed 
in children, adolescents, or young adults with FASD.   
2.   The tests were well-established, appropriate to mouse behaviour, and 
consistently shown to successfully test phenotypic features relevant to FASD.  
3.    The battery was conducted from least intrusive and/or cognitively demanding 
to those that tested higher executive functioning, in order to minimize pre-
testing confounds.  
Given these criteria, I developed a behavioural battery that tested mice at several 
stages of development, designed to evaluate a range of FASD-related behaviours.  The 
tests included in the behavioural battery are described below. 
 
2.3.1    Early developmental milestone achievement  
The appearance of early postnatal coordination, strength, sensory and motor skills 
were assessed using a behavioural battery adapted from Wu et al.(WU et al. 1997) and 
Hill et al.(HILL et al. 2007).  Testing was performed from P2 to P21 at 1000 hrs.  Dams 
were removed and placed in a separate clean cage for the duration of the testing.  Each 
pup was weighed then assessed for its ability to achieve specific age-appropriate 
developmental milestones.  Testing lasted approximately four minutes per pup.  Tests 
were performed each day until the pup was able to perform the task on two 
consecutive days.  At the completion of testing, the pup was returned to its home cage.  
Each developmental milestone task is outlined below and illustrated in Figure 2.1.     
 
2.3.1.1 Postnatal weight 
Pups were weighed daily from P2 until weaning at P25.  Following weaning, pups 
were weighed at P30 and P35, then every seven days until P70.   
 
Chapter 2.  Materials and Methods 
 
30 
  
2.3.1.2 Surface righting 
The latency of the pup to right itself with all four paws touching the surface of the 
table when placed on its back on a plastic surface was evaluated.  If the mouse did not 
respond or complete the task within 15 seconds (s), the test was terminated.  The test 
was continued daily until the pup was able to right itself on two consecutive days in 
less than 2 s.  
2.3.1.3 Negative Geotaxis 
The pup was placed head-down on a mesh screen set at an incline of 45°.  The time 
required for the pup to turn its body 180° to a head-up position was recorded.  The 
task was considered complete when the mouse was successful on two consecutive 
days within 30 s.   
2.3.1.4 Cliff aversion 
The pup was positioned at the edge of a plastic box, approximately 3.0 cm above the 
surface of the table, with the digits of its forepaws and nose over the edge.  The day 
on which the mouse was able to rotate away from the edge and place its body fully on 
the surface of the box (within 30 s) was recorded. 
2.3.1.5 Forelimb grasp 
The pup was placed with its forelimbs resting on a thin metal rod (1.5 mm diameter) 
suspended 10 cm above a soft surface (a 5cm thickness of fine wood shavings).  Task 
was completed when the pup was able to grasp the rod and remain suspended for 
more than one second on two consecutive days.  
2.3.1.6 Auditory startle 
The mouse pup was placed on a flat surface and the day it showed an audito ry reflex 
response (an involuntary startle) to a handclap at a distance of 10 cm from its head 
was recorded.   
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2.3.1.7 Ear twitch 
The reflex of the ear to flatten in response to a tactile stimulus was tested using a fine 
cotton filament brushed gently against the pup’s ear three times. The pup’s ability to 
flatten or twitch its ear in response on two consecutive days indicated a successful 
achievement of the reflex.   
2.3.1.8 Open field traversal 
The pup was placed in the centre of a circle 13 cm in diameter on a smooth plastic 
surface.  The day the pup was able to extinguish pivoting behavior and move outside 
of the circle with 30 s was recorded.  Success on two consecutive days marked the 
end of testing.  
2.3.1.9 Air righting 
The pup was gently held upside down, approximately 10 cm above a soft surface (5 
cm thickness of fine wood shavings), and released.  The day the pup was able to right 
itself and land with all four paws on the wood shavings on two consecutive days was 
recorded. 
2.3.1.10 Eye opening 
The first day both eyes were open on each pup was recorded.  
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FIGURE 2.1.  Images representative of behavioural tasks used to measure the 
achievement of early postnatal developmental milestones.  Pups were tested for their 
ability to reach age-appropriate tasks assessing neuromuscular coordination and reflexes.  
Task is indicated below the image.  
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2.3.2   Juvenile locomotor activity 
Locomotor activity in juvenile mice (P26-35) was tested using two methods.  The first 
tested spontaneous daytime locomotor activity in a novel environment, and served 
as a measure of both activity and anxiety-related traits. The second method tested 
nocturnal activity in a familiar home cage environment and was a measure of overall 
activity.  All locomotor testing occurred in a room reserved for testing that was 
separate from the general colony.  The experimenter was not present in the room 
during the testing.   
 
2.3.2.1 Activity in a novel open-field 
At P26-P28, spontaneous locomotor activity and exploration of a novel environment 
was assessed using an infrared Actimeter system (Panlab, Barcelona, Spain) (Figure 
2.2).   The apparatus consisted of a 45 cm (width) x 45 cm (depth) arena of black 
plexiglass enclosed with four clear acrylic walls (35 cm in height) (Figure 2.2B).  A 
square frame mounted outside of the arena created a 16 x 16 grid of intersecting 
infrared beams used to track the horizontal movement of each mouse in real-time.  A 
second frame placed above the lower frame was used to track the vertical movement 
of each mouse, set to detect hind-leg rearing.  Locomotor measures were recorded 
using ActiTrack software (Panlab), which uses infrared beam data to calculate 
parameters such as overall locomotor activity (total number of beam breaks), 
distance traveled, and number of rears.  Testing was conducted during the light phase 
between 1030 h and 1230 h for all mice. Mice were brought into the testing room in 
their home cage a half hour prior to testing. An individual mouse was then placed in 
the corner of the arena and allowed to freely explore it for 15 min. During testing, the 
lighting of the arena was 100 lx so as not to inhibit normal exploratory behavio ur.  At 
the end of testing, the mouse was removed and returned to its home cage and the 
surface and walls of the arena were wiped clean with 30% isopropanol. 
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2.3.2.2 Home cage activity 
Nocturnal locomotor activity in a familiar, home cage environment was evaluated 
using the infrared Actimeter system (Panlab, Barcelona, Spain) (see apparatus 
description above) at age P30-35 (Figure 2.2C).  Prior to testing, mice were re-housed 
individually in 38 cm (length) x 24 cm (width) x 14 cm (height) transparent plastic 
cages (Innovive, San Diego, CA, USA) with standard woodchip bedding and ad libitum 
access to food and water.  After re-housing, mice were moved from the colony room 
to the testing room.   After a 24 h acclimation period, cages were placed within the 
infrared Actimeter frame at least 3 h prior to the initialization of testing.  Testing was 
conducted over a 12 h-period from 1900 h to 0700h which spanned the dark phase 
of the light/dark cycle.  Data were collected using ActiTrack software (Panlab).  
Recordings were taken for two consecutive nights and averaged to obtain data for 
parameters such as locomotor activity per hour, distance traveled, mean speed, and 
number of rears.  Mice were re-housed in their original colony cages at the end of 
testing.   
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FIGURE 2.2.    Infrared Actimeter (Panlab) apparatus for locomotor activity tracking.   
(A) Actimeter system four-arena set-up allowing for the concurrent assessment of four 
animals.  Lower frame is used to track horizontal movements, while the upper frame 
tracks vertical movements (rearing).  (B) Novel open field arena apparatus and sample 
ActiTrack real-time tracking output.  (C) Apparatus used for assessment of nocturnal 
home cage activity, including a sample ActiTrack output.   
A.   Actimeter locomotor apparatus 
B.   Novel open field exploration 
C.   Home cage locomotor activity 
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2.3.3   Anxiety-associated behavioural measures 
Anxiety-related traits were assessed using three measures: locomotor activity in a 
novel open field arena, a light-dark box assay, and an elevated plus maze assay (Figure 
2.3).   Each test relies on the innate behaviour of mice to avoid open or highly-lit areas 
as these features are anxiogenic.  All treatment groups were analyzed using the open 
field arena.  Only the P4+7 control (saline-treated) and ethanol-treated groups were 
assessed using the latter two measures due to apparatus availability.   
 
2.3.3.1 Thigmotaxis in a novel open field  
Tracking of mouse locomotor activity using the Actimeter system (Panlab, Barcelona, 
Spain) in a novel open-field arena is described above (open-field activity in a novel 
environment).  This open-field data was also analyzed by dividing the arena into a 
11.25 cm-wide periphery zone bordering the walls of the arena and a 22.5 cm ×22.5 
cm central zone to allow for the evaluation of thigmotaxis, or the tendency of mice to 
explore mainly along the periphery walls of an enclosed arena rather than to travel 
directly through the centre (SIMON et al. 1994) (Figure 2.3A).   Testing parameters 
(time of day, presence of experimenter, duration of testing, and ambient lighting of 
the arena) are described above under section 2.1.2 (Juvenile activity in a novel open-
field).   
2.3.3.2 Elevated plus maze 
Mice were evaluated for anxiety-related testing using the elevated plus maze (EPM) 
at P35-40.  Mice were removed from the colony room and brought to the testing room 
1 h prior to testing.  Mice were placed in the centre of a maze consisting of four 
adjoining arms that intersected at a 90° angle (Figure 2.3B), constructed from a 
protocol described in Walf and Frye (2007).  The central area was 5 cm (length) x 5 
cm (width) and allowed the mouse to move freely between four 30 cm (length) x 5 
cm (width) arms that extended from the central region, with two opposite arms 
enclosed by 16 cm (height) walls along their length.  The arms and walls were 
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constructed of acrylic and plastic materials to facilitate cleaning and the removal of 
olfactory cues.  The maze was elevated atop a wooden support 100 cm above the 
ground.  Maze illumination from above by a bright (220 lx) ceiling-mounted light and 
a computer-generated 85 dB white noise were used during testing as adversive 
(anxiogenic) environmental stimuli.  Each mouse was allowed to explore the maze 
freely for one 5 min trial (WALF and FRYE 2007), during which its movements were 
tracked by a video camera mounted above the centre of the maze.  AnyMAZE video 
tracking software (San Diego Instruments, San Diego, CA, USA) was used to analyze 
the real-time movements of the mouse including entries into and time spent in the 
open and closed arms.  Following the conclusion of the trial, the mouse was returned 
to its home cage and the maze was cleaned with 30% isopropanol. 
2.3.3.3 Light/dark box 
Mice were also assessed for anxiety-related traits using the light/dark box test (LDB) 
at P35-40.   The LDB was constructed from acrylic materials according to the protocol 
outlined from Bourin and Hascoet (BOURIN and HASCOET 2003) (Figure 2.3C).  The 
apparatus consisted of a 45 cm (length) x 26 cm (width) arena enclosed by 30 cm 
(height) walls.  One third of the arena – 18 cm (length) x 26 cm (width) – was enclosed 
using black acrylic creating the “dark” region.   This region was open to a 27 cm 
(length) x 26 cm (width) uncovered “light” area of the arena via a 7cm (width) x 7 cm 
(height) opening that provided the mouse free access between each area.  At the 
beginning of each trial, the mouse was transferred from the colony room to the testing 
room and allowed to acclimatize for 1 h.  Following acclimation, the mouse was placed 
in the light area of the arena facing the opening to the dark area and the mouse was 
allowed to freely explore the arena for one 5 min trial.  Each trial was conducted using 
a 220 lx ceiling-mounted light and an 85 dB white noise as a mild environmental 
stressor.  The experimenter was not present in the room during testing.  Movement 
was recorded using a ceiling-mounted video camera and analyzed using AnyMAZE 
video tracking software (San Diego Instruments, San Diego, CA, USA).  Measurements 
recorded included the number of transitions between the light and dark areas, and 
the time spent in the light versus dark region.  Following cessation of the trial, the 
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A.   Novel open field exploration 
B.  Elevated plus maze 
C.  Light-dark box 
FIGURE 2.3.   Apparatus used to assess anxiety-related traits. 
(A)  Actimeter (Panlab) open field arena (left image) and ActiTrack real-time monitoring of 
mouse movement (right image), including the separation of the peripheral zone (red) and 
the central zone (blue) used for analysis of thigmotaxis.  (B)  Elevated plus maze test 
consisting of two “open” arms and two enclosed arms (left image). Beside the image of the 
maze is a screenshot of the AnyMAZE (San Diego Instruments) video tracking output, with 
the orange dot indicating the location of the mouse.  (C)  Light-dark box apparatus showing 
the light (open) area and dark (enclosed) area (left image), as well as AnyMAZE (San Diego 
Instruments) video tracking screenshot (right image).  
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mouse was returned to its home cage and returned to the colony room.  The arena 
(light and dark regions) was cleaned with 30% isopropanol between mice.  
 
2.3.4 Assessment of spatial learning and memory 
Spatial learning and reference memory were evaluated in mice using a modif ied 
Barnes maze constructed according to a protocol described by Sunyer et al.  (2007) 
(Figure 2.4).    The apparatus consisted of a white circular platform, 92 cm in diameter, 
elevated 75 cm from the floor.  Along the periphery of the platform were 20 evenly-
spaced circular holes of 5 cm in diameter located 2cm from the edge of the table.   Each 
hole was sealed by black card (not visible from the surface of the table) except for 
one, representing the target hole, under which a black plastic escape box of 13  cm 
(length) x 13.5 cm (width) x 5 cm (height) was placed.  Various large shapes of 
different colours were placed on the walls of the testing room to serve as extra -maze 
visual cues.  A light ceiling-mounted directly above the centre of the table (220 lx) and 
an 85 dB computer-generated white noise were used as adversive stimuli to promote 
escape to the target (SUNYER et al. 2007).  Due to the short duration of some trials, the 
experimenter remained in the room during testing but stood in the same location and 
was dressed in the same attire for each trial (white laboratory coat).  Mouse 
movements were tracked in real-time using AnyMAZE video tracking software (San 
Diego Instruments, San Diego, CA, USA) via an overhead-mounted video camera.  
Testing consisted of two stages: a 4-day acquisition period testing spatial learning 
and a 2-day probe period testing short and long-term recall memory, described 
below. 
 
2.3.4.1 Spatial acquisition learning 
Acquisition training began at P45 (day 1) and consisted of four, 3-min trials spaced 
15 min apart per day for four consecutive days.  Each testing day, mice to be tested 
were removed from the colony room and brought to the testing room 1 h prior to the 
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commencement of testing.  Following the 1 h acclimation period, the mouse was 
placed in a 14 cm (height) x 10 cm (diameter) cylindrical black start chamber in the 
centre of the platform.  The overhead light and the white noise were turned on and, 
after 10 s, the start chamber was lifted to allow the mouse to freely explore the maze.  
The trial was concluded once the mouse had entered the escape box, at which the 
noise and light were turned off and the mouse was left undisturbed in the box for 1 
min before it was returned to its home cage.  If the mouse had not found or entered 
the escape after the 3 min trial, the mouse was gently guided to the escape hole by the 
experimenter using one hand and without lifting the mouse from the table.  Again, 
once the mouse had entered the escape chamber, the overhead light and the white 
noise were turned off and the mouse was left in the chamber for 1 min before being 
returned to its home cage.  To avoid the influence of olfactory or proximal cues, the 
table and the escape box were cleaned with 30% isopropanol between mice and the 
table was rotated around its central axis between each of the four daily trials per 
mouse.  This altered the specific hole that represented the target but not its 
relationship to the extra-maze visual cues, which remained consistent between trials 
for each mouse.  AnyMAZE video tracking software was used to analyze variables 
such as latency to reach target and mean speed.  Number of errors (visits to non -
target holes) and search strategy were analyzed manually using video recordings of 
each trial by two separate evaluators blind to treatment.  Search strategies were 
defined as the following:   
1. Direct:  mouse moves directly to the target hole or adjacent hole (+1 or –1 only) 
before reaching and entering target 
2. Serial:  the first visit to the target hole is preceded by visiting at least two 
adjacent holes in a serial manner, in a clockwise or counter-clockwise direction. 
3. Mixed:  searches to various holes separated by crossing through the centre of the 
maze or in a general unorganized manner.   
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A.   Schematic of Barnes maze construction specifications 
B.   Barnes maze apparatus and testing room 
FIGURE 2.4.   Barnes maze apparatus for the testing of spatial learning and recall 
memory. 
(A)  Specifications used for the construction of the Barnes maze apparatus.    
(B)  Photograph of the Barnes maze showing the position of the start chamber, the 
target, and the placement of visual cues used for spatial orientation.   
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2.3.4.2 Short and long-term recall memory 
Following the conclusion of the acquisition days (days 1 – 4), the short-term spatial 
memory of each mouse was tested on the subsequent day (day 5 of testing) and the 
long-term spatial recall memory was tested 7 days later (day 12 of testing).  During 
these two “probe” trials, the escape box was removed and the target hole was closed 
with black card.  To initiate testing, the mouse was placed in the start chamber and 
the light and white noise were turned on.  After 10 s, the chamber was removed and 
the mouse was allowed to freely explore the maze for 1 min before being gently 
removed from the table by the experimenter and returned to its home cage.  
Behaviours measured (via video recording) included explorations to each hole and 
were scored manually by two separate evaluators blind to treatment groups.   
 
2.3.5 Statistical analysis of behaviour data 
All data were analyzed using SPSS v.16.0 (SPSS Inc., 2007, Chicago, IL, USA).  Analysis 
for developmental milestones were analyzed using Multivariate Analysis of Variance 
(MANOVA) using sex and treatment as fixed factors and were Bonferroni-corrected 
for multiple testing.   Given the multiple measures tested for during the open-field 
locomotor assay, these data were subjected to a principal components analysis (PCA).  
These results revealed two main components, driven by activity (major slope) and 
rearing (secondary slope).  As such, total activity (number of beam breaks) was 
analyzed as the main measure of activity and evaluated using a MANOVA (open-field 
activity) or repeated-measure-MANOVA (RM-MANOVA) using sex and treatment as 
fixed variables and hour as a repeated measure (home cage activity).  Anxiety-related 
data was analyzed using MANOVA (sex and treatment as fixed factors).  Barnes maze 
data were analyzed using a RM-MANOVA (where testing occurred over acquisition 
days) or MANOVA for sex and treatment as appropriate.  Latency measures were 
cube-root transformed to meet equality of variance between days of testing, then 
analyzed using RM-MANOVA.  Barnes maze error data were analyzed for goodness of 
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fit to expected explorations per hole using Chi-squared tests.  All data are reported as 
mean ± standard error of the mean (SEM).  The null hypothesis was rejected at p < 
0.05. 
 
2.4 Analysis of ethanol-induced gene expression changes 
Brain gene expression was assessed in two cohorts of mice using expression 
microarray analyses: the first evaluated transcript alterations acutely (4 hours) 
following ethanol exposure at P7 (short-term effects), and the second assessed mRNA 
level changes in the adult (P60) brain of mice treated at P4+7 (long-term effects).  
Only male mice were used for all molecular analyses due to estrous cycle gene 
expression variation in females (JORGE et al. 2002, KIM et al. 2011).  For the short-term 
cohort, whole brain RNA from 30 male mice were used (18 for array hybridization 
and 12 for qPCR confirmation).  For long-term evaluation of gene expression, 24 mice 
were used (12 for array hybridization and 12 for qPCR confirmation).   
 
2.4.1 Tissue collection and RNA isolation 
Male mice at P7 and P60 were euthanized using CO2 asphyxiation followed by cervical 
dislocation.  Whole brain tissue was isolated within 2 min of euthanization and snap -
frozen in liquid nitrogen and stored at -80° C.  Total RNA was isolated using Trizol® 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instruction and 
cleaned using RNeasy Mini kit (QIAGEN, Valencia, CA, USA).  The quality and quantity 
of RNA was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., 
Palo Alto, CA, USA) and a NanoDrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific Inc., Wilmington, DE, USA).   RNA samples used for all analyses had an 
optical density OD260/280 ratios of 2.0-2.1 nm and an RNA integrity number (RIN) of 
8.0 – 10.0.    
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2.4.2 RNA sample preparation for expression array analysis 
For the analysis of immediate (4 hours post-treatment) gene expression alterations 
induced by ethanol treatment, a total of six biological replicates – four control and 
two ethanol-treated – were used.   For sample preparation, whole brain RNA from 18 
male mice (12 control and 6 ethanol-treated) was diluted to 200 ng/µl and RNA from 
three non-littermate P7 males were pooled to create each biological replicate to 
reduce potential expression differences due to litter effects.  For each control (saline-
treated) RNA sample within a replicate, a littermate ethanol-treated RNA sample was 
included in the comparative replicate.    
For the analysis of long-term (P60, 53 days post-treatment) changes to gene 
expression induced by neurodevelopmental ethanol exposure, four biological 
replicates – two control and two ethanol-treated – were used.  Whole brain RNA from 
6 saline-treated and 6 ethanol-treated males were diluted to 200 ng/µl and three non-
littermate RNA samples was pooled to create each biological replicate.  For each 
control RNA sample included within a replicate, a littermate ethanol-treated male 
was included in the comparative replicate.   
 
2.4.3 Microarray hybridization 
Pooled whole-brain RNA samples were rechecked for concentration (200 ng/µl) 
using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific Inc., 
Wilmington, DE, USA).  Subsequent sample preparation and hybridization steps were 
performed at the London Regional Genomics Centre (Robarts Research Institute, 
London, ON, CA).  Briefly, single-stranded complementary DNA (sscDNA) was 
synthesized using 200 ng of total RNA using the Ambion WT Expression Kit for 
Affymetrix GeneChip® Whole Transcript WT Expression Arrays (Applied Biosystems, 
Carlsbad, CA, USA) and the Affymetrix GeneChip® WT Terminal Labeling kit according 
to the protocol outlined in the hybridization manual (Affymetrix, Santa Clara, CA, 
USA).  First-cycle cDNA was transcribed in vitro to cRNA, which was used to 
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synthesize 5.5 µg of sscDNA that was subsequently biotin-end-labeled and hybridized 
for 16 h at 45°C to Affymetrix Mouse Gene 1.0 ST expression arrays.  The arrays were 
then stained using streptavidin-phycoethyrin prior to scanning.  All liquid-handling 
steps were performed by a GeneChip® Fluidics Station 450 and arrays were scanned 
using the GeneChip® Scanner 3000 7G using Command Console v1.1 (Affymetrix, 
Santa Clara, CA, USA).   Command Console v1.1 was used to calculate the intensity 
value per array cell based on the pixel intensity of each cell from the array scans 
(DAT) file.  These data was converted to cell-based intensity calculations and 
exported as .CEL files.   
 
2.4.4 Microarray data analysis and gene identification 
Probe-level (.CEL) data were imported into Partek Genomics Suite software v.6.6 
(Partek Inc., St. Louis, MO, USA) for summarization to gene-level data and quality-
control analyses.  Data were background-corrected, quantile-normalized, 
summarized using the GeneChip®-Robust Multiarray Averaging (GC-RMA) algorithm 
to take into account probe sequence (GC content) (IRIZARRY et al. 2003), and log2-
transformed.  The Partek Suite was also used to determine gene-level ANOVA p-
values and fold changes.  Genes meeting the criteria of a 1.2-fold change with a false-
discovery rate (FDR)-corrected p value of < 0.05 were considered for further 
analyses.   Unannotated genes and standards used for array normalization were 
removed from gene lists used for clustering and pathway analyses.  Genes meeting 
the criteria for significance were subjected to hierarchical clustering analysis using 
Euclidean distance and average linkage to assess the consistency across replicates 
and to evaluate the general (visual) trends in changes to gene expression across each 
treatment.  All data files from the array experiments have been deposited in the 
National Center for Biotechnology Information (NCBI) Gene expression Omnibus 
(GEO) and can be found under the accessions GSE59512  (short-term P7 data) and 
GSE34549 (long-term P60 gene expression data).  Complete gene lists of transcripts 
meeting the criteria for significance are given in Appendices A and B.  
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2.4.5  Gene set analysis of differentially expressed transcripts 
To examine the biological roles of genes identified as affected by ethanol, the g ene 
lists generated from Partek were analyzed using publically and commercially 
available bioinformatic tools to assess over-represented Gene Ontology (GO) 
biological functions, molecular processes, canonical pathway associations, biological 
pathway associations, and gene interaction networks.  Gene o ntology biological 
functions term enrichment was performed using the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) (DENNIS et al. 2003). DAVID is a 
freely-available bioinformatic tool which extracts biological themes and clusters 
genes into functional groups from an input gene list and assigns significance of gene -
enrichment in each annotation term via a modified Fisher exact p-value.  The 
biological functions associated with differentially expressed genes were also 
evaluated using Ingenuity® Pathway Analysis, which clusters genes by functional 
annotation using QIAGEN’s Ingenuity Ontology ‘Knowledge Base’ and assigns 
significance to over-represented functions using a right-tailed Fisher exact test.  The 
Knowledge Base differs from standard gene ontology analyses in that it incorporates 
processes to resolve synonyms and homographs in order to maintain term identity 
and remove duplicate or redundant terms.  Ingenuity® software was also used to 
evaluate the gene lists for significant associations to canonical biological pathways, 
as well as to perform gene network analysis, which incorporates differentially 
expressed genes into predicted and networks involving annotated interacting genes 
and proteins.  
 
2.4.6 Confirmation of mRNA levels by qRT-PCR 
Quantitative reverse-transcription PCR (qRT-PCR) was performed to confirm the 
expression of select genes identified by the short-term and long-term array analyses.  
Whole brain RNA isolated from six non-littermate male mice not used for array 
hybridization were used for confirmation.  Complimentary DNA (cDNA) was 
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synthesized from 2 µg of total brain RNA using a High-Capacity cDNA Reverse 
Transcription kit (Applied Biosystems, Foster City, CA, USA) according to the 
manufacturer’s protocol.  PCR reactions were run using Gene-specific TaqMan® Assay 
Reagents and TaqMan® Gene Expression Assay products in a StepOne™ Real Time 
PCR System cycler (Applied Biosystems, Foster City, CA, USA).  Gene-specific primers 
and were obtained from Applied Biosystems Inventoried Assays and used according 
to the instructions supplied by the manufacturer.  Genes were selected for 
confirmation based on their functional relevance within significantly-identified 
pathways affected by ethanol treatment, as identified during functional clustering 
and pathway bioinformatic analyses, and are listed in Table 2.1.   All reactions were 
multiplexed with Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) (long-term 
genes) or Actin, beta (Actb) (short-term genes) as internal controls.  Target gene-
specific probes were labeled with a 5’ 6-carboxyfluorescein (FAM) fluorophore and a 
3’ tetramethylrhodamine (TAMRA) quencher.   Control gene probes were labeled 
with a 5’ VIC fluorophore and a 3’ TAMRA quencher.  Reactions were performed using 
a standard ramp speed protocol using 10 µl volumes of cDNA.  PCR cycling consisted 
of an initial denaturing at 95°C for 10 min, followed by 40 cycles of a 15 sec 95°C 
denaturation stage and an anneal and extension at 60°C for 60 seconds.  Three 
biological replicates per treatment group and three technical replicates per sample 
were used (total N=6).  Relative expression was calculated according to the 
comparative CT method (SCHMITTGEN and LIVAK 2008) using StepOne™ v.2.0 software 
(Applied Biosystems).  Significant differences were assessed using a two -tailed 
student’s t-test, assessed using SPSS v.16 (SPSS Inc., Chicago, IL, USA).   
 
 
 
 
 
Chapter 2.  Materials and Methods 
 
48 
  
 
 
Table 2.1.   Genes selected for mRNA level confirmation by quantitative RT-
PCR 
Treatment group 
Gene 
symbol 
Gene name 
Reference 
gene* 
P7 (short term) Dusp1 dual specificity phophatase 1 Actb 
 Jun jun proto-oncogene Actb 
 Nr4a1 
nuclear receptor subfamily 4, 
group A, member 1 
Actb 
 Pomc pro-opiomelanocortin-alpha Actb 
P4+7 (long term) Cnr1 cannabinoid receptor 1 (brain) Gapdh 
 Grin2b 
glutamate receptor, ionotropic, 
NMDA2B (epsilon 2) 
Gapdh 
 Htr5b 
5-hydroxytryptamine (serotonin) 
receptor 5B 
Gapdh 
 Pomc pro-opiomelanocortin-alpha Gapdh 
 miR-26b microRNA 26b Actb 
 
*Reference genes used for qRT-PCR:  Actb:  Actin, beta; Gapdh: Glyceraldehyde-3-
phosphate dehydrogenase 
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2.5 Analysis of microRNA alterations in the adult brain  
2.5.1 miRNA array hybridization 
To evaluate changes to miRNA levels in the adult brain of mice exposed to ethanol 
during synaptogenesis, whole brain RNA samples isolated from young adult (P60) 
mice were evaluated for genome-wide microRNA (miRNA) expression differences 
using Affymetrix miRNA 2.0 arrays (Affymetrix, Santa Clara, CA, USA).  Similarly to 
the mRNA expression arrays, a total of four arrays – two control and two ethanol-
treated – were used.  Each biological replicate consisted of pooled whole-brain RNA 
samples from three P60 non-littermate male mice (total N=12 mice).  The 
experimental design was balanced for litter, with an ethanol-treated male matched 
for weight and litter with each control male.  All labeling and hybridization steps were 
performed at the London Regional Genomics Center (Robarts Research Institute, 
London, ON, CA).  One µg of total brain RNA from each  replicate was labeled using 
the Flash Tag Biotin HSR kit (Genisphere, Hatfield, PA, USA) and hybridized to 
Affymetrix miRNA 2.0 arrays (Affymetrix, Santa Clara, CA, USA) for 16 hours at 45°C.  
All liquid-handling steps were performed using a GeneChip® Fluidics Station 450 and 
arrays were scanned using the GeneChip® Scanner 3000 using Command Console 
v.1.1 (Affymetrix).   The expression data generated from the miRNA arrays were 
deposited to the NCBI Gene Expression Omnibus database and are accessible under 
the accession GSE 34413.   
 
2.5.2 miRNA array analysis and mRNA target filtering 
Probe-level (.CEL) data were imported into Partek Genomics Suite software v.6.6 
(Partek Inc., St. Louis, MO, USA) for summarization to miRNA expression data and 
quality-control analyses.   Differential miRNA expression was evaluated using a one -
way ANOVA with treatment as the between-subjects factor.  The miRNA genes 
identified by this analysis were filtered using a 1.2-fold change and a FDR-corrected 
p-value of 0.05.  The complete miRNA list is shown in Appendix C.   This list was 
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imported concurrently with the long-term mRNA gene list results into Ingenuity® 
Pathway Analysis software (Ingenuity Systems, Redwood, CA, USA, 
www.ingenuity.com) and analyzed using the microRNA Target Filter subprogram to 
develop a list of potential regulatory interactions between altered mRNA and miRNA 
transcripts.  Results were further filtered based on brain-specific gene expression and 
an inverse miRNA to target mRNA expression relationship.  The subsequent miRNA-
mRNA transcript list meeting these criteria was evaluated using Ingenuity® Pathway 
Analyses for biological function and pathway associations.  
 
2.5.3 miRNA expression confirmation by quantitative RT-PCR 
Whole brain RNA samples not used for array hybridization were used to confirm the 
expression of miRNA mmu-miR-26b using quantitative reverse-transcription PCR 
(qRT-PCR).   The altered expression of the putative target of this miRNA, Cannabinoid 
receptor 1 (brain) (Cnr1), was also confirmed using qRT-PCR.  Two µg  of whole brain 
RNA was used in reverse-transcription reactions using the TaqMan® Small RNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA), which includes 
hairpin stem-loop primers for only one specific non-coding RNA.   Small nucleolar 
RNA 202 (snoRNA 202) was used as an endogenous control (BRATTELID et al. 2011) 
and it was not identified as differentially expressed between control and ethanol-
treated by the miRNA array experiments.  Reverse transcription was performed in a 
StepOne™ Real Time PCR System (Applied Biosystems) according to the protocol 
outlined by the reverse transcription kit.  Non-coding RNA (ncRNA)-specific primers 
and FAM-labeled TaqMan® probes were selected using the Applied Biosystems 
search engine to identify gene-specific TaqMan® ncRNA assays.  PCR reactions were 
conducted using TaqMan® Small RNA Assay products on a StepOne™ Real Time PCR 
System (Applied Biosystems).  Reactions for each target ncRNA were run in separate 
reaction tubes but using the same PCR master mix and assessed within the same PCR 
plate.  Six biological replicates were used for each ncRNA-of-interest, and three 
technical replicates were included per biological replicate.  Reactions were run 
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following the recommended ramp protocol: an initial 2 min hold at 50°C, a 10 min 
enzyme activation hold at 95°C, and 40 cycles of a 15 sec denature at 95°C and a 60 
sec anneal/extend period at 60°C.  Relative expression was determined using the 
comparative CT method (SCHMITTGEN and LIVAK 2008) using StepOne™ v.2.0 software 
(Applied Biosystems) and Excel (Microsoft 2007).  All qRT-PCR data are described as 
mean ± standard error of the mean relative expression values.  Significant differences 
were assessed using a two-tailed student’s t-test, assessed using SPSS v.16 (SPSS Inc., 
Chicago, IL, USA).   
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FIGURE 2.5.  Experimental design overview.   
Important treatment or testing days are outlined and indicated as the 
postnatal day of age of the pup (P).  
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Chapter 3 
RESULTS 
 
 
 
3.1 Effect of ethanol exposure during synaptogenesis on FASD-
relevant behaviours 
The effect of ethanol exposure during synaptogenesis on behavioural phenotypes 
were measured from time of treatment extending into early adulthood (P60).  Early 
postnatal characteristics such as weight and the achievement of tasks designed to test 
the acquisition of neuromuscular coordination were performed given that these 
features are affected in infants with FASD.  As the pups matured, they were then 
tested for other FASD-relevant behavioural characteristics such as hyperactivity, 
anxiety-related traits, and learning and memory impairments.  The results from these 
analyses are outlined in the following sections.   
 
3.1.1 Postnatal weight  
Mice treated with ethanol at P4, P7, or P4+7 were assessed for differences in weight 
during postnatal growth and into early adulthood.  Weight graphs of each treatment 
group stratified by sex are shown in Figure 3.1.   Analysis using repeated-measures 
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univariate ANOVA (RM-ANOVA) revealed a significant interaction between postnatal 
day and sex, as expected, for both the single-treatment groups (P4, F11, 30 = 23.23, p < 
0.001; P7, F11, 27 = 20.97, p < 0.001), but no interaction between treatment, sex, or day 
of testing was detected.  A significant interaction between postnatal day and sex (F 11, 
29 = 35.30, p < 0.001) and between postnatal day and treatment (F 11, 29 = 3.27, p = 
0.005) was detected for the P4+7 treatment group, with both males and females 
showing a trend to be underweight as compared to littermate controls of the same 
sex (Figure 3.1).  This difference was most prominent in juveniles and adolescents 
(P10 to P35) and was not maintained into early adulthood (P56 to P70).   
 
3.1.2 Delayed achievement of early postnatal developmental milestones  
Mice treated with ethanol at P4, P7, and P4+7 were assessed during early postnatal 
development for reflexes, strength, coordination, and the appearance of early 
neurobehavioural developmental milestones.  Multivariate ANOVA (MANOVA) 
analysis of only the control (saline-treated) mice from all treatment groups showed 
no overall significant effect of sex (F10, 49 = 0.679, p = 0.738) or day of treatment (F20, 
98 = 0.269, p = 0.999), as well as no interaction between the two (F 20, 98 = 0.865, p = 
0.993) suggesting consistency between the control groups.  A number of differences 
were identified by analysis of developmental milestone achievement between control 
and ethanol-treated groups (Table 3.1).  Generally, ethanol exposure resulted in the 
delay of achievement of many of the developmental milestones tested.  MANOVA 
analysis using sex and treatment as fixed factors of the P4 treatment group showed 
an overall significant effect of treatment (F10, 32 = 6.71, p < 0.001).  Pups treated with 
ethanol at P4 showed delayed ability to right themselves when placed on their back 
(surface righting) (F1, 41 = 6.38, p = 0.022), delayed ability to grasp a metal rod using 
their forelimbs and support their weight for greater than one second (forelimb grasp) 
(F1,41 = 7.66, p = 0.011), delayed ear twitch reflex (F1, 41 = 2.77, p = 0.015), delayed 
extinguishing of pivoting behaviour (open field traversal) in 30 s (F 1, 41 = 15.09, p = 
0.017) and in 15 s (F1, 41 = 45.45, p < 0.001), delayed eye opening (F1, 41 = 2.77, p =  
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FIGURE 3.1.   Weight graphs for mice treated with ethanol during the trimester three-
equivalent and matched littermate controls. Mice were treated with ethanol in saline 
or saline alone (control) at postnatal day 4 (P4), 7 (P7) or 4 and 7 (P4+7).  Data is 
presented as the mean of each group at select postnatal days ((n = 8 – 12 mice per group) 
and is stratified by sex.  Significant effect of treatment: *, p < 0.05; **, p < 0.01, ***, p < 
0.001. 
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0.034), and delayed ability to right themselves in the air (air righting) (F 1, 41 = 39.98, 
p < 0.001).  Similar analysis of the P7 treatment group as compared to their respective 
saline-treated controls showed an overall significant effect of treatment (F 19, 28 = 5.48, 
p < 0.001), but no significant effect of sex or interaction between sex and treatment.  
Mice treated with ethanol at P7 showed delays in their ability to extinguish pivoting 
behaviour and traverse and open field in 30 s (F 1, 37 = 16.12, p = 0.005) and in 15 s (F1, 
37 = 51.60, p < 0.001), as well as a delayed ability to right themselves in the air when 
dropped (air righting) (F1, 37 = 68.69, p < 0.001).  Finally, a MANOVA revealed a 
significant overall effect of treatment in mice treated with ethanol on P4+7 (F10, 30 = 
12.33, p < 0.001), with ethanol-treated mice showing a significant delay in milestone 
achievement.  No significant effect of sex or interaction between sex and treatment 
were detected.  Specifically, a significant effect of treatment was observed for the 
ability for an ethanol-treated pup to right itself when placed on its back (surface 
righting) (F1, 39 = 10.07, p = 0.007), appearance of an acoustic startle reflex (F1, 39 = 
7.16, p = 0.004), appearance of an ear twitch reflex (F1, 39 = 4.03, p = 0.016), ability to 
grasp an object and support its own weight for more than 1 s (forelimb grasp) (F 1, 39 
= 9.22, p = 0.004), achieve open field traversal in less than 30 s (F1, 39 = 22.01, p < 
0.001) or 15 s (F1, 39 = 66.47, p < 0.001), achieve eye opening (F1,39 = 5.40, p = 0.001), 
and achieve the ability to right in the air when dropped from a small distance (air 
righting) (F1, 39 = 109.56, p < 0.001). 
In general, pups exposed to alcohol experienced a delay in the ability to ach ieve 
developmental milestones. The P4 ethanol-treated group experienced delays in 
behaviours that perhaps required more motor control, such as surface righting, 
forelimb grasp, extinguishment of pivoting behaviour (open field traversal), and air 
righting.  The P7-treated group showed some delays, but they were limited to 
behaviours that required (arguably) substantially more neuromuscular coordination 
and perhaps reflected delays in later-appearing milestones.  Mice treated at P4+7 
showed significant delays in the greatest number of tested behaviours (8/10), though 
the behaviours affected were consistent with the other single-treatment groups.   
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TABLE 3.1.  Postnatal day of achievement of developmental milestone behaviours in control and ethanol-treated mice. 
 
 
Chapter 3.  Results 
 
58 
  
3.1.3 Ethanol exposure alters juvenile locomotor behaviour  
3.1.3.1 Changes to activity in a novel open-field arena are dependent on 
treatment day 
The activity of mice treated with ethanol at P4, P7, or P4+7 in an open-field arena was 
assessed as a measure of novelty-induced exploration (Figure 3.2).  ANOVA analysis 
including only the control groups from all treatment paradigms detected a significant 
effect of sex, with control males generally exhibiting less infrared beam-breaks than 
control females across treatment groups (F1, 54 = 6.88, p = 0.01).   No effect of 
treatment day (F2, 54 = 1.62, p = 0.21) nor an interaction between sex and treatment 
day (F2, 54 = 1.07, p = 0.35) was detected, suggesting consistency between the control 
groups.   
No significant difference in locomotor activity levels (all p ≥ 0.124) or rearing 
frequency (all p ≥ 0.128) was detected between control and ethanol-treated mice 
within the P4 treatment group.   Similarly, within the group treated on P7, no 
significant effect of ethanol treatment on activity was observed.   A signif icant effect 
of treatment (F1,37 = 14.77, p < 0.001) on rearing frequency, however, was detected, 
with both male and female ethanol-treated mice displaying more vertical rears (total 
mean = 156.67 ± 7.79) than saline-treated controls (total mean = 117.40 ± 6.56).  
Within the P4+7 treatment group, an interesting interaction between treatment and 
sex was observed (F1,38 = 5.05, p = 0.031) with female ethanol-treated mice displaying 
less activity (mean = 2650 ± 106) than control females (mean = 3180 ± 135).  A  main 
effect of ethanol treatment on rearing behaviour was also observed (F 1,38 = 4.13, p = 
0.049), driven by the increased rearing activity of ethanol-treated females (mean = 
170.46 ± 8.74) as compared to controls  (mean = 126.42 ± 10.64).   
 
3.1.3.2 Ethanol exposure induces nocturnal home cage hyperactivity 
To further evaluate effects of trimester three-equivalent ethanol exposure on 
locomotor activity levels as well as an indicator of possible alterations to Circadian  
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FIGURE 3.2.  Open field activity of adolescent mice treated with ethanol during the trimester three-equivalent.   Treatment day 
(P4, P7, or P4+7) is indicated above the appropriate bar graphs showing average infrared beam breaks (A) and rearing frequency (B) 
of control and ethanol-treated male and female mice within a 15 min period.  Data are presented as mean ± SEM (n = 8 – 12 mice per 
group).  Significance is indicated: *, p < 0.05;  **p < 0.01. 
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rhythm, adolescent mice were assessed for nocturnal activity in a familiar, home cage 
environment.   Due to the number of different measurements recorded by the 
Actimeter system, a correlation matrix principal components analysis (PCA) was 
conducted using the control data from each of the three treatment groups (P4, P7, and 
P4+7) to see if the measurements were correlated with one another and a single 
measure could accurately reflect the overall activity data trends.  Measures included 
in PCA analysis were overall activity (total number of infrared beam breaks), 
locomotion (horizontal non-repetitive beam breaks), mean velocity, distance 
traveled, and vertical rearing.  Bartlett’s test of sphericity indicated that the dataset 
was significantly collinear and that factor analysis could be performed (χ2 = 474.22, 
df = 10, p < 0.001).  Also, Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy 
showed that the degree of common correlation between the variables was strong 
(KMO = 0.622), indicating that the factors extracted by data reduction would account 
for a substantial amount of variance in the data.  The eigenvalues associated with each 
extracted component determined that 90.10% of the variance in the data could be 
explained by two components (Table 3.2, Figure 3.3) and that all measures were 
positively correlated (Table 3.3).  The component matrix indicated that two main 
extracted components were driven primarily by a significant correlation between 
total activity, locomotion, mean velocity, and distance travelled (component 1) and 
number of rears (component 2) (Table 3.3).  Given that overall activity (total number 
of beam breaks) was significantly correlated with each of the other four measures 
(Table 3.3), hourly activity was used as the measure of home cage activity in all 
subsequent analyses.   
Univariate ANOVA analysis of total nocturnal activity across the three control groups 
from each treatment paradigm indicated no overall significant effect of sex (F 1,50 = 
0.184, p = 0.670), day of saline treatment (F2,50 = 1.835, p = 0.170), or an interaction 
between the two (F2,50 = 0.199, p = 0.821), suggesting statistical consistency across 
control groups.   Given that nocturnal activity of mice varies considerably from hour 
to hour (TANG et al. 2002), activity was measured in 12 one-hour bins from 19:00h to 
07:00h rather than one 12-hour period.   
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TABLE 3.2.  Total variance explained by each extracted correlation matrix PCA  
component for measures of home cage locomotor activity.   
 
 
 
 
 
 
 
 
 
 
 
 
  Initial Eigenvalues 
Component Total % of Variance Cumulative % 
1 3.404 68.083 68.083 
2 1.101 22.022 90.105 
3 0.475 9.505 99.610 
4 0.015 0.300 99.910 
5 0.004 0.089 100.000 
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FIGURE 3.3.  Scree plot showing the total amount of variance 
(eigenvalue) in the home cage activity dataset measures that can be 
accounted for by each component extracted by a correlation matrix 
PCA.  Five indicators of locomotor activity were used in the analysis 
(N=56). 
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TABLE 3.3.  Correlation matrix showing the relationship between five indicators of home cage locomotor activity (N=56).  
 
    total 
activity 
locomotor 
activity 
mean 
velocity 
distance 
travelled 
number of 
rears 
total activity 
Pearson 
correlation 
1.000 0.990 0.666 0.638 0.491 
  Significance (p) - < 0.001 < 0.001 < 0.001 < 0.001 
locomotor 
activity 
Pearson 
correlation 
0.990 1.000 0.588 0.563 0.500 
  Significance (p) < 0.001 - < 0.001 < 0.001 < 0.001 
mean velocity 
Pearson 
correlation 
0.666 0.588 1.000 0.985 0.166 
  Significance (p) < 0.001 < 0.001 - < 0.001 0.110 
distance 
travelled 
Pearson 
correlation 
0.638 0.563 0.985 1.000 0.176 
  Significance (p) < 0.001 < 0.001 < 0.001 - 0.097 
number of rears 
Pearson 
correlation 
0.491 0.500 0.166 0.176 1.000 
  Significance (p) < 0.001 < 0.001 0.110 0.097 - 
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Repeated-measures ANOVA (RM-ANOVA) of the P4 ethanol treatment group and 
controls using “hour” as the within-subjects factor and sex and treatment as between-
subjects factors indicated a significant effect of “hour” on activity, as expected (F 11,24 
= 33.06, p < 0.001) (Figure 3.4). However, ethanol treatment at P4 did not significantly 
affect activity levels in the home cage envinronment, and no significant interaction 
between hour and sex, hour and treatment, or hour and sex and treatment was 
detected. 
Analysis of home cage nocturnal activity in male and female mice treated with ethanol 
at P7 indicated that ethanol treatment at P7 significantly increased nocturnal home 
cage activity.  The data show a trend for female mice show a more pronounced 
increase in activity, and this difference was evident primarily from 21:00h to 01:00h.  
There also seemed to be a trend for increased activity towards the end dark phase 
and beginning of the light phase of the light/dark cycle.  Where control animals 
showed a marked reduction in activity from 06:00h to 07:00h (mean = 1596.7 ± 
159.76 beam breaks per hour), the ethanol-treated mice remained significantly more 
active (mean = 5833.9 ± 608.14 beam breaks per hour). RM-ANOVA indicated a 
significant effect of hour on activity (F11,21 = 44.29, p < 0.001) and a significant 
interaction between hour and treatment (F11, 21 = 18.11, p < 0.001) (Figure 3.5).  No 
significant interaction between hour and sex (F 11,21 = 1.81, p = 0.12) was observed.  
Interestingly, however, a significant interaction between hour and sex and treatment 
(F11,21 = 4.10, p = 0.003) on activity levels was observed.   
Lastly, RM-ANOVA was performed on the activity levels of the group treated at P4+7 
(Figure 3.6).   Again, a significant effect of hour on activity was observed (F 11,29 = 
63.79, p < 0.001), as well as an interaction between hour and treatment (F 11,29 = 7.38, 
p < 0.001), with ethanol-treated animals showing an increase in activity as compared 
to controls.  No interaction between hour and sex or hour, sex, and treatment was 
observed.  The pattern of increased activity was similar to the P7 treatment paradigm, 
with much of the increase in activity towards the latter hours of the dark phase,  
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FIGURE 3.4.  Locomotor activity of mice treated with ethanol at P4 in a familiar home 
cage environment.   Data shown represent the mean (± SEM) infrared beam breaks by 
ethanol-exposed and control males (A) and females (B) over a 12-hour period during the 
dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the light/dark 
cycle (n= 8-11 mice per group). No significant differences between control or ethanol-
treated male or females were detected. 
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FIGURE 3.5.  Locomotor activity of mice treated with ethanol on P7 in a familiar home 
cage environment.   Data shown represent the mean (± SEM) infrared beam breaks by 
ethanol-exposed and control males (A) and females (B) over a 12-hour period during the 
dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the light/dark 
cycle (n= 7-10 mice per group). *, p < 0.05; **, p < 0.01. 
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FIGURE 3.6.  Locomotor activity of mice treated with ethanol on P4 and P7 in a familiar 
home cage environment.   Data shown represent the mean (± SEM) infrared beam breaks 
by ethanol-exposed and control males (A) and females (B) over a 12-hour period during 
the dark phase (20:00h to 06:00h) and the last and first hour of the light phase of the 
light/dark cycle (n= 9-12 mice per group). *, p < 0.05; **, p < 0.01. 
Chapter 3.  Results 
 
68 
  
occurring between 21:00h and 02:00h.  Also, similar to the P7 treatment group, there 
was an increase in activity towards the latter hours of the dark phase and, 
particularly, during the first hour of the light phase of the light/dark cycle (06:00h to 
07:00h control mean = 1183.82 ± 178.23, ethanol mean = 4080.25 ± 340.88 beam 
breaks).   
 
3.1.4 Ethanol exposure increases anxiety-related traits in adolescent mice 
3.1.4.1 Increased open field thigmotaxis is dependent on treatment day  
Decreased tendency to explore the inner area of a novel open field arena was used as 
an indicator of increased thigmotaxis as an anxiety-related behaviour.  Univariate 
ANOVA analysis of only the control groups for time spent in the centre zone, latency 
to enter the center zone, and number of entries into the centre zone using “sex” and 
“day of treatment” as between-subjects factors indicated no significant effect of 
treatment day (P4, P7, or P4+7) between control groups.  A significant effect of sex 
was detected for amount of time spent in the centre zone (F 1,54 = 4.39, p = 0.04) and 
latency to enter the centre zone (F1,54 = 5,75, p = 0.02), with female mice (mean = 
58.20 ± 3.70 seconds) spending less time in the centre than males (mean = 71.39 ± 
4.82 seconds) as well as an increased latency to enter the centre zone (female mean 
= 102.71 ± 10.74 seconds, male mean = 72.79 ± 7.02 seconds).  Female mice also 
showed a fewer number of entries into the centre zone (mean = 31.62 ± 2.44) as 
compared to male mice (mean = 37.42 ± 2.38) but this trend did not reach significance 
(F1,54 = 2.64, p = 0.11). 
Analysis of thigmotaxis measures in adolescent control and ethanol-exposed mice 
treated at P4 showed no significant effect of treatment or interaction between sex and 
treatment were observed for any measures.   Mice treated with ethanol at P7 showed 
a trend for females towards increased thigmotaxic behaviours, but also detected 
some significant effects of ethanol treatment (Figure 3.8).  ANOVA analysis of time 
spend in the centre showed a significant effect of sex (F 1,37 = 7.31, p = 0.010) and a 
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significant effect of treatment (F1,37 = 6..25, p = 0.017), with ethanol-treated males and 
females showing a decreased amount of time in the centre zone.  Effects of treatment 
on latency to enter the centre zone (F1,28 = 5.70, p = 0.022) and number of entries into 
the centre zone (F1,38 = 4.42, p = 0.042) were both detected, with ethanol-treated mice 
showing an increased latency to enter the centre and a reduction in the number of 
times each explored the centre zone as compared to their control littermates (Figure 
3.8).   No significant interaction between sex and treatment for any measures were 
detected.  Analysis of the P4+7 treatment group showed the most pronounced effect 
of ethanol treatment on anxiety-related measures (Figure 3.9).  Ethanol-treated mice 
spend less time within the centre zone (F1,38 = 5.86, p = 0.020), and increased latency 
to enter the centre zone (F1,38 = 5.70, p = 0.022), and a decreased number of entries 
into the centre (F1,38 = 4.42, p = 0.42).  No significant interaction between sex and 
treatment was detected for any measures within the P4+7 treatment group.   
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FIGURE 3.7.  Anxiety-related behaviours in a novel open field arena in mice treated at P4 with ethanol.   Data shown represent 
the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number of entries 
into the centre zone, stratified by sex (n = 8-11 mice per group).  No effect of treatment was detected for any measure.   
 
A. B. C. 
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FIGURE 3.8.  Anxiety-related behaviours in a novel open field arena in mice treated at P7 with ethanol.   Data shown represent 
the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number of entries 
into the centre zone, stratified by sex (n = 7-10 mice per group). *, p < 0.05; **, p < 0.01. 
 
A. B. C. 
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FIGURE 3.9.  Anxiety-related behaviours in a novel open field arena in mice treated at P4 and P7 with ethanol.   Data shown 
represent the mean (± SEM) (A) time spent in the centre zone of the open field arena, (B) latency to enter the centre, and (C) Number 
of entries into the centre zone within a 15 min testing period, stratified by sex (n = 9-12 mice per group). *, p < 0.05; **, p < 0.01. 
 
A. B. C. 
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3.1.4.2 Ethanol exposure results in sex-specific anxiety-related behaviour in 
the light/dark box and elevated plus maze 
Given the subtlety of the increased anxiety-related traits exhibited by ethanol-treated 
mice in the open field test and the availability of other assays, the P4+7 treatment 
group was also tested in two other assays designed to assess anxiety-related 
phenotypes: the light/dark box and the elevated plus maze.  For the light/dark box 
test, univariate ANOVAs of the P4+7 group using “sex” and “treatment” as between-
subjects factor were performed on the time spent in the light section of the apparatus 
and number of entries into the light  section as a measure of movement between the 
light and dark regions.  Results indicated a significant interaction between sex and 
treatment (F1,39 = 5.13, p = 0.029), with both ethanol treated males and females 
showing a reduced amount of time spent in the light as compared to controls (Figure 
3.10A).  This interaction was driven by the significant decrease observed in female 
ethanol-treated mice, which, while this also appeared as a trend in ethanol-treated 
males, did not reach significance.  Analysis of the number of entries into the light 
region indicated significant main effects of both sex (F 1,39 = 5.50, p = 0.024) and 
treatment (F1,39 = 12.86, p = 0.001).  Female mice tended to be less explorative of the 
light/dark box and move less between light and dark regions than males, and ethanol 
treatment appeared to reduce movement between the light and dark regions further 
in both sexes (Figure 3.10B).   
The results from the light/dark box were consistent with those from the elevated plus 
maze, indicating an increase in anxiety-related phenotypes resulting from ethanol 
exposure that was more pronounced in females.    Significant main effects of sex (F1,39 
= 11.93, p = 0.001) and treatment (F1,39 = 22.88, p < 0.001) were detected by ANOVA 
analysis of time spent in the open arms, with ethanol-treated mice (mean = 50.20 ± 
5.43 s) spending less time in the open arms than controls (mean = 78.73 ± 3.49 s).  
Similar main effects of sex (F1,39 = 6.44, p =  0.015) and treatment (F1,39 = 13.17, p = 
0.001) were found for the number of entries into the open arms, again with ethanol-
treated mice showing a reduction in the number of transitions (mean = 5.90 ± 0.61) 
as compared to controls (mean = 8.73 ± 0.50). 
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FIGURE 3.10.  Light/dark box assay of anxiety-related phenotypes.  Mice treated with 
ethanol or saline (control) at P4+7 were tested over a 5 min period for (A) time spent in 
the light region and (B) number of entries into the light region.  Data presented represent 
mean ± SEM (n = 9-12 mice per group).  **, p < 0.01; ***, p < 0.001. 
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FIGURE 3.11.  Elevated plus maze assay of anxiety-related phenotypes.  Mice treated 
with ethanol or saline (control) at P4+7 were tested over a 5 min period for (A) time 
spent in open arms and (B) number of entries into open arms.  Data presented represent 
mean ± SEM (n = 9-12 mice per group).  *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
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3.1.5 Ethanol exposure results in deficits in spatial learning and memory  
Mice treated at P4, P7 or P4+7 with ethanol or saline were assessed for learning 
deficits in a mouse-oriented spatial learning task, the Barnes maze.  The primary 
measure of learning used was latency to reach the target (a measure of escape time), 
though search strategy used to find the escape target was also analyzed for the four 
acquisition (learning) days.  Short and long-term recall memory were assessed using 
number of explorations to each hole when the location of the “escape” hole was 
blocked.  It should be noted that due to the variance differences between latency 
measures depending on day of testing, latency measures were natural-log (ln)-
transformed prior to analyses to improve the homoscedasticity of the data to meet 
the assumptions of general linear models.  Following transformation, Box’s M test of 
homogeneity of covariance matrices and Mauchly’s sphericity test indicated that the 
within-group covariance matrices of the latency data was not significantly different 
(p values > 0.05) and that a RM-ANOVA could be applied appropriately.   
 
3.1.5.1 Spatial acquisition is impaired by ethanol exposure 
First, the control groups from each treatment paradigm were compared to ensure 
consistency between latency measures.  Escape latencies for the control groups 
ranged from 77.39 ± 4.86 to 72.15 ± 6.68 seconds on the first learning day to 8.34 ± 
0.73 to 7.85 ± 0.62 seconds (mean ± SEM) on the last training day (day 4).  Repeated-
measures ANOVA of ln-transformed latency to reach the target hole using “sex” and 
“treatment day” (or “acquisition day”) as the between-subjects factors and “day of 
testing” as the within-subjects factor showed a significant effect of testing day, as 
expected (F3,171 = 678.97, p < 0.001).  No significant interaction between testing day 
and sex (F3,171 = 0.423, p = 0.737), interaction between testing day and day of 
treatment (F3,171 = 0.385, p = 0.888), or interaction between testing day, sex, and 
treatment day (F3,171 = 0.503, p = 0.806) on latency to reach the target were detected 
for the control groups.  This suggested consistency between the control groups of 
each treatment paradigm.    
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Latency to reach the escape hole in control and experimental mice treated at P4 were 
assessed using a repeated-measures ANOVA using “sex” and “treatment” as between-
subjects factors and “day of testing” as the within-subjects factor.  Mean escape 
latencies of control and ethanol-treated mice across the four acquisition trial days are 
shown in Figure 3.12A.  Analysis indicated a significant effect of day of testing (F 3,117 
= 389.37, p < 0.001), as expected, as well as a significant interaction between day of 
testing and treatment (F3,117 = 6.84, p < 0.001).  No interaction between sex and day 
of testing or sex, treatment, and day of testing was detected.  Post-hoc univariate 
ANOVA analyses were conducted with the a priori intention of comparing the control 
and treatment group not stratified by sex (which was not indicated as significant by 
the RM-ANOVA) at each particular testing day rather than performing a full set of 
pairwise contrasts.  These tests revealed that ethanol exposure at P4 resulted in a 
significant increase in Barnes maze escape latency in young adult mice on acquisition 
testing day 3 (F1,41 = 15.17, p < 0.001) and testing day 4 (F1,41 = 24.74, p < 0.001).  
A similar approach was used to assess the escape latencies of mice treated with 
ethanol or saline at P7.  Mean escape latencies of P7-treated control and ethanol-
exposed mice across the four acquisition trial days are shown in Figure 3.12B.  A 
significant effect of testing day was detected (F3,114 = 313.24, p < 0.001), as well as a 
significant interaction between treatment and testing day (F 3,144 = 4.74, p = 0.004).  
No significant interactions between sex and day of testing and sex, treatment, and day 
of testing were indicated.  Post-hoc univariate ANOVA analyses indicated that ethanol 
treatment on P7 delayed the the latency to reach the target on acquisition day 2 (F 1,41 
= 8.10, p = 0.007), day 3 (F1,41 = 20.37, p < 0.001) and day 4 (F1,41 = 55.11, p < 0.001).   
Analysis of the latency to escape of mice treated with ethanol at both P4+7 indicated 
a more pronounced delay to reach the target than the ethanol-treated mice of the 
single-day P4 or P7 treatment groups (Figure 3.12C).   RM-ANOVA of the ln-
transformed latencies to reach the target indicated a significant effect of acquisition 
testing day (F3,117 = 270.29, p < 0.001) and a significant interaction between testing 
day and treatment (F3,117 = 10.12, p < 0.001).  No other interactions between factors 
were significant.  Post-hoc univariate ANOVAs indicated that ethanol-treated mice 
Chapter 3.  Results 
 
78 
  
showed delays in reaching the target on acquisition day 2 (F 1, 41 = 15.44, p < 0.001), 
day 3 (F1,41 = 47.51, p < 0.001), and day 4 (F1,41 = 41.20, p < 0.001).  While control 
animals tended to reach the target more quickly than ethanol-treated mice on the 
later trials of acquisition day 1, the average between the two groups across all four 
trials on the first day of testing did not significantly differ (F 1,41 = 3.60, p = 0.065). 
 
3.1.5.2 Ethanol exposure alters learning strategy 
The effect of trimester three-equivalent ethanol exposure on acquisition learning was 
also evaluated using the search strategy used to find the target hole during the Barnes 
maze trials.  Each trial (four per acquisition day) was scored for one of three search 
strategies: direct, serial, or mixed.  The total number of trials using each strategy in 
both control and ethanol-treated mice was evaluated using a chi-squared test to 
determine if learning strategy was associated with treatment.  Percentage of trials 
using each learning strategy for control and ethanol-treated mice is shown in Figure 
3.13.  Generally, mice treated with ethanol at P4, P7, or P4+7 showed a reduced 
tendency to use a direct search strategy as compared to contro ls.  Ethanol treatment 
resulted in a prolonged use of a mixed strategy through acquisition training and 
increased use of a serial strategy towards the end of training.  Mice treated at P4 
showed a significant association between treatment and learning stra tegy on 
acquisition testing day 3 (χ2 = 7.35, df = 5, p = 0.03) and day 4 (χ2 = 11.00, df = 5, p = 
0.004).  This trend held consistent for mice treated at P7, again with a significant 
association between search strategy used and treatment at testing day 3 (χ2 = 7.38, df 
= 5, p = 0.02) and day 4 (χ2 = 15.08, df = 5, p < 0.001).  Significant associations between 
treatment and search strategy was detected in the P4 and P7-treated group at testing 
day 1 (χ2 = 6.20, df = 5, p = 0.045), day 3 (χ2 = 18.86, df = 5, p < 0.001) and day 4 (χ2 = 
30.82, df = 5, p < 0.001).   
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FIGURE 3.12.  Latency to escape in the Barnes maze task for spatial learning.  The mean (±SEM) time (seconds) to reach the target for 
mice treated with saline (control) or ethanol at P4 (A), P7 (B), or P4 and P7 (C).  Data represent the average of four trials per day of each 
animal across four consecutive acquisition (learning) days.  Data shown are collapsed across sex (n = 20-23 per group).  *, p < 0.01;  **, p 
< 0.001. 
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FIGURE 3.13.  Type of search strategy used to locate the escape in the Barnes maze task.  
Data represent the percentage of trials mice treated with saline (control) or ethanol at P4, 
P7, or P4 and P7 (P4+7) used a direct, serial, or mixed search strategy on each acquisition 
(testing) day.  Data shown are collapsed across sex (n = 20-23 per group).  
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3.1.5.3 Short and long-term recall memory are impaired by ethanol exposure  
Following the acquisition learning phase of the Barnes maze testing, each mouse was  
tested for their ability to recall the location of the escape when all holes were closed.  
This was accomplished by assessing the number of explorations to each hole during 
a one minute testing period at testing day 5 (short-term recall memory) and day 12 
(long-term recall memory).   
Multivariate ANOVA analysis of the number of explorations to each hole using only 
the control mice from all treatment groups (saline exposure at P4, P7, and P4+7) at 
day 5 indicated no significant main effect of sex (F20,37 = 1.18, p = 0.324), treatment 
day (F40,76 = 1.09, p = 0.367) or interaction between the two (F40,76 = 0.77, p = 0.812), 
indicating consistency between the control groups.  Also, no significant difference 
was detected in the total number of explorations between each group (mean = 37.64 
± 1.76 to 41.55 ± 2.05), including no main effect of sex (F 1,56 = 1.18, p = 0.282), 
treatment day (F2,56 = 1.23, p = 0.301) or interaction between sex and treatment day 
(F2,56 = 1.17, p = 0.318).    
Analysis of mice treated at P4 with ethanol or saline revealed a trend for the ethanol-
treated mice to exhibit less explorations to the target and surrounding holes, but this 
trend did not reach significance (Figure 3.14A).  No main effect of sex or interaction 
between sex and treatment was detected (p > 0.05).   No significant difference in total 
number of explorations between control and ethanol-treated animals was detected 
(F1,39 = 0.20, p = 0.654).  Conversely, multivariate analysis of mice treated at P7 
indicated a significant effect of treatment (F20,18 = 2.50, p = 0.028), with ethanol-
treated mice showing significantly less explorations to the target (mean = 2.95 ± 0.24 
explorations) than controls (mean = 5.12 ± 0.23) and more explorations to holes 
opposite to the target (Figure 3.14B).  No significant effect of sex or interaction 
between sex and treatment was detected.  Further, no significant difference in 
number of explorations between sexes or between treatment groups was detected (p 
> 0.05).  Ethanol treatment at P4+7 resulted in a pronounced difference between 
control and ethanol-treated groups, with a significant main effect of treatment (F 20,20 
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= 3.57, p = 0.003) detected.  Control mice showed more explorations to the target 
(mean = 6.85 ± 0.33 explorations) than ethanol-treated mice (mean = 3.76 ± 0.28) and 
less explorations to opposite holes (Figure 3.14C).  No significant effect of sex or 
interaction between sex and treatment was detected (p > 0.05).  Also, no significant 
differences between the total number of explorations was indicated. 
To evaluate if this deficit in recall memory persisted past the first week of testing, 
mice were re-tested for long-term recall of the location of the escape during the 
second week (at day 12) without further acquisition training.   Multivariate analysis 
of only the control mice of all treatment paradigms detected no effect of day of testing 
(F40,76 = 0.76, p = 0.828).  Also, no significant effect of sex or interaction between sex 
and treatment was detected (p > 0.05).  Analysis of total number of explorations 
detected no significant effect of treatment day (F 2,56 = 1.27, p = 0.288), as well as no 
significant main effect of sex or interaction between sex and day of treatment (p > 
0.05).  
Analysis of the long-term (day 12) recall memory of mice treated with ethanol or 
saline at P4 detected no significant effect of sex, treatment, or interaction between the 
two (p > 0.05) across the average number of explorations to each hole (Figure 3.15A).  
No significant main effects or interactions were detected in the total number of 
explorations between sexes or treatment groups.  Mice treated with ethanol at P7 did 
show significantly less explorations to the target (mean = 3.52 ± 0.0.22) as compared 
to controls (mean 5.02 ± 0.28) (F20,18 = 3.96, p = 0.002) during the long-term recall 
testing (Figure 3.15B).   No significant main effect of sex or interaction between sex 
and treatment on hole exploration was detected, as well as no significant main effects 
or interactions on the total number of explorations.  A significant main effect of 
treatment on the overall pattern of number of explorations to each hole during the 
day 12 long-term recall trial was also detected for animals treated at P4+7 (F20,20 = 
3.51, p = 0.004).  Control animals showed significantly more explorations to the target 
(mean = 5.10 ± 0.23) than ethanol-treated mice (mean = 3.10 ± 0.27) and fewer 
explorations at the opposite side of the Barnes maze platform (Figure 3.15C). Again, 
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no significant effect of sex or interaction between sex and treatment were detected.  
There were no significant differences in total number of explorations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3.  Results 
 
84 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.14.  Number of explorations to each Barnes maze hole during short-term 
recall memory trials.  The mean number of explorations (±SEM) to each hole located 
around the periphery of the Barnes maze is indicated for mice treated with saline (control) 
or ethanol at P4 (A), P7 (B), or P4+7 (C).  Data represent short-term recall memory, tested 
on day 5 following four days of learning (acquisition) trials.  Data shown are collapsed across 
sex (n = 20-23 per group).  *, p < 0.05;  **, p < 0.01;  ***, p < 0.001. 
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FIGURE 3.15.  Number of explorations to each Barnes maze hole during long-term 
recall memory trials.  The mean number of explorations (±SEM) to each hole located 
around the periphery of the Barnes maze is indicated for mice treated with saline (control) 
or ethanol at P4 (A), P7 (B), or P4+7 (C).  Data represent short-term recall memory, tested 
on day 12 following four days of learning (acquisition) trials.  Data shown are collapsed 
across sex (n = 20-23 per group).  *, p < 0.05;  **, p < 0.01;  ***, p < 0.001. 
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3.1.6 Summary of behaviour results 
Exposure to ethanol during the third trimester-equivalent resulted in pronounced 
changes in behavioural phenotypes that are apparent during early and late postnatal 
development, adolescence and early adulthood.  Interestingly, the effect of ethanol on 
these phenotypes appeared to be dependent on the timing of ethanol exposure, and 
some consistent differences emerged between animals treated at P4 versus P7 (Table 
3.4).  Treatment at P4 appeared to affect early neuromuscular reflexes and 
coordination, with ethanol-treated mice showing a delay in their ability to achieve 
many developmental milestones.  Ethanol treatment later during the trimester three-
equivalent at P7 resulted in increased home-cage nocturnal activity levels and 
increased anxiety-related traits in a novel open-field, the light/dark box, and the 
elevated plus maze (particularly in females).  All ethanol treatment paradigms 
resulted in impaired learning during the Barnes maze acquisition trials; however, the 
P7 and P4+7 treatment groups showed marked increases in latency to escape the 
Barnes maze.  This trend was consistent when assessing the search strategy used to 
navigate the Barnes maze:  while control mice were quickly able to travel directly 
towards the escape, ethanol-treated mice showed a preference for a serial strategy in 
which they would travel to numerous holes in a clockwise or counter-clockwise 
fashion prior to locating the target.  Also, the ethanol-treated mice showed an 
increased use of a serial strategy and a reduced use of a direct strategy.   This was 
reflected in the short and long-term memory trials, with mice treated with ethanol at 
P7 or at P4+7 showed a decreased tendency to explore the previous location of the 
target hole.  This difference was apparent at day 5 (short-term) as well as a week later 
during the long-term recall memory trial (day 12).   Taken together, ethanol 
treatment during the trimester three-equivalent results in behavioural phenotypes 
consistent with those observed in human children, adolescents, and young adults 
with FASD.   
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TABLE 3.4.  Summary of behavioural consequences of ethanol exposure during the third trimester-equivalent.  
aChanges are relative to control mice:  ↑: increased relative to control;  ↓: decreased relative to control; NS:  no significant difference relative to controls 
bLDB: light/dark box; EPM: elevated plus maze 
cPostnatal day testing was conducted 
   P4a P7a P4+7a 
Behaviour Assayb 
Day of 
testingc 
male female male female male female 
Coordination and reflexes Developmental milestones 2-21 ↓ (7/10) ↓ (7/10) ↓ (3/10) ↓ (3/10) ↓ (8/10) ↓ (8/10) 
Activity Novel open field 26-28 NS NS NS NS NS ↓ 
 Home cage 30-35 NS NS ↑ ↑ ↑ ↑ 
Anxiety Novel open field 26-28 NS NS ↑ ↑ ↑ ↑ 
 LDB 35-40 - - - - ↑ ↑ 
 EPM 35-40 - - - - ↑ ↑ 
Spatial learning Barnes maze 45-48 ↓ ↓ ↓ ↓ ↓ ↓ 
Learning strategy Barnes maze 42-48 
↓ direct 
↑ serial 
↓ direct 
↑ serial 
↓ direct 
↑ serial 
↓ direct 
↑serial 
↓ direct 
↑ serial 
↓ direct 
↑ serial 
Short-term memory Barnes maze 49 NS NS ↓ ↓ ↓ ↓ 
Long-term memory Barnes maze 56 NS NS ↓ ↓ ↓ ↓ 
Chapter 3.  Results 
 
88 
  
3.2 Gene expression changes following ethanol exposure 
during synaptogenesis 
To evaluate the changes to gene expression induced by ethanol exposure during the 
trimester three-equivalent and how they may lead to the observed emergent 
behavioural phenotypes, I examined the alterations to whole-brain gene expression 
patterns acutely following ethanol exposure at postnatal day 7 (4-hours post-
treatment) (short-term) as well as those transcript changes that persisted into 
adulthood at postnatal day 60 (long-term) using expression microarrays.  The results 
of these analyses comprise the following section of this chapter.  
 
3.2.1 Gene expression changes acutely following ethanol treatment 
The changes to whole brain gene expression following ethanol exposure at P7 four 
hours post-injection were assessed using expression microarray analysis.  This time 
point was chosen due to the multi-phenotype behavioural alterations detected by the 
behavioural battery after ethanol treatment at P7 as compared to P4.   Ethanol 
exposure at P7 resulted in the acute alteration of 315 transcripts at a fold-change of 
1.2 (FDR-corrected p < 0.05), with 138 (44%) showing up-regulation four hours after 
ethanol exposure.  A complete gene list using these stringency criteria is shown in 
Appendix A.  Changes ranged from -1.73-fold (Dual specificity phosphatase 6) to 2.63-
fold (Thioredoxin interacting protein), though most gene expression changes were 
subtle, with 78 per cent (245/315) of gene expression changes showing less than a 
1.3-fold difference. 
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3.2.2 Array hierarchical clustering and functional annotation of genes 
altered acutely following ethanol exposure 
Hierarchical clustering of probe signal intensity values showed good consistency 
between short-term arrays, with the two ethanol-treatment arrays clustering 
together distinctly from the four control arrays (Figure 3.16). The clustering also 
revealed four subsets of genes that responded similarly to ethanol treatment. Some 
of these groups were not large enough to be subjected to meaningful gene functional 
clustering analysis, so the groups that showed up-regulation (one and four) or down-
regulation (two and three) in response to ethanol treatment were submitted to the 
Database for Annotation, Visualization, and Integrated Discovery (DAVID) (DENNIS et 
al. 2003) to assess Gene Ontology (GO) biological process terms common between 
similarly-responsive genes. 
Genes showing up-regulation four hours following ethanol exposure at P7 were 
significantly enriched for GO terms associated with positive regulation of apoptosis, 
which included genes such as Cysteine-serine-rich nuclear protein 3 (Csrnp3), a 
transcriptional activator involved in apoptotic genes, Glutamate (NMDA) receptor 
subunit epsilon-2 (Grin2b), growth factors (Tgfb3, Igfbp3), and Bcl2-like 11 (apoptosis 
facilitator) (Bcl2l11) (Table 3.5). Interestingly, a large cluster of genes (61 
transcripts) were associated with cell membrane integrity. Also significant were 
genes with GO terms associated with post-synaptic density, amino acid 
dephosphorylation, glycosylation, and regulation of synaptic transmission. 
Down-regulated genes showed enrichment for GO terms related to ribosome 
biogenesis, mitotic cell cycle regulation, MAP kinase phosphatase activity, 
transcriptional regulation, and hormone activity, including a significant down-
regulation in genes associated with steroid hormone receptor activity (Table 3.5). 
Other significantly reduced transcripts were associated with chromosomal 
remodeling or a constituent of chromatin or DNA structure, such as Ube2a, required 
for DNA damage repair, histone deacetylase 1 (Hdac1), and Nuclear FMRP-interacting 
protein 1 (Nufip1). 
Chapter 3.  Results 
 
90 
  
To further characterize the biological functions targeted by ethanol identified by the 
broad GO analyses, the up- and down-regulated transcripts were also evaluated 
independently for biological function clusters using Ingenuity Pathway Analysis™ 
(IPA) (Ingenuity Systems, Redwood, CA, www.ingenuity.com). The results confirmed 
and extended the biological functions identified by DAVID and showed that many 
genes altered by ethanol exposure influenced cell survival and development, 
particularly those processes involving neuronal apoptosis and plasticity (Table 3.6). 
IPA analysis identified abnormal expression of genes associated with dopaminergic 
neuron development and neuroglia function. Also, this analysis identified alterations 
to genes associated with endocrine system development and function including the 
hydroxylation of melatonin, corticosterone secretion, phospholipid metabolism, and 
calcium mobilization and influx. 
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FIGURE 3.16.  Heat map hierarchical clustering of arrays representing transcripts altered 
in the brain acutely following ethanol treatment on P7 based on normalized intensity of 
the probe sets.  Heat map was generated by Partek® Genomics Suite software based on 
ANOVA-calculated significance levels and fold-changes.  Clusters of up-regulated (green) 
and down-regulated (red) genes are indicated.  
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TABLE 3.5.  Gene Ontology (GO) biological function annotation clustering of transcripts altered in the brain acutely following ethanol 
exposure at P7. 
GO Term GO ID 
No. 
genes 
p-value Up-regulated genes 
     
positive regulation of apoptosis 0043065 10 0.000170 Csrnp3, Grin2a, Tgfb3, Trp53inp1, Foxo3, Sp110, Perp, Igfbp3, Bcl2l11, Jmy 
integral to membrane 0016021 61 0.00643 Mchr1, Slc16a14, B3galt5, Osmr, Slc44a5, Ints2, Sdc4, Megf10, Pigm, Clec4e, 
Slc24a4, Grin2b, Slc25a24, Kcnk6, Slc2a1, Atp8b2, Htr1d, Htr5a, Slc43a2, 
Gpr139, Vmn2r33, Pigv, Lifr, Grin2a, Vmn2r37, Ntsr1, Pik3ip1, Parp16, 
Folh1, Cldn1, Mfsd11, Steap2, Vmn2r43, Gcnt2, Tmem194b, Enpp3, Aph1b, 
St8sia1, Gpr6, Csmd3, Igsf10, Igf1r, Prrg4, B3gnt5, Pcdhb18, Scn9a, Tmc7,  
Fam26e, Rnf144b, Fktn, St6gal1, Abca8b, Acer2, Bcg1, Cdhb21, Kctd6, 
Slc7a3, Slc16a9, Itpripl2, Mertk, Perp 
postsynaptic density 0014069 4 0.00761 Grin2b, Grin2a, Psd3, Cpeb1 
protein amino acid dephosphorylation 0006470 5 0.0139 Dusp1, Ppmik, Ptpn4, Dusp16, Dusp8 
glycosylation 0070085 4 0.0366 St6gal1, B3gnt5, B3galt5, St8sia1 
regulation of synaptic transmission 0050804 4 0.0464 Grin2b, Edn1, Grin2a, Cpeb1 
     
     
    Down-regulated genes 
     
ribosome biogenesis 0042254 7 0.0000618 Utp11l, Tbl3, Gtpbp4, Nop2, Utp18, Mphosph10, Nmd3 
mitotic cell cycle 0000278 8 0.000719 Ccnd1, E2f4, Incenp, Aurka, Pmf1, Sirt7, Nup43, Rbbp8 
MAP kinase phosphatase activity 0033549 3 0.00280 Dusp4, Dusp6, Dusp7 
regulation of transcription 0045449
  
25 0.00293 E2f4, Nufip1, Zbtb17, Cited4, Med27, Per2, Olig2, Cry1, Etv5, Etv4, Klf6, Egr3, 
Egr4, Snapc1, Rxrg, Nr4a1, Mcm2, Pmf1, Sirt7, Nrob1, Inhba, Hdac1, Vegfa, 
Zfp143, Hdac9 
chromosomal part 0044427 8 0.00363 Ube2a, Hdac1, Incenp, Nufip1, Pmf1, Mcm2, Sirt7, Nup43 
hormone activity 0005179 4 0.0401 Inhba, Pomc, Apln, Adcyap1 
steroid hormone receptor activity 0003707 3 0.0425 Rxrg, Nr4a1, Nrob1 
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TABLE 3.6.  Ingenuity Pathway Analysis™ biological functions associated with ethanol-induced gene expression changes at P7. 
Category Function annotation p-value No. genes Up-regulated genes Down-regulated genes 
      
Cell death and survival apoptosis of neurons 0.000497 17 Agt, Bcl2l11, Btg2, Dusp1, Grin2b, 
Igf1r, Jun, Mt1e, Mt1h, Perp, 
St8sia1, Tgfb3, Zfp110/Zfp369 
Adcyap1,  Hdac1, Klf6, Vegfa 
Nervous system 
development and 
function 
proliferation of pituitary cells 0.00220 3 Tgfb3 Inhba, Srsf2 
 proliferation of neuroglia 0.0155 5 Cpeb1, Foxo3 Adcyap1, Ccnd1, Etv5 
 abnormal morphology of 
astrocytes 
0.0252 3 Mt1e, Mt1h Ldlr 
 quantity of neurons 0.0334 10 Dusp1, Igf1r Adcyap1, Egr3, Inhba, Lifr, 
Olig2, Pomc, Trpa1, Vegfa 
 plasticity of neuronal synapse 0.0371 2 Cpeb1, Grin2b  
Tissue development regeneration of nerves 0.000544 3 Agt, Jun, St8sia1 - 
Cell cycle mitosis 0.00175 3 Edn1, Tgfb3 Ccnd1 
 mitogenesis of central nervous 
system cells 
0.00216 2 Edn1, Tgfb3 - 
Lipid metabolism hydrolysis of phospholipid 0.0181 2 Agt, Edn1 - 
 turnover of phospholipid 0.00216 2  Edn1 Adcyap1 
 metabolism of membrane lipid 
derivative 
0.0462 2  St8sia1 Pomc 
Neurological disease neuromuscular disease 0.0116 15 Agt, Mertk, Mt1e, Mt1h, Sdc4, 
Slc16a9, Zfp932  
Egr4, Etv5, Gabra5, Hla-b, 
Lifr,  Nr4a1, Rgs4, Rxrg 
 disorder of basal ganglia 0.0171 14 Mertk, Mt1e, Mt1h, Sdc4, Slc19a9, 
Zfp932 
Egr4, Etv5, Gabra5, Hla-b, 
Lifr,  Nr4a1,  Rgs4, Rxrg 
 neuropathy of brain 0.00216 2 Mt1e, Mt1h - 
 damage of brain 0.0479 4 Edn1, Folh1, Grin2a, Grin2b - 
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TABLE 3.6. continued… 
Category Function annotation p-value No. genes Up-regulated genes Down-regulated genes 
      
Cellular growth and 
proliferation 
proliferation of cells 0.0197 13 Cpeb1, Foxo3, Tgfb3 Adcyap1, Ccnd1, Etv5, Gnl3, 
Gtpbp4, Inhba, Klf6, Pomc, 
Srsf3, Vegfa 
Vitamin and mineral 
metabolism 
mobilization of Ca2+ 0.0122 2 - Adcyap1, Trpa1 
 influx of Ca2+ 0.0371 2 Grin2b Trpa1 
Cell-to-cell signaling and 
interaction 
damage of dopaminergic 
neurons 
0.00356 2 Mt1e, Mt1h - 
 plasticity of neuronal synapse 0.0371 2 Cpeb1, Grin2b - 
Endocrine system 
development and 
function 
proliferation of pituitary cells 0.00220 3 Tgfb3 Inhba, Srsf2, 
 hydroxylation of melatonin 0.0193 1 Cyp1b1 - 
 production of L-
triiodothyronine 
0.0193 1 - Dio2 
 secretion of corticosterone 0.0193 1 - Pomc 
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3.2.3 Canonical signaling pathways affected acutely following ethanol 
exposure 
To assess biological pathways that may be affected immediately following ethanol 
treatment at P7, the genes identified by the array analysis were subjected to IPA’s 
canonical pathway analysis to identify pathways associated with altered gene 
expression and the identified biological functions.  The canonical pathways identified 
were also consistent with the gene ontology and biological functions analyses.  
Canonical pathways that possessed a significant number of altered genes are shown 
in (Table 3.7). Significantly affected pathways included p53 signaling (p = 0.0002), 
which included the upregulated transcription factor jun proto-oncogene (Jun), 
classically associated with early cellular stress response, and a down-regulation of 
the histone deacetylase Hdac1.  Circadian rhythm signaling was also significantly-
affected (p = 0.0002) and included altered genes that control the proper timing of 
cellular and metabolic events such as glutamate neurotransmission (Grin2a, Grin2b), 
period genes (Per1, Per2) and the cryptochrome protein Cry1.  Other canonical 
pathways identified as significantly affected acutely following ethanol exposure at P7 
were associated with cell cycle: G1/S checkpoint regulation (p = 0.0008), which is 
consistent with the cell cycle-associate genes identified by the IPA biological 
functions analysis and included the growth factor transforming growth factor beta-3 
(Tgfb3) as well as the histone deacetylases Hdac1 and Hdac9.  Other pathways of note 
included phosphoinositide biosynthesis (p = 0.11), associated with membrane 
integrity, retinoic acid-associated TR/RXR activation (p = 0.017), and the related 
canonical PTEN signaling pathway (p = 0.02), associated with regulation of cell 
growth and mitotic progression.  
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TABLE 3.7.  Ingenuity® canonical pathways associated with transcripts altered by ethanol exposure at P7. 
 
 
     
Canonical pathway p-value No. 
molecules 
Up-regulated genes Down-regulated genes 
 
     
p53 signaling 0.00023 8 Jmy, Jun, Perp, Pik3r1, Tp53inp1 Ccnd1, Gnl3, Hdac1 
Circadian  rhythm signaling 0.00024 6 Grin2a, Grin2b, Per1 Adcyap1, Cry1, Per2 
Cell cycle: G1/S checkpoint regulation 0.00077 6 Tgfb3 Ccnd1, E2f4, Gnl3, Hdac1, 
Hdac9 
Chronic myeloid leukemia signaling 0.00698 9 Pik3r1, Tgfb3 Ccdn1, E2f4, Hdac1, Hdac9 
3-phosphoinositide biosynthesis 0.00927 7 Dusp1, Dusp8, Dusp16, Nudt11, Pik3r1, 
Ppm1k 
Pptc7 
D-myoinositol tetraphosphate 
biosynthesis 
0.0110 6 Dusp1, Dusp8, Dusp16, Nudt11, Ppm1k   Pptc7 
Cyclins and cell cycle regulation 0.0132 5 Tgfb3 Ccnd1, E2f4, Gnl3, Hdac1, 
Hdac9 
ErbB2-ErbB3 signaling 0.0165 4 Jun, Pik3r1 Ccnd1, Etv4 
TR/RXR activation 0.0172 5 Pik3r1, Slc2a1 Dio2, Ldlr, Rxrg 
PTEN signaling 0.0203 5 Pik3r1, Slc2a1 Dio2, Ldlr, Rxrg 
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3.2.4 Interacting gene networks involving genes altered by ethanol 
exposure 
To evaluate how the ethanol-responsive genes altered acutely following ethanol 
treatment at P7 may interact with one another, I utilized the gene network analysis 
tool within the Ingenuity® software platform to predict interacting molecular 
networks (algorithmically generated pathways). The molecular networks 
represented pleiotropic, broadly-acting functions and correlated well with the GO 
functions and the canonical pathways identified by the previous analyses. Network 
analysis identified three significant networks, shown in Figures 3.15, 3.16, 3.17.   The 
returned networks were associated with ‘cellular development, cellular growth and 
proliferation, tumor morphology’ (CDCG), which contained 17 focus molecules 
identified by the array (IPA network score = 20) (Figure 3.15), ‘tissue morphology, 
cell-to-cell signaling and interaction, cellular growth and proliferation’ (TMCS) (focus 
molecules = 13; score = 13) (Figure 3.16), and ‘behaviour, cell-to-cell signaling and 
interaction, nervous system development and function’ (BCSN) (focus molecules = 
11; score = 10) (Figure 3.17). As the network descriptors suggests, these networks 
were highly interrelated.  The CDCG network centralized on three highly connected 
‘hub’ molecules: jun proto-oncogene (Jun), which was detected as highly up-regulated 
in the ethanol-treatment arrays as compared to controls, and cAMP responsive 
element binding protein 1 (Creb1) and FBJ osteosarcoma oncogene (Fos), which were 
not detected as differentially expressed but served as connector molecules between 
multiple up- and down-regulated transcripts (Figure 3.17). The TMCS also included 
Jun, as well as tumor necrosis factor (Tnf) (not differentially expressed) and 
transforming growth factor, beta 1 (Tgfb1)(up-regulated) as hub molecules, as well as 
interleukins 15 (down-regulated) (Figure 3.18). Also relevant to this network was 
adenylate cyclase activating polypeptide 1 (Adcyap1) (down-regulated) that acted as 
a molecular hub connecting the down-regulated pro-opiomelanocortin-alpha (Pomc) 
to tumor necrosis factor (Tnf) via expression regulation (E) and co-localization (LO) 
annotations.  Finally, the BCSN network was characterized by the presence of multiple 
glutamate receptor subunits, including glutamate receptor, ionotropic, N-methyl 
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FIGURE 3.17.  Ingenuity Pathway Analysis™ network analysis indicating annotated 
interactions between transcripts altered acutely following ethanol exposure at P7 
associated with ‘cellular development, cellular growth and proliferation, and tumor 
morphology’ (CDCG).  Up (red) and down (green) regulated genes are indicated.  Arrowhead 
indicates the direction of action. Notations in brackets adjacent to the edge key labels 
indicate the number of lines of evidence (publically available data sourced by Ingenuity ®) 
supporting the interaction.   
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FIGURE 3.18.  Ingenuity Pathway Analysis™ network analysis indicating annotated interactions 
between transcripts altered acutely following ethanol exposure at P7 associated with ‘tissue 
morphology, cell-to-cell signaling and interaction, cellular growth and proliferation’ (TMCS).  
Up (red) and down (green) regulated genes are indicated. Arrowhead indicates the direction of 
action. Notations in brackets adjacent to the edge key labels indicate the number of lines of 
evidence (publically available data sourced by Ingenuity®) supporting the interaction.   
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FIGURE 3.19.  Ingenuity Pathway Analysis™ network analysis indicating annotated 
interactions between transcripts altered acutely following ethanol exposure at postnatal 
day 7 associated with ‘behavior, cell-to-cell signaling and interaction, nervous system 
development and function’ (BCSN).  Up (red) and down (green) regulated genes are 
indicated.  Arrowhead indicates the direction of action. Notations in brackets adjacent to 
the edge key labels indicate the number of lines of evidence (publically available data 
sourced by Ingenuity®) supporting the interaction.   
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D-aspartate 2A (Grin2a) and Grin2b, both up-regulated (Figure 3.19).  Further, this 
network included components of circadian rhythm patterning (Per1) and histone 
modification (Hdac1).  Interestingly, Huntingtin (Htt) was implicated as a major hub 
of this network which, though it was not detected as differentially expressed, 
interacts with differentially expressed genes including Per1 (up-regulated), 
glutamate receptor subunits, serotonin transporter genes (Slc1a1), and the RNA 
spliceosome protein Srsf2 (down-regulated).  
To identify molecules that may be key effectors of the ethanol-induced changes in 
gene expression, the three networks were merged to identify hub molecules that may 
unify the interactions of all three (Figure 3.20). Early immediate transcriptional 
regulators controlling cell cycle and proliferation, such as cell-cycle control genes 
such as Jun, Fos, early growth response 1 (Egr1) and Egr2, and Creb1, appeared as 
central hubs.  Also highly-represented are signaling molecules such as cytokines and 
growth hormones, including growth hormone 1 (Gh1), nerve growth factor (Ngf), 
Tumor necrosis factor (Tnf), Transforming growth factor, beta 1 (Tgfb1), and 
interleukin 6 (Il6). The glutamate receptors (Grin2a, Grin2b, and Grin1) prominent in 
the BCSN network remain as hubs in the merged model of molecular interactions, as 
does Htt. Finally, an interesting interaction emerged between Adcyap1, Pomc, and 
nuclear receptor subfamily 4, group A, member 1 (Nr4a1), all of which showed reduced 
mRNA levels. Taken together, these genes and their interactions may be viewed as 
the primary response of developing brain cells to ethanol exposure at synaptogenesis 
and illustrate a balance between the role of cell cycle genes, genes critical to synaptic 
formation and maintenance, and the expression of early response growth factors.  
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FIGURE 3.20.  Merged Ingenuity Pathway Analysis™ networks showing interactions 
between the most significant gene networks (see Figure 3.15, 3.16, and 3.17) affected 
acutely following ethanol exposure at postnatal day 7.  Up (red) and down (green) 
regulated genes are indicated.   Centralized “hub” molecules linking multiple interacting 
genes are enlarged. Arrowhead indicates the direction of action. Notations in brackets 
adjacent to the edge key labels indicate the number of lines of evidence (publically 
available data sourced by Ingenuity®) supporting the interaction.   
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3.2.5 Validation of array-identified mRNA levels by quantitative RT-PCR 
Real-time quantitative RT-PCR (qRT-PCT) expression analysis was performed for 
four genes, selected based on their fold changes and prominence in biological 
functions and networks identified by bioinformatics analyses.  Genes chosen for qRT-
PCR analysis were: Dual-specificity phosphatase 1 (Dusp1), jun proto-oncogene (Jun), 
nuclear receptor subfamily 4, group A, member 1 (Nr4a1), and pro-opiomelanocortin-
alpha (Pomc).  Real-time results as compared to array fold-changes are shown in 
Figure 3.21.  Fold-changes calculated from deltaCt values showed good consistency 
with the array results.  All genes confirmed (student’s t-test, p < 0.05) with the 
exception of Pomc, which approached but did not reach significance (t = 2.078, p = 
0.071).   
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FIGURE 3.21.  Quantitative RT-PCR confirmation of array-identified genes altered acutely 
following ethanol treatment at P7.  Data are shown as mean (±SEM). Genes are listed 
alphabetically: Dual-specificity phosphatase 1 (Dusp1), jun proto-oncogene (Jun), nuclear 
receptor subfamily 4, group A, member 1 (Nr4a1), and pro-opiomelanocortin-alpha (Pomc).  
All genes were significantly different from controls (students’ t-test, p < 0.05) with the 
exception of Pomc.  ns: not significantly different from controls.   
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3.3 Long-term alterations to brain gene expression following 
ethanol exposure during synaptogenesis 
In addition to identifying genes that were acutely affected by third-trimester ethanol 
exposure (4 hours post-injection at P7), I examined the brain gene expression 
changes in the adult brain (P60) resulting from ethanol exposure during  
synaptogenesis, or the human third trimester-equivalent (at postnatal days 4 and 7).  
These results represent alterations to the transcriptome that are initiated during 
neurodevelopment but persist into adulthood in mice displaying behavioural 
phenotypes relevant to FASD.   
 
3.3.1 Gene expression changes in the adult brain 
Expression microarray analysis identified 376 transcripts as differentially expressed 
between ethanol-treated mice and controls (1.2-fold change, FDR-correct p < 0.05).  
Changes to gene expression were relatively subtle, ranging from -2.21-fold (Triadin) 
to 3.3-fold (Proline-rich protein 2).  Interestingly, the distribution of up- and down-
regulated genes was not equal, with 92% of genes (361/376) identified as down-
regulated as compared to controls.  Further, the gene expression changes were subtle 
with 173/376 (47%) of genes showing less than a 1.3-fold change.  A full list of genes 
meeting the stringency parameters is provided in Appendix B.  This list was used for 
subsequent biological functions, pathway, and gene network analyses.   
 
3.3.2 Array hierarchical clustering and functional annotation of genes 
altered in the adult brain  
Hierarchical clustering analyses of each array indicated that the consistency between 
arrays was good, with the ethanol and control arrays cleanly pairing when grouped 
by probe intensity (Figure 3.22).  When subjected to statistical stringency measures 
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for fold-change and p-value cutoffs, genes detected as up-regulated in the ethanol-
treated samples as compared to controls were greatly reduced, indicating that many 
up-regulated genes showed low fold-changes and/or p-value significance.  Due to the 
low number of significant up-regulated transcripts, the total gene list (both up- and 
down-regulated transcripts) was analyzed using DAVID (DENNIS et al. 2003) for over-
represented gene ontology processes.  DAVID analysis identified a number of 
biological processes associated with synaptic function, including glutamate receptor 
activity, synaptic transmission, and regulation of synaptic plasticity (Table 3.8).  
These annotations were comprised of a number of altered glutamate receptor 
subunits, including Grin2b, Grin2c, Grin2d, Grin3b, Grik1, and Grik3.    These gene 
ontology functions shared multiple genes with other significant functions related to 
behaviour, such as “adult behaviour”, “learning”, and “locomotory behaviour”.  
Interestingly, a significant number of genes were associated with folic acid 
metabolism, including 5, 10-methenyltetrahydrofolate synthetase (Mthfs), and folate 
hydrolase 1 (Folh1), and 5-methyltetrahydrofolate-homocysteine methyltransferase 
(Mtr), involved in folate usage and one-carbon metabolism.  Other gene clusters were 
also related to epigenetic processes such as chromatin organization and histone 
modification, indicating that these processes may be disrupted by trimester three -
equivalent ethanol exposure.  Other significant clusters of genes were associated with 
cytoskeletal transport and cell adhesion, protein phosphorylation, and mitogen-
activated protein (MAP) kinase signaling cascade. 
The transcripts identified were independently analyzed for over -representation 
within biological functions using Ingenuity Pathway Analysis™ (IPA) (Ingenuity 
Systems, Redwood, CA, www.ingenuity.com) (Table 3.9).  The results supported the 
gene ontology biological functions and identified a significant number of differentially  
expressed genes associated with neurotransmission and synaptic plasticity, including 
again the glutamate receptor subunits Grik1 and Grin2b. Also identified were a 
number of genes associated with retinoic acid signaling (Fadd, Casp3, Rarb, Tnfsf10, 
Rxrb, Irf1), lipid metabolism and accumulation, involving the hormone precursor  
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FIGURE 3.22.  Heat map hierarchical clustering of arrays representing transcripts altered 
in the adult (P60) brain of control (n=2) and ethanol-treated (n=2) mice exposed at P4 +7 
based on the normalized intensity of the probe sets.  Heat map was generated by Partek® 
Genomics Suite software based on ANOVA-calculated significance levels and fold-changes.  
Clusters of up-regulated (green) and down-regulated (red) genes are indicated. 
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TABLE 3.8.  Gene Ontology (GO) biological function annotation clustering of transcripts altered in the adult brain of mice treated with ethanol 
at P4+7. 
GO term GO ID No. genes p-value Genes 
     
glutamate receptor activity 0008066 9 5.84E-7 Grm4, Grin2b, Grik1, Grin2c, Grik3, Grin2d, Ubc, Grin3b, 
Grind1 
synaptic transmission 
 
0007268 16 0.000012 Grik1, Ntf3, Nlgn1, Grm4, Grin2b, Grin2c, Grin2d, Chrm1, 
Cnr1, Pcdhb16, P2rx3, Dmd, Syngap1, Cacna1c, Sv2c, Apba1 
regulation of synaptic plasticity 0048167 8 0.00035 Apoe, Grin2b, Grik1, Grin2c, Htt, P2rx3, Syngap1, Syngr1 
cellular ion homeostasis 0006873 15 0.00071 Ftl1, Grik1, Ntf3, Htt, Grik3, Hexa, Pex5l, Vdr, Grin2b, Grin2c, 
Apoe, Grin2d, Pth, Cacna1c, Cln5 
folic acid and derivative metabolic 
process 
0006760 4 0.00189 Mthfs, Folh1, Mtr, Aldh1l2 
chromatin organization 0006325 15 0.00408 Hist1h2bf, Crebbp, Hdac10, Dmap1, Mbd3, Hltf, Nap1l5, 
Hist2h4, Hist1h2bm, Hist1h3c, Hist1h4d, Kdm5a, Rbm14, 
Hdac8, Myst1, Kdm6b 
histone modification 0016570 7 0.00982 Crebbp, Hdac10, Dmap1, Mbd3, Rbm14, Hdac8, Kdm6b 
regulation of protein kinase cascade 0045449 9 0.0120 Traf3ip1, Spry1, Grin2b, Iltifb, Fgf9, Mdfic, Map3k1, Itsn1, 
Syngap1 
locomotory behaviour 0007626 
 
11 0.0207 Cmtm2a, Npas3, Grin2c, Htt, Hexa, Grin2d, Pcdh15, Gpr77, 
Cacna1c, Apba1, Itgam 
regulation of transcription, DNA-
dependent 
0006355 41 0.0220 Nkap, Kchn1, Irx5, Pax3, Dmap1, Vdr, Trp53bp1, Npas3, 
Hsf1, Tgif2lx1, Elk4, Mdfic, Tead4, Pth, Etv2, Yeats2, Rarb, 
Nfatc1, Maf, Ntf3, Rxrb, Crebbp, Gsx1, Mbd3, Zfp59, Six4, Hltf, 
Mycn, Traf3ip1, Myt1l, Mef2d, Zfp9, Cmtm2a, Foxf1a, Irf5, 
Iltifb, Thrap3, Irf1, Rbm14, Kdm6b, Tbx19 
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TABLE 3.8 continued…     
GO term GO ID No. genes p-value Genes 
     
learning 0007612 5 0.0262 Grm4, Grin2b, Htt, Cacna1c, Syngap1 
cytoskeleton-dependent intracellular 
transport 
0030705 4 0.0203 Htt, Rhot2, Dst, Hap1 
neuron differentiation 0030182 15 0.0278 Irx5, Sox1, Ntf3, Htt, Wnt3a, Gsx1, Ntng2, Pcdh15, Pax3, 
Ephb1, Tulp3, Dmd, Efna5, Syngap1, Dst 
regulation of phosphorylation 0042325 12 0.0298 Egfr, Traf3ip1, Casp3, Spry1, Vav3, Iltifb, Mdfic, Map3k1, 
Tlr1, ll34, Dnajc3, Kitl 
regulation of MAPKKK cascade 0043408 6 0.0372  Spry1, Grin2b, Fgf9, Mdfic, Map3k1, Syngap1 
adult behaviour 0030534 6 0.0373 Grik11, Adh1, Hexa, Grin2d, Pcdh15, Cacna1c 
regulation of cell adhesion 0030155 6 0.0388 Lama4, Vav3, Prlr, Srcin1, Fbln2, Cml5 
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TABLE 3.9.  Ingenuity Pathway Analysis™ biological functions associated with gene expression changes in the adult brain of mice treated 
with ethanol at P4+7. 
Category Function annotation p-value No. genes Genes 
     
Cell-to-cell signaling and 
interaction 
neurotransmission 0.0000829 10 Apoe, Chrm1, Cnr1, Ephb1, Grik1, Grin2b, Htr1a, 
Htt, Nlgn1, Ntf3 
Cell growth and proliferation proliferation of cells 0.000378 17 Alk, Anxa2, Cnr1, Efnb2, Egfr, Htt, Irx5, Lama4, mir-
221, Mknk1, Mycn, Nbn, Npas3, Ntf3, Pomc, Spry1, 
Wnt3a 
Cell death retinoic acid-mediated apoptosis 
signaling 
0.00055 6 Fadd, Casp3, Rarb, Tnfsf10, Rxrb, Irf1 
Cell death cell viability of cerebral cortex 
cells 
0.00141 5 Alk, Apoe, Htt, Ksr1,Ntf3 
Lipid metabolism secretion of steroid 0.00181 3 Apoe, Pomc 
Lipid metabolism accumulation of lipid 0.00360 3 Chrm1, Cnr1. Htt 
Neurological disease movement disorder 0.00534 9 Anxa2, Atxn3, Capn3, Casp3, Ftl, Htt, Nbn, Ptges3, 
Ran 
Carbohydrate metabolism quantity of carbohydrate 0.00553 3 Htt, Inppl1, Insr 
Cell death neuronal cell death 0.00707 21 Alka, Apoe, Casp3, Cnr1, Efnb2, Fadd, Grin2b, Hsf1, 
Htt, Inppl1, Insr, Itsn1, Kitlg, Ksr1, Map3k1, Mycn, 
Nbn, Ntf3, Smpd2, Tyk2, Xrcc5 
Cell-to-cell signaling and 
interaction 
plasticity of synapse 0.0144 6 Apoe, Grik1, Grin2b, Htt, Inppl1, Syngap1 
Nervous system development 
and function 
quantity of microglia 0.0197 2 Apoe, Htt 
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TABLE 3.9 continued… 
    
Category Function annotation p-value No. genes Genes 
     
Cell morphology formation of cellular protrusions 0.0329 17 Apoe, Dst, Efna5, Efnb2, Egfr, Ephb1, Grm4, Htt, 
Kif23, Nbl1, Ntf3, Ntng2, Pcdh15, Rhog, Syne1, 
Syngap1, Wnt3a 
Cell death cell death of dopaminergic 
neurons 
0.0344 3 Casp3, Efnb2, Fadd 
Neurological disease gliosis of hippocampus 0.0400 2 Apoe, Htt 
Nucleic acid metabolism concentration of cyclic AMP 0.0400 2 Htt, Pth 
Cellular assembly and 
organization 
transport of synaptic vesicles 0.0443 3 Apba1, Htt, Itsn1 
Cellular assembly and 
organization 
microtubule dynamics 0.0446 18 Apoe, Dst, Efna5,Efnb2, Egfr, Ephb1, Grm4, Htr1a, 
Htt, Kif23, Nbl1, Ntf3, Ntng2, Pcdh15, Rhog, Syne1, 
Syngap1, Wnt3a  
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protein pro-opiomelanocortin-alpha (Pomc), muscarinic cholinergic and cannabinoid 
receptors Chrm1 and Cnr1, as well as groups of genes associated with cytoskeletal 
function including genes important for the transport of synaptic vesicles and 
microtubule dynamics. 
 
3.3.3 Canonical signaling pathways associated with gene expression 
changes in the adult brain  
Genes differentially expressed between control versus ethanol-treated adults were 
analyzed using the IPA for associations to canonical biological pathways (Table 3.10).  
Consistent with the biological functions analyses, glutamate receptor signaling and 
synaptic long-term potentiation were identified, driven by the altered expression of 
a number of glutamate receptor subunits.   Also identified was a significant cluster of 
genes associated with retinoic acid signaling, ephrin receptor signaling, calcium 
signaling, and neuronal nitric oxide synthase (nNOS) signaling.  Interestingly,  
Circadian rhythm signaling and serotonin receptor signaling were also identified, 
indicating that both glutamate and serotonergic-based neurotransmission may be 
affected by trimester three-equivalent ethanol exposure.  Other pathways of interest 
were folate-mediated one-carbon metabolism, also identified by the biological 
functions analyses, and mammalian target of rapamycin (mTOR) signaling.  
 
3.3.4 Interacting gene networks involved in gene expression changes in the 
adult brain 
The genes detected as altered in the brain of adult mice exposed to alcohol at P4 and 
P7 were analyzed using the gene network analysis tool within the Ingenuity ® 
software platform to predict interacting molecular networks.  The predicted 
networks were highly interrelated and focused around various glutamate receptor 
subunits.  While five networks were identified as significant, most of the interactions 
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between altered transcripts were described by the first two, associated with the 
functions of “neurological disease, psychological disorders, behaviour” (NPD) (focus 
molecules = 17) and “cell morphology, cell-to-cell signaling and interaction, nervous 
system development and function” (CCN) (focus molecules = 14).  These networks are 
shown in Figures 3.23 and 3.24.    The NPD network contained huntingtin (Htt) as a hub 
molecule, which was not differentially expressed acutely following ethanol exposure but 
was identified as a major hub of the short-term gene network. Other hub molecules 
included glutamate receptor, ionotropic, N-methyl D-aspartate 2B (Grin2b) and the 
apoptosis enzyme caspase 3 (Casp3), both of which were also down-regulated. The CCN 
network also contained a number of glutamate receptor subunits and Grin2b appeared 
again as a network hub molecule. Other hub molecules included the synaptic protein discs, 
large homolog 4 (Drosophila) (Dlg4) and, interestingly, retinoic acid receptor, alpha 
(Rara). Given that the functions associated with these networks were interrelated, the 
networks were merged to evaluate molecules that may be effectors of the neurologica l 
changes associated with third trimester ethanol exposure (Figure 3.25).  The merged 
networks implicated Htt as a central hub, as well as the glutamate receptor proteins Grin2b 
and glutamate receptor, ionotropic, AMPA1 (alpha 1) (Gria1). Neurotrophin 3 (Ntf3), 
which appeared within many gene clusters identified by the biological functions analyses, 
also appeared within the merged network as a central hub molecule, as did apolipoprotein 
E (Apoe). 
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TABLE 3.10.  Ingenuity® canonical pathways associated with transcripts altered in the adult brain of mice treated with ethanol at P4+7. 
 
 
Canonical pathway p-value No. molecules Genes 
    
Glutamate receptor signaling 0.0000074 9 Grin2b, Grin3b, Gnb3, Grid1, Grin2c, Grin2d, Grik3, Grm4, Grik1 
Retinoic acid-mediated apoptosis 
signaling 
0.000550 6 Fadd, Casp3, Rarb, Tnfsr10, Rxrb, Irf1 
Ephrin Receptor Signaling 0.00224 11 Grin2b, Efnb2, Ephb1, Grin3b, Gnb3, Itsn1, Grin2c, Efna5, Grin2d, Vegfc, 
Figf 
Calcium Signaling 0.00417 10 Rcan1, Grin2b, Grin3b, Hdac8, Grin2c, Grin2d, Mef2d, Trdn, Hdac10, Grik1 
nNOS Signaling in Neurons 0.00447 5  Grin2b, Grin3b, Grin2c, Grin2d, Capn3 
Aminosugars Metabolism 0.00501 6 Gnpnat1, Gnpda1, Pde12, Mdp1, Hexa, Gfpt2 
Circadian Rhythm Signaling 0.00692 4 Grin2b, Grin3b, Grin2c, Grin2d 
One Carbon Pool by Folate 0.00794 3 Tyms, Mthfs, Mtr 
CREB Signaling in Neurons 0.0170 9 Grin2b, Gnb3, Polr2d, Grid1, Grin2c, Grin2d, Grik3, Grm4, Grik1 
mTOR Signaling 0.0288 14 Fau, Rhog, Rps10, Rhot2, Rptor, Vegfc, Figf,  Insr, Rpsa, Efnb2, Ephb1, Gnb3, 
Itsn1, Vav3 
Ephrin B Signaling 0.0295 5 Efnb2, Ephb1, Gnb3, Itsn1, Vav3 
Serotonin Receptor Signaling 0.0347 3 Htr5b, Htr1a, Htr1d 
Synaptic Long Term Potentiation 0.0347 6 Grin2b, Grin3b, Grin2c, Grin2d, Cacna1c, Grm4 
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FIGURE 3.23.  Ingenuity Pathway Analysis™ network analysis indicating annotated 
interactions between transcripts altered in the adult brain by ethanol exposure at P4+7 
associated with ‘neurological disease, psychological disorders, behaviour’ (NPD).  Down-
regulated (green) genes are indicated.  Arrowhead indicates the direction of action. 
Notations in brackets adjacent to the edge key labels indicate the number of lines of 
evidence (publically available data sourced by Ingenuity®) supporting the interaction.   
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FIGURE 3.24.  Ingenuity Pathway Analysis™ network analysis indicating annotated 
interactions between transcripts altered in the adult brain by ethanol exposure at P4+7 
associated with ‘cell morphology, cell-to-cell signaling and interaction, nervous system 
development and function’ (CCN).  Down-regulated (green) genes are indicated.  
Arrowhead indicates the direction of action. Notations in brackets adjacent to the edge 
key labels indicate the number of lines of evidence (publically available data sourced by 
Ingenuity®) supporting the interaction.   
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FIGURE 3.25.  Merged Ingenuity Pathway Analysis™ networks showing interactions 
between the most significant gene networks (see Figures 3.23 and 3.24) affected in the 
adult brain following ethanol exposure at P4+7.  Down-regulated (green) genes are 
indicated.   Centralized “hub” molecules linking multiple interacting genes are enlarged. 
Arrowhead indicates the direction of action. Notations in brackets adjacent to the edge 
key labels indicate the number of lines of evidence (publically available data sourced by 
Ingenuity®) supporting the interaction.   
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3.3.5 Quantitative RT-PCR confirmation of array-identified mRNA levels 
Four genes detected by the array analysis were chosen for confirmation by real-time 
quantitative RT-PCR (qRT-PCT), selected based on their fold changes and prominence 
in biological functions and networks identified as affected following ethanol 
treatment.  Genes chosen for qRT-PCR analysis were: cannabinoid receptor 1 (brain) 
(Cnr1), glutamate, ionotropic, N-methyl D-aspartate 2B (Grin2b), 5-hydroxytryptamine 
(serotonin) receptor 5B (Htr5b), and pro-opiomelanocortin-alpha (Pomc).   Real-time 
results as compared to array fold-changes are shown in Figure 3.26.  Fold-changes 
calculated from deltaCt values showed good consistency with the array results.  All 
genes confirmed as significantly different from controls (student’s t-test, p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3.  Results 
 
119 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.26.  Quantitative RT-PCR confirmation of array-identified changes in mRNA 
levels in the adult (P60) brain of mice treated with ethanol at P4+7.  Data are shown as 
mean (±SEM). Genes are listed alphabetically: cannabinoid receptor 1 (brain) (Cnr1), 
glutamate receptor, ionotropic, N-methyl D-aspartate 2B (Grin2b), 5-hydroxytryptamine 
(serotonin) receptor 5B (Htr5b), and pro-opiomelanocortin-alpha (Pomc).  Expression of 
all genes was significantly different from controls (students’ t-test, p < 0.05).  
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3.4 Comparison of acute and long-term gene expression 
changes resulting from ethanol exposure during 
synaptogenesis  
The gene expression changes that were identified by the short-term microarray 
analysis (4 hours post-treatment) were compared to the transcript list generated by 
adult gene expression analysis to evaluate potential common genes and pathways 
that may represent the molecular adaptation of neural cells to developmental ethanol 
exposure.   Twelve transcripts that showed altered expression acutely following 
ethanol exposure at P7 were also detected as differentially expressed in the adult  
brain (Table 3.11).  Five of these genes showed down-regulation in both samples, 
while the remaining seven showed an inverse relationship (upregulated acutely 
following ethanol exposure but down-regulated in the adult brain samples) between 
the acute versus long-term gene expression changes.  Among these were genes critical 
to both neurodevelopment and adult brain function, including glutamate signaling 
(Folh1 and Grin2b), serotonin signaling (Htr1d, Slc16a6), hypothalamic-pituitary-
adrenal stress response (Pomc), and cellular organization (Hmcn1, Pcdhb18).   Other 
genes identified have been previously implicated in neurological phenotypes, such as 
seizure threshold 2 (Szt2) and XRCC6 binding protein 1 (Xrcc6bp1), or have roles as 
zinc finger-containing transcription factors (Zbtb10 and Zfp9).  
The DAVID gene ontology biological functions, IPA gene ontology and IPA canonical 
pathways associated with the altered short- and long-term transcripts were 
compared to identify common potentially-targeted pathways that may represent 
some continuity between the acute and the persistent effects of ethanol exposure 
during synaptogenesis.    This analysis revealed that, while the number of overlapping 
transcripts identified by both the short- and long-term gene arrays was limited, there 
were a number of closely associated biological functions and canonical pathways 
represented within both gene lists (Table 3.12). Genes associated with synaptic 
transmission and plasticity were present in both the short- and long-term gene lists, 
with both showing a number of glutamate receptor subunit transcripts including 
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TABLE 3.11.  Genes altered by alcohol exposure acutely following treatment (at P7) that remain altered during early adulthood (at P60). 
 
 
 
 
 
Accession No. Gene Symbol Gene Name 
Chr. 
Location 
Fold Change 
acute (P7) long-term (P60) 
      
      
NM_016770 Folh1 folate hydrolase 1 7 D1-D2 1.44 -1.28 
NM_008171 Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) 6 G1 1.25 -1.27 
NM_144835 Heatr1 HEAT repeat containing 1 13 A1 -1.31 -1.33 
NM_001285482.1 Htr1d 5-hydroxytryptamine (serotonin) receptor 1D 4 D3 1.23 -1.27 
NM_001024720 Hmcn1 hemicentin 1 1 G1 -1.20 -1.28 
NM_053143 Pcdhb18 protocadherin beta 18 18 B3 1.21 -1.43 
NM_008895 Pomc pro-opiomelanocortin-alpha 12 A1 -1.21 -1.57 
NM_001029842 Slc16a6 solute carrier family 16 (monocarboxylic acid 
transporters), member 6 
11 E1 
 
1.35 -1.45 
 
NM_198170 Szt2 seizure threshold 2 4 D2 -1.22 -1.24 
NM_026858 Xrcc6bp1 XRCC6 binding protein 1 10 D3 -1.20 -1.36 
NM_177660 Zbtb10 zinc finger and BTB domain containing 10 3 A1 1.38 -1.30 
NM_011763 Zfp9 zinc finger protein 9 6 F1 1.25 -1.29 
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TABLE 3.12.  Related gene ontology biological functions and canonical pathways associated with transcripts altered acutely following 
ethanol treatment at P7 and those altered in the adult (P60) brain of mice treated at P4+7.  
aBiological functions or canonical pathways identified by DAVID gene ontology functional clustering, IPA gene ontology functional clustering, or IPA canonical pathways 
analysis.
      
Short term response  Long term response 
Function Identified bya p-value Genes   Function Identified bya p-value Genes 
         
regulation of 
synaptic 
transmission 
DAVID 0.0464 Grin2b, Edn1, 
Grin2a, Cpeb1 
 synaptic 
transmission 
IPA GO 0.00014 Apoe, Chrm1, Cnr1, 
Ephb2, Grik1, Grin2b, 
Htr1a, Nrgn1, Ntf3 
plasticity of 
neuronal synapse 
IPA GO 0.0371 Cpeb1, Grin2b  plasticity of 
synapse 
IPA GO 0.0144 Apoe, Grik1, Grin2b, Htt, 
Inppl1, Syngap1 
     glutamate receptor 
signaling 
IPA Canonical 
pathway 
0.000007 Grin2b, Grin3b, Gnb3, 
Grid1, Grin2c, Grin2d, 
Grik3, Grm4, Grik1 
steroid hormone 
receptor activity 
DAVID 0.0425 Rxrg, Nr4a1, 
Nrob1 
 secretion of 
steroid 
IPA GO 0.0018 Apoe, Pomc 
hormone activity DAVID 0.0401 Inhba, Pomc, 
Apln, Adcyap1 
     
secretion of 
corticosterone 
IPA GO 0.0193 Pomc      
Circadian  rhythm 
signaling 
IPA Canonical 
pathway 
0.000244 Adcyap1, Cry1, 
Grin2a, Grin2b, 
Per1, Per2 
 Circadian rhythm 
signaling 
IPA Canonical 
pathway 
0.00692 Grin2b, Grin3b, Grin2c, 
Grin2d 
TR/RXR activation IPA Canonical 
pathway 
0.0172 Dio2, Ldlr, 
Pik3r1, Rxrg, 
Slc2a1 
 retinoic acid-
mediated 
apoptosis signaling 
IPA Canonical 
pathway 
0.00055 Fadd, Casp3, Rarb, 
Tnfsf10, Rxrb, Irf1 
PTEN signaling IPA Canonical 
pathway 
0.0203 Dio2, Ldlr, 
Pik3r1, Rxrg, 
Slc2a1 
 mTOR Signaling IPA Canonical 
pathway 
0.0288 Fau, Rhog, Rps10, Rptor, 
Vegfc, Figf, Insr, Rpsa 
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Grin2a, Grin2b, and Grik1 . Also common between the short- and long-term lists were 
GO functions related to hormone activity and signaling, specifically steroid and 
corticosterone secretion and, interestingly, Circadian rhythm signaling. Finally, 
retinoic acid signaling and the canonical PTEN/ATK/mTOR signaling pathway were 
identified as associated with transcripts within both the short- and long term gene 
lists. 
 
3.5 microRNA expression changes in the adult brain following 
ethanol exposure during synaptogenesis 
Given that the long-term changes to mRNA levels may be mediated by epigenetic 
regulatory mechanisms, I evaluated the changes to microRNA (miRNA) expression in 
the adult brain (P60) following ethanol exposure at P4 and P7 as one possible 
regulatory influence for the adult gene expression observations.  miRNA expression 
array analysis identified 33 miRNA transcripts that were differentially ex pressed 
between control and ethanol-treated whole brain RNA (fold change > 1.2, FDR-
corrected p = 0.05) (Appendix C).  Fold changes ranged from -4.17 (mmu-miR-704) to 
2.44 (mmu-miR-721).   Again, most miRNAs were down-regulated following ethanol 
exposure, with 73% (24/33) showing a negative fold-change as compared to saline-
treated controls.  A complete miRNA list showing differential expression between 
control and ethanol-treated samples is provided in Appendix C.   
 
3.5.1 Relationship between miRNA and predicted target mRNA expression 
changes in the adult brain 
Ingenuity Target Filtering™ analysis was performed using the gene lists from the 
miRNA array and the long-term (P60) mRNA expression array to assess potential 
regulatory interactions between altered miRNAs and mRNAs in the adult brain of 
mice exposed to ethanol at P4+7.  High-confidence (experimentally shown or strongly  
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predicted based on sequence) interactions showing an inverse relationship between 
altered miRNA and mRNA expression were included.  A number of miRNAs were 
paired with a number of potential mRNA targets (Table 3.13), suggesting that a single 
miRNA may have multiple targets and exert an effect on multiple biological pathways, 
shown in Table 3.13.  These genes were associated with a number of  previously-
identified gene ontology functions and canonical pathways including axonal guidance 
(Adam9, L ingo1, Sema6d, Shank2, Prkcb, and Efnb2), cytoskeletal organization 
(Arhgap6, Shank2, Rhou), intracellular signaling (Lingo1, Lrrk2, Map3k7, Mras, Prkcb, 
Rhou, and Ppm1b), chromatin organization and structure (Ino80, Ncor2), and 
transcriptional regulation (Rbm9, Spen, Ncor2, Ncoa3).  Interestingly, hormonal 
signaling-related transcripts were abundant among the potential mRNA targets 
showing altered expression in the adult brain, including corticotrophin-releasing 
hormone signaling, glucocorticoid receptor signaling, estrogen, and androgen 
receptor signaling (Adam9, Cnr1, Mras, Ncor2, Ncoa3, Prkcb, Ppargc1a, Rbm9, and 
Spen).  Lastly, altered mRNA transcripts identified as potential targets of miR-721 
were associated with retinoid acid signaling (Ncor2, Irf1, Ncoa3, Ppargc1) and the 
canonical PI3K/AKT/mTOR signaling pathway (Tsc1).  
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TABLE 3.13.  miRNAs and putative mRNA transcript targets showing altered inverse 
expression in the adult (P60) brain following ethanol exposure at P4+7 and associated 
biological pathways. 
      
miRNA ID miRNA 
fold 
change 
 Target 
gene ID 
Target 
mRNA 
fold change 
Associated pathways 
      
mmu-miR-26b 1.284  Adam9 -1.114 Axonal Guidance Signaling 
mmu-miR-26b 1.284  Cnr1 -1.332 Corticotropin Releasing 
Hormone Signaling 
G-Protein Coupled Receptor 
Signaling 
Reelin Signaling in Neurons 
cAMP-mediated signaling 
mmu-miR-26b 1.284  Exoc8 -1.221 Cdc42 Signaling 
mmu-miR-26b 1.284  Hs6st1 -1.523 Cysteine Metabolism 
LPS/IL-1 Mediated Inhibition 
of RXR Function 
Xenobiotic Metabolism 
Signaling 
mmu-miR-26b 1.284  Lingo1 -1.153 Axonal Guidance Signaling 
mmu-miR-26b 1.284  Map3k7 -1.193 Acute Phase Response 
Signaling 
BMP signaling pathway 
mmu-miR-26b 1.284  Mras -1.200 14-3-3-mediated Signaling 
AMPK Signaling 
Actin Cytoskeleton Signaling 
Acute Phase Response 
Signaling 
Androgen Signaling 
mmu-miR-26b 1.284  Pfkfb3 -1.143 AMPK Signaling 
Fructose and Mannose 
Metabolism 
mmu-miR-26b 1.284  Ppm1b -1.429 AMPK Signaling 
mmu-miR-26b 1.284  Rhou -1.250 CXCR4 Signaling 
Glioblastoma Multiforme 
Signaling 
Glioma Invasiveness Signaling 
HMGB1 Signaling 
mmu-miR-26b 1.284  Sema6d -1.181 Axonal Guidance Signaling 
mmu-miR-26b 1.284  Shank2 -1.291 Axonal Guidance Signaling 
mmu-miR-26b 1.284  Tab3 -1.253 NF-κB Signaling 
mmu-miR-26b 1.284  Tdrd7 -1.568 Pluripotency 
mmu-miR-26b 1.284  Ube2j1 -1.151 Hypoxia Signaling 
Protein Ubiquitination 
Pathway 
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Table 3.13 continued…   
miRNA ID 
miRNA 
fold 
change 
 
Target 
gene ID 
Target 
mRNA 
fold change 
Associated pathways 
      
mmu-miR-184 1.485  Ncor2 -1.273 Aryl Hydrocarbon Receptor 
Signaling 
Estrogen Receptor Signaling 
Glucocorticoid Receptor 
Signaling 
Huntington's Disease Signaling 
LXR/RXR Activation 
PPAR Signaling 
PPARα/RXRα Activation 
RAR Activation 
mmu-miR-184 1.485  Prkcb -1.115 14-3-3-mediated Signaling 
Aldosterone Signaling 
Androgen Signaling 
Axonal Guidance Signaling 
mmu-miR-721 2.437  Akap11 -1.111 β-adrenergic Signaling 
Protein Kinase A Signaling 
cAMP-mediated signaling 
      
mmu-miR-721 2.437  B4galt5 -1.257 N-Glycan Biosynthesis 
mmu-miR-721 2.437  Cnr1 -1.332 Corticotropin Releasing 
Hormone Signaling 
G-Protein Coupled Receptor 
Signaling 
Reelin Signaling in Neurons 
cAMP-mediated signaling 
mmu-miR-721 2.437  Efnb2 -1.261 Axonal Guidance Signaling 
Ephrin Receptor Signaling 
mmu-miR-721 2.437  Fam20b -1.271 Inositol Phosphate Metabolism 
Nicotinate and Nicotinamide 
Metabolism 
mmu-miR-721 2.437  Ino80 -1.247 Purine Metabolism 
mmu-miR-721 2.437  Irf1 -1.323 Production of Nitric Oxide and 
Reactive Oxygen Species 
Retinoic acid Mediated 
Apoptosis Signaling 
Role of PKR in Interferon 
Induction  
mmu-miR-721 2.437  Lrrk2 -1.196 Mitochondrial Dysfunction 
mmu-miR-721 2.437  Ncoa3 -1.247 Aryl Hydrocarbon Receptor 
Signaling 
Estrogen Receptor Signaling 
Glucocorticoid Receptor 
Signaling 
PPARα/RXRα Activation 
Role of Wnt/GSK-3β Signaling 
TR/RXR Activation 
VDR/RXR Activation 
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Table 3.13  continued…   
miRNA ID 
miRNA 
fold 
change 
 
Target 
gene ID 
Target 
mRNA 
fold change 
Associated pathways 
mmu-miR-721 2.437  Pfkfb3 -1.143 AMPK Signaling 
Fructose and Mannose 
Metabolism 
mmu-miR-721 2.437  Ppargc1a -1.123 Estrogen Receptor Signaling 
FXR/RXR Activation 
PPAR Signaling 
PPARα/RXRα Activation 
PXR/RXR Activation 
RAR Activation 
TR/RXR Activation 
Xenobiotic Metabolism 
Signaling 
mmu-miR-721 2.437  Rbm9 -1.311 Estrogen Receptor Signaling 
mmu-miR-721 2.437  Shank2 -1.291 Axonal Guidance Signaling 
mmu-miR-721 2.437  Spen -1.140 Estrogen Receptor Signaling 
mmu-miR-721 2.437  Sphk2 -1.304 Ceramide Signaling 
PDGF Signaling 
Sphingolipid Metabolism 
mmu-miR-721 2.437  Tsc1 -1.381 14-3-3-mediated Signaling 
AMPK Signaling 
Glioblastoma Multiforme 
Signaling 
PI3K/AKT Signaling 
mTOR Signaling 
mmu-miR-721 2.437  Wdfy3 -1.327 N-Glycan Biosynthesis 
mmu-miR-1970 -1.694  Arhgap6 1.188 RhoA Signaling 
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3.5.2 Confirmation of miR-26b and putative mRNA target Cnr1 inverse 
expression by quantitative RT-PCR 
Given the roles of cannabinoid receptor 1 (Cnr1) in neurological phenotypes including 
corticotropin releasing hormone signaling, the relationship between Cnr1 and its 
putative regulatory miRNA miR-26b were confirmed by qRT-PCR.  The down-
regulation of Cnr1 was confirmed successfully, showing reduced transcript levels in 
the brain of adult (P60) mice treated with ethanol at P4 and P7 as compared to saline-
treated controls (fold-change = -1.13 ± 0.04, p = 0.0042) (Figure 3.26).  The up-
regulation of mmu-miR-26b also confirmed successfully, showing increased 
transcript levels (fold-change = +3.70 ± 0.20) in the adult brain of mice treated with 
ethanol during the trimester three-equivalent (p < 0.001).   
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This project was initiated to evaluate if human FASD could be effectively modeled 
using mice and to utilize that model to investigate the molecular underpinnings of 
the range of neural and phenotypic abnormalities associated with these spectrum 
disorders.  The work included in this thesis sought to assess if a binge-like dose of 
ethanol during third trimester-equivalent could produce, in mice, behavioural and 
cognitive phenotypes consistent with human FASD, and if that model could then 
be used to elucidate molecular alterations in the brain that may initiate and 
maintain these phenotypes.  The results presented indicate that a trimester three -
equivalent binge exposure to alcohol is sufficient to produce multiple behavioural 
phenotypes that reflect those commonly observed in human children, 
adolescents, and adults prenatally exposed to alcohol.  Further, there is 
substantial specificity and consistency with regard to the genes, biological 
pathways, and processes that are associated with this exposure paradigm both 
acutely following ethanol exposure and those that persist into adulthood.  Finally, 
utilization of the process outlined in this thesis is discussed in terms of its efficacy 
to model human FASD, its contributions furthering our understanding of the 
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disorder, and to evaluate the results within the context of potential diagnostic or 
therapeutic strategies.  
 
4.1 Effects of ethanol exposure during synaptogenesis on 
behaviour 
The results presented indicate that a binge-like dose of ethanol within a narrow 
neurodevelopmental period during the trimester three-equivalent in mice is 
sufficient to produce a number of behavioural and cognitive phenotypes relevant 
to FASD in humans.    
This finding is interesting given that a large proportion of prenatally-exposed 
infants are likely exposed via low to moderate consumption (1-2 drinks) at 
multiple points during gestation (KESMODEL and OLSEN 2001, ZELNER and KOREN 
2013).  Binge drinking is even more rare, and only a small percentage of women 
(approximately 16%) of binge-drinkers self-report on binge-like alcohol 
consumption after the first trimester (GLADSTONE et al. 1997).  As such, most FASD-
related research has focused on physiological or cognitive consequences of early-
gestation exposure.  High doses of alcohol consumed during the first trimester of 
pregnancy are associated with distinctive cranio-facial abnormalities, decreases 
in brain volume, and detectable changes to neuronal tract connectivity in 
numerous brain regions (ARCHIBALD et al. 2001, LEBEL et al. 2008, NORMAN et al. 
2009, LIPINSKI et al. 2012).  These features may assist in the identification of 
alcohol-exposed children; however, the majority of prenatally- exposed offspring 
show changes in cognitive function and behaviour in the absence of a ny 
physiological abnormalities (MATTSON et al. 1998, GREEN et al. 2009).  It is 
therefore important to understand the effects of alcohol on the developing brain 
at all developmental stages to understand how timing contributes to specific 
phenotypic changes, even in the absence of physiological markers.  Further, it is 
prudent to understand the biological mechanisms that underlie certain windows 
Chapter 4.  Discussion 
 
131 
 
of ethanol vulnerability such as synaptogenesis, which is a critical period for 
establishing the basis of neuronal communication that supports adult brain 
function.      
 
4.1.1 Effects of ethanol exposure on neonatal development  
Early neonatal indications of prenatal alcohol exposure are useful both 
diagnostically and prognostically, as they can facilitate FASD identification and 
intervention to perhaps improve the later-life secondary behavioural and 
cognitive outcomes associated with these disorders (STREISSGUTH et al. 2004).   The 
weight of pups treated with ethanol at P4 or P7 was not affected by ethanol 
treatment, while exposure at both postnatal days (P4 and P7) did significantly 
decrease the weight of neonates compared to their saline-treated controls.  This 
is likely attributable to reduced feeding ability and nutritional intake rather than 
a direct effect of alcohol (BARRON et al. 1991), however it is interesting that this 
difference persisted well into adolescence.  Low birth weight has 
epidemiologically associated with moderate to high alcohol consumption, 
including late-gestational binges (WHITEHEAD and LIPSCOMB 2003), though, studies 
including self-reports of binge-like alcohol consumption during the third 
trimester in humans are rare.  Animal studies corroborate these findings, 
indicating that high, punctuated ethanol exposures producing low neonatal 
weight (ABEL 1996, WOZNIAK et al. 2004); although, the pattern of ethanol 
administration between studies varies considerably making comparisons 
difficult.  Reduced birth and neonatal weight generally appears to be dose-
dependent with no clear threshold, but is consistently associated with prenatal 
alcohol exposure.    
Prenatal alcohol exposure has been linked to infant delays in muscle tone, motor 
coordination, reflexes and balance (STAISEY and FRIED 1983, COLES et al. 1985, 
JACOBSON et al. 1998, KALBERG et al. 2006), but literature on the effects of alcohol 
exposure on early-life coordination and neuromuscular reflexes is somewhat 
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lacking in animal studies, particularly when compared to quantity of research 
examining other behaviours such as learning. It is reasonable to believe that the 
abnormalities consistently observed in higher cognitive functions would be 
reflected in the disruption of basic neurodevelopmental achievement. Therefore, 
a more detailed evaluation of the early postnatal development of ethanol-exposed 
neonates was a goal of this investigation.  Ethanol exposure did not have a strong 
effect on reflexive behaviours that appear early in postnatal development such as 
negative geotaxis, cliff aversion, and auditory startle (Table 3.1).  However, 
milestones that rely on the concurrent development of strength and coordination 
were affected in mice treated at P4 or P4+7, such as surface righting and forelimb 
grasp. Also affected in these two groups were the later development of an ear-
twitch reflex and delayed eye opening, suggesting that ethanol was able to 
differentially target multiple developmental systems.  
These milestone delays were not observed in P7-treated mice, suggesting that 
treatment earlier during the trimester three-equivalent synaptogenesis period 
affected the development of these traits but that the neuromuscular coordination, 
acoustic startle reflex, and ocular maturation processes  responsible for the 
achievement of these milestones were sufficiently established by P7.   Alcohol 
exposure at P7 resulted in the delay of more complex coordination-dependent 
milestones such as air righting and open field traversal.  During the early period 
of neonatal development in mice (as well as in humans), forelimb coordination 
and strength develops prior to hindlimb and interlimb coordination (ALTMAN and 
SUDARSHAN 1975, THELEN 1985).  Given that these milestones are dependent on this 
rostal-caudal gradient of limb maturation, the results suggests that ethanol 
exposure may significantly delay this ability to coordinate reflexes with full limb 
control.  As motor development and motor learning are largely determined by the 
cerebellum (ITO 2000), these delays in developmental milestone achievement 
may be due to ethanol’s teratogenic effect on this brain region.  Indeed, the 
cerebellum matures along a protracted timeline, including a rapid period of 
growth during synaptogenesis (VOLPE 2009), and has been shown to be 
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exquisitely sensitive to ethanol-induced apoptosis during this period (IKONOMIDOU 
et al. 2000, OLNEY et al. 2002a).  This is consistent with reports of reduced 
cerebellar volume in children with FASD (RILEY et al. 2004, NORMAN et al. 2009, 
MEINTJES et al. 2014).  Additionally, cerebellar Purkinje cells that survive third 
trimester-equivalent ethanol exposure show altered GABA subunit expression, 
affecting GABAergic tone of remaining neurons (DIAZ et al. 2014b).  Interestingly, 
delayed motor development may be indicative of cognitive performance given 
that the cerebellum is also involved in higher-level cognitive processes (DIAMOND 
2000, BEN-YEHUDAH and FIEZ 2008, BELLEBAUM and DAUM 2011).  At the least, 
neonatal developmental assessment was able to reveal consistent delays in early 
postpartum milestone achievement in ethanol-treated pups, a hallmark of which 
was delayed limb coordination that may be an indicator of third trimester-
equivalent exposure and also, potentially, of performance at older ages on more 
complex behavioural tasks.  
 
4.1.2 Ethanol exposure during synaptogenesis results in environment-
dependent hyperactivity  
Hyperactivity, impulsivity, and inattention has been consistently associated with 
children prenatally exposed to alcohol, with significant differences from non -
exposed children detectable at very young ages (BHATARA et al. 2006, NASH et al. 
2008, ALVIK et al. 2013).  There is further evidence that these traits show some 
gender specificity, with males more likely to be diagnosed with attention 
deficit/hyperactivity disorder (ADHD), a common psychiatric co-morbidity to 
FASD (HERMAN et al. 2008).  Literature is conflicted, however, on the effect of 
prenatal ethanol exposure on locomotor activity in animal models.  Depending on 
animal model, ethanol dosage, and timing of administration, studies have found 
hyperactivity, hypoactivity, or a lack of effect of ethanol (TRAN et al. 2000, ALLAN 
et al. 2003, DOWNING et al. 2009, MARCHE et al. 2010, MANTHA et al. 2013).  We have 
published data supporting that the timing and method of ethanol exposure is 
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critical to this phenotype, suggesting there are windows of vulnerability (KLEIBER 
et al. 2011, MANTHA et al. 2013).  The results generated from the novel open field 
exploration assay were subtle, and showed that individual ethanol treatments on 
P4 or P7 alone did not significantly alter locomotor activity in a novel open field 
arena, and that treatment on both days (P4 and P7) resulted in hypoactivation in 
females only (Figure 3.2).  This was contrasted by an increased number of rears 
in both the P7 group and the P4+7 females.  Given the increased rearing activity 
and the sex-specificity of the hypoactivity in P4+7 females, it is possible that the 
lack of significant effect may have been confounded by neophobia caused by 
exposure to a novel environment.  This was supported by the trend towards 
decreased time spent in the centre zone by ethanol-treated animals (Figure 3.6), 
an indicator of anxiety-associated behaviour.  Consequently, I examined the 
nocturnal locomotor activity of ethanol-exposed and control mice in a familiar, 
home cage environment to evaluate activity in the absence of novelty-induced 
stress.   
The infrared Actritrack system is able to record a variety of measures related to 
locomotor activity, including total number of infrared beam breaks, which 
includes locomotor activity and stereotypic movement, velocity of motion, 
distance travelled, and rearing behaviour.   In young children and adolescents 
with FASD, hyperactivity is among the most consistently-associated phenotype, 
but a recent meta-analysis has also suggested impairments in balance and 
coordination (LUCAS et al. 2014), which is certainly consistent with the ability of 
ethanol-treated mice to achieve early developmental milestones (Table 3.1).  As 
such, I sought to assess the locomotor behaviour of control and ethanol-treated 
mice, including changes in other activity and motor-related features captured by 
the Actimeter system, over the course of the nocturnal dark cycle.  Following PCA 
analysis, the Actimeter measures were found to be all significantly positively 
correlated with total activity (Table 3.3), suggesting that this measure could give 
an adequate indication of the overnight behaviour of control and ethanol-treated 
mice.  Increases in activity were detected during the early part of the dark cycle in 
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ethanol-treated mice, significant in mice treated at P7 and P4 and P7, suggesting 
that treatment at P7 was critical to this behaviour. There is also evidence that 
hyperactivity is associated with altered glutamate and GABA signalling in the 
neural pathways linking the hippocampus, accumbens, and subpallidal region 
(MOGENSON and NIELSEN 1984).  The hippocampus and areas of the mesolimbic 
pathway are particularly susceptible to ethanol exposure during the brain growth 
spurt.  In particular, binge-like ethanol exposure during the third trimester 
equivalent results in drastic reductions of the CA1 region of the hippocampus 
(OLNEY et al. 2002a) and reduced expression of numerous glutamate receptor 
subunits in the adult brain (KLEIBER et al. 2013), presumably altering the efficiency 
of glutamatergic synaptic transmission involving this region – a feature that is also 
a hallmark of animal models of hyperactivity (JENSEN et al. 2009).    
Interestingly, mice treated at P7 and P4+7 also show increased activity at the end 
of the dark cycle and beginning of the light cycle (Figures 3.5, 3.6).  Whereas 
control mice typically show extremely low levels of activity during this period, 
ethanol-exposed mice continue to remain active.  Altered activity patterns during 
light/dark cycling may be an indication of impairments in suprachiasmatic nuclei 
control of circadian clock function (HOUBEN et al. 2014).   Prenatal alcohol 
exposure is a strong predictor of sleep disturbance in children that are 
characterized by frequent sleep disruption, shortened sleep duration, and 
increased sleep anxiety as compared to non-ethanol exposed children (STRATTON 
et al. 1996, WENGEL et al. 2011, CHEN et al. 2012). While the association between 
altered activity levels during the early light cycle and circadian rhythm disruption 
in this study may be speculative, it is intriguing given the strong evidence from 
animal models that ethanol exposure during the third trimester-equivalent leads 
to shortened sleep-wake cycles, delayed sleep onset, and delayed sleep cycle 
transitions (EARNEST et al. 1997, SAKATA-HAGA et al. 2006, VOLGIN and KUBIN 2012).  
These phenotypes may be attributed to a number of biological mechanisms, 
including vulnerability of the suprachiasmatic nuclei to ethanol teratogenesis 
leading to the dampening of BDNF rhythmicity (EARNEST et al. 1997, EARNEST et al. 
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2001), reduction in serotonergic tone and neuronal density (TAJUDDIN and DRUSE 
1999, SARI and ZHOU 2004), and, as reported by this study, altered mRNA levels of 
serotonin receptor subunit genes, Period genes, and Cryptochome genes that 
regulate Circadian function (CHEN et al. 2006a, KLEIBER et al. 2013, KLEIBER et al. 
2014b). Given this biological and epidemiological data, it is evident that the third 
trimester equivalent may be a window of vulnerability for phenotypes associated 
with alterations in activity levels and circadian function resulting from ethanol’s 
ability to target those systems governing these behaviours.  While evaluating 
sleep disturbance and circadian cycling was not directly assessed by this study, 
evidence suggests that altered circadian function may play a role to, in the least, 
exacerbate risk for other phenotypes such as hyperactivity, anxiety, and cognitive 
impairments that are hallmarks of fetal alcohol exposure, and that later 
gestational exposures appear to be a stronger window of vulnerability as 
compared to early exposures (TRAN et al. 2000, O'LEARY-MOORE et al. 2006).    
 
4.1.3 Ethanol exposure results in anxiety-related phenotypes 
In the assessment of anxiety-related phenotypes, this study utilized three well-
established assays that are indicative of behavioural responses to perceived 
environmental stress: thigmotaxis in a novel open field, exploratory behaviour in 
the light region of a light/dark box (LDB) assay, and willingness to explore a 
narrow, elevated open arm of the elevated plus maze (EPM).   Unfortunately, the 
latter two assays became available late during the course of this study and only 
the double-treatment (P4 + 7) group was able to be tested using all three assays, 
but the results revealed some interesting features regarding anxiety-related 
phenotypes and third trimester-equivalent ethanol exposure.   
Thigmotaxic behaviour was observed in mice treated with ethanol at P7 (Figure 
3.8) and at P4+7 (Figure 3.9).   These data indicated that ethanol exposure during 
this neurodevelopmental period may contribute to anxiety-related behaviours, 
and that the severity of these behaviours may be dose-dependent.  Also, they 
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suggested a possible sex difference in vulnerability to anxiety-related traits.  As 
such, mice treated at P4+7 were also assessed in the LDB and EPM, both of which 
are more anxiogenic tasks than open field exploration, to perhaps more 
sensitively assess anxiety-related phenotypes related to third trimester-
equivalent exposure.  Interestingly, results from the LDB assay showed that while 
both males and females showed a decrease in the amount of time spent in the light 
region and a reduction in the number of entries into the light zone, a clear 
distinction between males and females emerged with females showing 
significantly less light zone exploration than their control counter parts (Figure 
3.10).  This trend was echoed in the EPM assay, with both males and females 
showing increases in anxiety-related open arm exploration, but with females 
showing a marked decrease in the time spent in the open arms and number of 
open arm entries (Figure 3.11).   
These findings are interesting given that maternal binge drinking during 
pregnancy confers risk for adult anxiety and depressive disorders in ethanol-
exposed individuals (FAMY et al. 1998, BARR et al. 2006).  These disorders are 
frequently linked to altered hypothalamic-pituitary-adrenal (HPA) axis function, 
either via altered cortisol or adrenocorticotropin (ACTH) levels, or altered 
expression of HPA axis regulator genes  at basal or under stressful conditions (DE 
KLOET et al. 2005).  Prenatal alcohol exposure is linked to hypothalamic-pituitary-
adrenal (HPA) dysregulation, with heavy drinking during pregnancy associated 
with higher basal cortisol levels and elevated post-stress cortisol (JACOBSON et al. 
1999).   Further, the appearance of anxiety-related behaviours seems to be 
dependent on timing of exposure as mice exposed to alcohol during the first 
trimester-equivalent show no differences from control mice in the LDB or EPM 
assays, while exposure during the second trimester equivalent leads to a decrease 
in anxiety-related phenotypes (MANTHA et al. 2013).  This is in contrast to the 
findings of this study, which suggest that late-gestation ethanol exposure may 
result in an increase in some anxiety-related phenotypes in mice. 
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HPA axis hyper-responsiveness has been identified in both male and female 
animal models of prenatal alcohol exposure; however, sexually dimorphic 
phenotypes have also been consistently reported.  The findings within this study 
corroborate other reports of higher instances of anxiety-related behaviour in the 
EPM in females (OSBORN et al. 1998), potentially due to higher stress hormone 
reactivity in female rodents (CHOI et al. 2008).  Further, Brocardo et al. (2012) 
showed that prenatal alcohol exposure resulted in anxiety and depressive-like 
behaviours in both male and female mice; however, only males showed an 
improvement in these phenotypes following voluntary exercise.  In humans, a 
strong effect of sex has been reported among a sample of adults with fetal alcohol 
exposure; a study by Famy et al. (1998) (FAMY et al. 1998) reported 50% of women 
diagnosed with anxiety disorder co-morbidity as compared to no instances in 
men.  These results may be attributed to the interaction between alcohol and the 
development of the HPA axis and activational effects related to gonadal hormonal 
differences (VIAU and MEANEY 1991, KOFMAN 2002, KUDWA et al. 2014).   
 
4.1.4 Ethanol exposure affects spatial learning and learning strategy 
Learning deficits are a hallmark of FASD and are well-documented in human and 
animal studies of prenatal alcohol exposure (COLES et al. 1991, CLARREN et al. 1992, 
KODITUWAKKU 2009, MATTSON et al. 2010, BRADY et al. 2011).  Human studies have 
emphasized the role of impairments in “executive control” in individuals with 
FASD (COLES et al. 1997, GREEN et al. 2009, MATTSON et al. 2010), which depends on 
inhibition of task-inappropriate responses and a working memory of the goal.  In 
particular, prenatal alcohol exposure appears to affect executive function, spatial 
processing, attention, and memory, with binge-like exposures more detrimental 
to these processes than mild-to-moderate exposures (MATTSON et al. 2010, FLAK et 
al. 2014).  Given that cognitive behaviours such as learning and attention are such 
a widely-reported consequence of prenatal alcohol exposure, it is important that 
any animal model of the disorder replicates these phenotypes.  The findings of this 
Chapter 4.  Discussion 
 
139 
 
study corroborate this human literature and indicate that spatial learning is 
impaired, in a timing and dose-dependent manner, in mice exposed to alcohol 
during the third trimester equivalent (Figure 3.12).  Ethanol treatment at P4 
resulted in minor delays in reaching the target on acquisition days three and four, 
whereas exposure at day 7 resulted in more severe deficits beginning at day 1 and 
significantly lasting throughout days 2 to 4.  This may reflect the sensitivity of 
hippocampal-dependent learning circuitry to ethanol at later stages of 
neurodevelopment, particularly at the peak of the brain growth spurt that occurs 
postnatally in mice but during the third trimester in humans (LIVY et al. 2003, 
WOZNIAK et al. 2004).  This finding is consistent with other studies that suggest 
that ethanol treatment at a specific neurodevelopmental window (P7) can 
produce significant and enduring impairments in spatial learning (SULIK 2005, 
WAGNER et al. 2014).  Learning ability appeared to be susceptible to dose effects 
as multiple ethanol exposures at P4+7 appeared to increase the severity of spatial 
learning deficits during adulthood (Figure 3.12).   These deficits may be attributed 
to the effect of ethanol on learning-associated brain structures, such as apoptosis 
to diencephalic structures that form the hippocampal circuit (OLNEY et al. 2002a, 
WOZNIAK et al. 2004) as well as decreases in cell volume in the within CA1 and CA3 
pyramidal cells and dentate gyrus neurons (LIVY et al. 2003, TRAN and KELLY 2003).   
It is important to note that all mice – ethanol and saline treated alike – showed 
evidence of learning in the Barnes maze task.  The delayed latency to reach the 
target during the later acquisition days in ethanol-treated mice may be attributed 
to differences in learning strategy.  This is perhaps most evident following 
analysis of the type of search strategy used by ethanol and control mice during the 
acquisition learning trials (Figure 3.13).  Interestingly, control mice were rapidly 
able to utilize extra-maze cues to learn the precise location of the target, and the 
number of trials during which they utilized a “direct” search strategy, that is, 
travelled directly to the target hole following release from the central starting 
zone, dramatically increased during acquisition days 2 to 4.  Conversely, ethanol-
treated mice did not exhibit the same increase in “direct” search strategies; 
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observationally, they tended to travel toward the quadrant of the maze in which 
the target was placed, but often the initial hole visited was two or more holes away 
from the target and they progressively searched, hole by hole, in a clockwise or 
counterclockwise manner until they had located the target.  This finding is 
illustrated by the divergence between control and ethanol-treated animals in the 
increase in “direct” search strategy in controls and the increase in “serial” search 
strategy in ethanol-treated mice in later acquisition days (Figure 3.13).  It is 
important to note that both groups showed clear reductions in their use of a 
“mixed” strategy, suggesting that, in both groups, the search for the target was not 
random.  However, the differences in search strategy used may indicate that 
prenatal ethanol exposure may alter spatial learning acquisition styles.   
The spatial learning deficits apparent during the acquisition trails were reflected 
in both the short- and long-term memory recall trials on day 5 and day 12 of 
Barnes maze testing (Figure 3.14, Figure 3.15).  Mice treated with ethanol at P4 
showed a small and non-significant reduction in explorations to the target hole 
location at day 5, but treatment at P7 or at P4+7 resulted in a significant reduction 
of explorations at or around the target, which was not driven by a decrease in the 
total number of explorations.  These trends persisted during the long-term recall 
task at testing day 12.  These results suggest that ethanol exposure may not only 
impair learning during task acquisition, but also the ability of the mouse to recall 
the relationship between the maze layout, the extra-maze cues, and the target 
during spatial memory trials.   Further, the increase in explorations to non-target 
holes opposite the target in ethanol-treated mice may reflect the learning strategy 
acquired during the acquisition phase of testing: while control mice tended to 
travel back and forth remaining around the previous location of the target, the 
ethanol-treated mice persisted in searching each hole on the Barnes maze 
platform in a clock-wise or counter-clockwise direction, as they had during 
acquisition.  
There is evidence that certain types of learning occur similarly in ethanol-exposed 
and non-exposed children but learning in FASD individuals is benefitted by 
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increased repetition and more frequent positive reinforcement (ROEBUCK-SPENCER 
and MATTSON 2004, ENGLE and KERNS 2011).  Other studies have suggested that 
learning and memory strategies do differ between exposed and non-exposed 
children, including variations in visual versus verbal learning styles, deficits in 
attention, problems with planning and spatial working memory, and deficits in 
cognitive flexibility, planning, and strategy use  (RASMUSSEN 2005, GREEN et al. 
2009, RASMUSSEN et al. 2009).  Results from this study suggest that ethanol 
treatment during the third trimester-equivalent results in alterations to both 
learning, memory, and overall strategy in a spatial learning task, consistent with 
findings from the human studies.  Also, while these findings show that prenatal 
alcohol exposure does not prevent learning altogether, they do indicate that 
ethanol induces changes to attention and learning style that are detectable in early 
adulthood.  In humans with FASD, this may establish a pattern of educational 
disadvantage that, when matched with poor early environmental enrichment or 
educational support that recognizes these changes to learning styles, may 
ultimately lead to poor long-term educational and socio-economic outcomes 
(STREISSGUTH et al. 1994, FAMY et al. 1998, JIRIKOWIC et al. 2008b).  
 
4.1.5 Ethanol exposure during synaptogenesis in mice as a model for 
human FASD: a summary 
Modeling complex human disorders in animals requires careful attention to 
behavioural endophenotypes commonly observed in humans with the disorder 
and an appropriate choice of animal and behavioural battery that can most 
accurately represent these phenotypes.  Most neurobehavioural or psychiatric 
disorders are extremely complex via their mode of causation, their effect on 
multiple neurological pathways, and their interaction with environmental factors.  
Usually, modeling them in in their entirety in animals is not possible either 
conceptually or practically (e.g., (O'NEIL and MOORE 2003, O'TUATHAIGH and 
WADDINGTON 2015)); however, it is possible to model smaller aspects of a larger 
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phenotype, with the results to be used with caution when extending behaviours 
observed in an animal model to any human disorder, particularly one that 
involves changes to behavioural and cognitive phenotypes (NESTLER and HYMAN 
2010b, KOOB 2012).    
As compared to other neurobehavioural disorders, the causation of FASD is clear.  
As such, any model involving ethanol exposure during neurodevelopment has a 
certain etiological validity.  In humans, however, the timing and dose of ethanol 
exposure is extremely variable from case-to-case, and not likely to be accurately 
reported (HANNIGAN et al. 2010, LANGE et al. 2014).  It is difficult to ascertain, 
therefore, the relationship between ethanol exposure and the numerous 
behavioural phenotypes that may result.  I thought it important that a behavioural 
battery attempting to evaluate a mouse model of FASD should test a number of 
relevant phenotypes reliably and with regard to the innate behaviour of mice.   
The behavioural battery used in this study was designed to evaluate behaviours 
that are common in humans with FASD as they appear across infanthood, 
childhood, adolescence, and early adulthood within the confines of a mouse model 
system.  This study was the first to use a thorough evaluation of early postnatal 
coordination and reflexive behaviours, given that infants with FASD often show 
delays in the appearance of these behaviours.  Also, this is the first behavioural 
paradigm to take into account the emergence of various behavioural changes 
across development and maturation. The results indicate that the analysis of early 
behaviours are indeed informative, and may be predictive of later-life neuro-
motor and cognitive impairments.  Further, single binge-like exposures during the 
third trimester-equivalent were able to reliably produce changes to activity, 
anxiety-related traits, and learning ability, which often were made more severe 
by a subsequent second ethanol treatment.   The behavioural battery is certainly 
not exhaustive, and there are a number of behavioural phenotypes exhibited by 
humans with FASD that cannot accurately be modeled in mice, but the results 
suggest that at least some of the behaviours exhibited in humans can be replicated 
by this paradigm.  Also, this particular type of treatment paradigm itself may have 
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limited face validity in that it is likely an uncommon practice for women to 
consume a substantial quantity of alcohol only during late gestation; however, it 
serves as a mechanism to evaluate the specific changes that may occur resulting 
from third trimester ethanol exposure in the absence of confounding previous 
exposures.  Also, it serves to show that there may be temporal windows of 
neurodevelopmental vulnerability of brain regions responsible for specific later -
life emergent phenotypes.  Finally, while this thesis is focused on a third-trimester 
paradigm, we have previously shown that the model developed here may be 
applied to other exposure paradigms to evaluate and compare the effects of dose 
and timing of exposure (KLEIBER et al. 2011, MANTHA et al. 2013).   These are 
etiologically valid models that then can be used within a larger experimental and 
theoretical framework to evaluate underlying biological mechanisms including 
developmental trajectories of genetic and epigenetic changes that result from 
neurodevelopmental alcohol exposure (KLEIBER et al. 2012, KLEIBER et al. 2013, 
LAUFER et al. 2013, KLEIBER et al. 2014b, MANTHA et al. 2014b).  
As a whole, the results presented suggest that this trimester three-equivalent 
exposure paradigm can provide an effective model for the evaluation of 
behavioural and cognitive phenotypes associated with FASD that may be 
particularly vulnerable to late-gestation alcohol exposures in humans.  Also, the 
data suggests that this multi-phenotype behavioural battery is a useful strategy to 
evaluate phenotypes that reflect a more holistic neurocognitive profile common 
to human individuals prenatally exposed to ethanol.   As with any model, its value 
lies not only in its ability to recapitulate behaviours observed in humans, but also 
if it can be used to examine the underlying biological causes of those behaviours.  
This second goal forms the focus of the following sections of discussion.   
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4.2 Disruption of gene expression during neurodevelopment 
by ethanol and its role in FASD 
This study sought to evaluate the changes in gene expression that occur in the 
developing brain acutely following a binge-like dose of ethanol during 
synaptogenesis in the B6 mouse strain.  These changes represent the in vivo 
response within a previously naïve biological system that is highly dynamic and 
acutely sensitive to the effects of ethanol.  The response also represents a 
discontinuity in normal developmental processes that may result in apoptosis 
(IKONOMIDOU et al. 2000, OLNEY et al. 2002a, DIKRANIAN et al. 2005) or, in surviving 
cells, a ‘molecular footprint’ of neurodevelopmental disruption that may persist 
long past the initial ethanol insult (SANDERSON et al. 2009, PUGLIA and VALENZUELA 
2010, KLEIBER et al. 2013).   The discussion below evaluates how the mRNAs 
detected by array analysis of short and long-term gene expression changes 
resulting from ethanol exposure may affect neurodevelopment, adult brain 
function, and how they may be reflected in the cognitive and behavioural 
phenotypes associated with FASD.   
 
4.2.1.Effects of ethanol exposure on gene expression in the postnatal 
brain 
Ethanol is known to affect the expression of a large subset of genes in the brain 
acutely following exposure (TREADWELL and SINGH 2004), including in the 
developing brain (HARD et al. 2005, GREEN et al. 2007).  I analyzed the effects of 
ethanol exposure at P7 in mice, a time neurodevelopmentally equivalent to the 
human third trimester, and known to be particularly sensitive to ethanol (OLNEY 
et al. 2002a).  The 315 transcripts affected acutely (4h) following ethanol 
exposure (Appendix A) were categorized into broader biological functions and 
gene networks, identifying over-represented affected molecular processes.  The 
genes differentially expressed between control and ethanol-treated mice and the 
Chapter 4.  Discussion 
 
145 
 
associated biological processes were perhaps unsurprising given that the ethanol 
insult occurred at such a vulnerable developmental time for synapse formation 
and neuronal pruning (DOBBING 1974).   The ability of ethanol to affect the 
expression of ionotropic glutamate receptor subunits likely has some impact on 
excitotoxic cell death triggered by abnormal glutamate signaling.  Not all cells, 
however, succumb to cellular death; many of the identified changes to the 
transcriptome were certainly categorized by an acute stress response, but there 
appeared to be a precarious balance between cell death and survival cues, 
including alterations to genes associated with cell cycle signaling, cell 
proliferation and maturation, neurotransmitter signaling, cell membrane 
integrity, and protein modification.   
 
4.2.1.1 Acute stress response, apoptosis and cell survival 
Up- and down-regulated gene lists were separated and subsequently submitted 
as two gene groups to DAVID for over-represented biological functions, which 
allowed for the evaluation of processes that may be activated or inhibited by 
ethanol exposure.   Up-regulated transcripts were strongly associated with 
‘positive regulation of apoptosis’ and ‘cell death and survival’ (Table 3.5, 3.6).  
These results corroborate physiological evidence that this binge-like ethanol 
treatment at synaptogenesis results in wide-spread cell death across the cortex, 
hippocampus, cerebellum, and other brain regions (OLNEY et al. 2002a, WOZNIAK 
et al. 2004, DIKRANIAN et al. 2005).   A number of GO annotations and genes present 
within these annotations suggest a series of events by which ethanol may trigger 
this apoptotic response, including a number of stress-related mechanisms.  
Several studies have shown that ethanol exposure during rodent 
neurodevelopment, particularly during the early postnatal period, can interfere 
with a number of neurotrophic factors (HEATON et al. 2000b, CLIMENT et al. 2002, 
MOORE et al. 2004) that play key roles in neuronal survival and maturation 
including normal apoptosis of cells during brain maturation (KIRSTEIN and FARINAS 
Chapter 4.  Discussion 
 
146 
 
2002, LYKISSAS et al. 2007).  The results from this study corroborate these findings, 
with a number of pro-survival and pro-maturation factors growth and 
transcription factors showing down-regulation, including Etv4, E2f4, Egr3, Egr4, 
and Tgfb3, Vegfa (Table 3.5, 3.6).  Other studies using early postnatal ethanol 
exposure paradigms have also implicated the nerve growth factor receptor 
tropomyosin receptor kinase A (TrkA), brain-derived neurotrophic factor (Bdnf) 
and its receptor TrkB, nerve growth factor (Ngf), and the neurotrophin p75 
receptor (HEATON et al. 2000b, HEATON et al. 2003, TOESCA et al. 2003).  These 
molecules have well-established roles in multiple developmental processes and 
their reduced expression may alter the maturation of neurons, extent of dendritic 
branching, synapse formation, and neuronal plasticity (RUZHYNSKY et al. 2007, 
ROSENSTEIN et al. 2010, PEREZ-CADAHIA et al. 2011).  Alterations in levels of survival 
factors can alter the signaling function of cell survival pathways, including 
mitogen-activated protein kinase (MAPK/ERK) and phosphoinositide 3-
kinase/protein kinase B (PI3K/AKT) pathways, which is associated with 
increased levels of apoptosis in the developing cortex (CLIMENT et al. 2002).    
It is interesting that a number of up-regulated transcripts associated with ‘protein 
amino acid dephosphorylation’ and down-regulated transcripts under the 
annotation ‘MAP kinase phosphatase activity’ (Table 3.5) are dual-specificity 
phosphatase (Dusp) genes.  A number of these genes are present in the genome, 
each with different target specificity, cellular, and tissue localization, and are 
rapidly activated in response to oxidative stress or growth factor signa ling 
(induced as early response genes). They function to inactivate various MAPK 
isoforms, negatively regulating cellular proliferation (reviewed in (LANG et al. 
2006)).  The regulation of Dusp genes is somewhat gene-dependent, with Dusp 
genes acting through the inhibition of the MAPK/ERK pathway, the mammalian 
target of rapamycin (mTOR) pathway or both (BERMUDEZ et al. 2008, LAWAN et al. 
2011, RASTOGI et al. 2013). An increase in transcription in some Dusp genes and a 
down-regulation of others suggest a fast-acting induced response to cellular 
stress that may indicate a balance between pro- and anti-apoptotic pathways to 
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decide cell fate.  Further, the abnormal increased or decreased presence of these 
genes may also affect the regulation of other genes via epigenetic mechanisms, as 
they have also been shown to have the ability to alter histone phosphorylation 
states (LAWAN et al. 2011).   The simultaneous up- and down-regulation of 
members of this gene family may mediate a balance between pro-survival and 
pro-apoptotic signaling through the activation and deactivation of specific MAPK 
signaling pathways.   
Cellular stress response leading to cell cycle arrest and potential cell death via 
MAPK/ERK and PI3K/AKT/mTOR pathways is also indicated by the up-regulation 
of the p53 pathway-associated proteins Jun proto-oncogene (Jun), PERP, TP53 
apoptosis effector (Perp), and Junction-mediating and regulatory protein (Jmy).  
The p53 pathway may be initiated by both oxidative and osmotic stress, both of 
which are induced in the developing brain by high doses of ethanol (GOLDSTEIN 
1986, BROCARDO et al. 2011).  Jun is an immediate early gene (IEG) canonically 
associated with the p53 pathway, but may act as a pro-apoptotic or pro-survival 
cue, depending on other signals present in the cell (HUGHES et al. 1999, SCHREIBER 
et al. 1999).  However, Perp is expressed in a p53-dependent manner at high levels 
in apoptotic cells (ATTARDI et al. 2000), while Jmy, a p53 cofactor, has been shown 
to be a negative regulator of neuritogenesis (FIRAT-KARALAR et al. 2011) (Table 3.7) 
and has also been identified by array analysis of gene expression changes 
associated with trimester two-equivalent ethanol exposure (MANTHA et al. 2014a).    
Also indicative of changes in MAPK and PI3K/AKT signaling is the up-regulation 
of Forkhead transcription factor Foxo3, which has been shown to be involved 
oxidative stress-induced apoptosis in mouse neurons (Table 3.5, 3.6).   In the 
neonatal mouse brain, the expression and apoptotic function of Foxo3 is 
associated with Jun N-terminal kinase 3 activity (PIRIANOV et al. 2007), 
phosphorylation and activation of Jun and, interestingly, has recently shown to be 
exerted via its association with histone deacetylase 2 (Hdac2) (PENG et al. 2015).   
While Hdac2 was not identified in this study, the expression of Hdac1 and Hdac9 
were found to be down-regulated.  Given the sequence similarity of Hdac family 
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genes, it is likely that Forkhead transcription factors may also be regulated by 
other Hdac molecules.  In support of this, Hdac1 was found to be sufficient to 
activate Forkhead family transcription factors and trigger apoptosis associated 
with muscle fiber atrophy (BEHARRY et al. 2014).    
While the genes identified in this study represent a snap-shot of gene response 
four hours following a binge-like dose of ethanol across the multitude of cell types 
found in whole brain tissue, it is clear that ethanol triggers a strong cellular stress 
response in the postnatal brain that likely involves a number of pathways.  
Further, there appears to be changes to molecules associated with both pro -
survival and pro-apoptotic cues.  Overall, these results support other studies 
reporting that ethanol exposure during this early neonatal period instigates an 
acute stress response that leads to apoptotic neurodegeneration in a large 
number of brain regions (IKONOMIDOU et al. 2000, OLNEY et al. 2002a).  Also, these 
results suggest that a number of cells that undergo this stress response and 
experience an interruption to normal developmental processes, but do not 
succumb to apoptosis.  It is these cells that form the foundation for further 
neurodevelopment.   
  
4.2.1.2 Maintenance of cell viability 
A number of altered transcripts may be functionally grouped as having an 
association with the maintenance of cell integrity, including an up-regulation of 
‘integral to membrane’-associated transcripts and the down-regulation of 
notoriously energetically costly processes, such as ‘ribosome biogenesis’, ‘mitotic 
cell cycle’ progression, ‘cellular growth and proliferation’, and ‘regulation of 
transcription’ (Table 3.5, 3.6).  While ‘integral to membrane’ is a fairly broad Gene 
Ontology classification and the transcripts identified within this group play 
numerous roles with regard to their association to membrane dynamics, cell 
membrane composition can strongly affect the function of intrinsic membrane 
proteins.  High alcohol concentrations have been shown to force the 
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transmembrane proteins into unfavorable conformations affecting the chemical 
and physical functioning of the cell, including at synaptic plasma membranes 
(AVDULOV et al. 1994).   In support of this, a number of up-regulated genes are 
involved with the maintenance of cell membrane-associated molecules such as 
oligosaccharides and cell-surface carbohydrates (Bgalt3, St6gal1), 
phosphatidylinositol (Pigm, Pigv, Pik3ip1, Itprip2), sphingosine (Acer2), and 
aminophospholipids (Atp8b2).   Coinciding with this, the up-regulation of genes 
associated with glycosylation (Table 3.5) may be related to reinstating membrane 
integrity as glycoproteins are developmentally integral to cell membrane stability, 
cell-cell recognition and interaction (KLEENE and SCHACHNER 2004), as well as 
regulating excitatory synapse development and modulation of synaptic efficacy 
(DE WIT et al. 2013).  These findings agree with previous reports that ethanol 
targets glycosylation machinery (TOMAS et al. 2002).   
Conversely, the down-regulation of genes associated with ribosome biogenesis 
may also be a response to re-direct cellular energy to stress response and cell 
survival mechanisms.  The synthesis of ribosomal protein mRNAs requires a large 
proportion of the cell’s energy, and is balanced by the growth requirements of the 
cell, and is regulated by nutrient availability, cell cycle, and cell stress (THOMAS 
2000, MOIR and WILLIS 2013).    Similarly, down-regulation of cell cycle 
progression, proliferation, and differentiation-associated transcription factors, 
growth factors, and cyclins may provide a comparable function (Table 3.5, 3.6, 
3.7) and act to halt developmental processes to deal with the acute cellular insult.   
 
4.2.1.3 Neurotransmitter signaling systems 
In addition to the prominent effect of ethanol on cell survival and stress response 
mechanisms, a number of transcripts were identified that, while they may have 
roles in cellular stress, also have demonstrated roles in neurodevelopment and 
have been implicated in long-term risk for neurological disorders.  Particularly 
notable is alteration of genes associated with major excitatory and inhibitory 
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neurotransmitter systems, including glutamate and γ-aminobutyric acid signaling 
(Table 3.5, 3.6; Figure 3.17).  Among the genes affected by ethanol treatment were 
Cpeb1, Gabra5, Grin2a, and Grin2b all of which are canonically critical to synaptic 
formation and maintenance (Table 3.6).  Cpeb1 regulates translation at synapses 
and reduced or elimination of expression during development results in poor 
synaptic efficacy leading to reduced long-term potentiation (ALARCON et al. 2004) 
and, in adulthood, rapid extinction of hippocampal-dependent spatial learning 
memories (BERGER-SWEENEY et al. 2006).  Cpeb1 protein is activated in response to 
N-methyl-D-aspartate ionotropic (NMDA) glutamate receptor stimulation to 
facilitate activity-dependent gene transcription (WELLS et al. 2000).  Further, 
during early postnatal development, the formation of functional circuit formation 
is dependent on the synchronous activity of depolarization of GABA A receptors 
and activation of NMDA receptors (WANG and KRIEGSTEIN 2008, CSEREP et al. 2012).   
In this study, γ-aminobutyric acid (GABA) A receptor, subunit alpha 5 (Gabra5), 
glutamate receptor, ionotropic, NMDA2A (epsilon 2) (Grin2a), and Grin2b 
transcript levels were identified as altered following ethanol exposure, with 
Gabra5 down-regulated and the glutamate subunits up-regulated (Table 3.5, 3.6)).  
While these genes are associated with the major inhibitory (GABA) and excitatory 
(glutamate) neurotransmitter systems in the adult brain, it has also been 
established that they play key roles in the neurodevelopmental patterning of 
synaptic networks (LUJAN et al. 2005).  Both NR2A, encoded by Grin2a, and NR2B, 
encoded by Grin2b are modulatory NMDA receptor subunits, with Grin2a widely 
expressed in the postnatal brain and Grin2b expressed in multiple regions 
embryonically, but restricted to the forebrain during postnatal stages (LUJAN et al. 
2005), the transition of which occurs during synaptogenesis (YASHIRO and PHILPOT 
2008).  NR2B-containing receptors are important for circuit formation and 
establishment, and the developmental switch to NR2A-containining receptors 
results in excitatory postsynaptic currents with a more rapid decay (VAN ZUNDERT 
et al. 2004).  It is possible that the up-regulation of both Grin2a and Grin2b 
modulatory subunits may alter the sensitivity of developing synapses, 
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contributing to abnormal synapse formation and arborization, as well as (in some 
cells) excitotoxic cell death.  Other studies have shown that the subunit 
composition (NR2A versus NR2B) of NMDA receptors can control 
neurodevelopmentally-critical processes such as dendritic spine motility, synapse 
formation and stabilization (GAMBRILL and BARRIA 2011).  The Gabra5 subunit is 
expressed in the brain throughout pre-and postnatal development (KILLISCH et al. 
1991).   The coincident down-regulation of inhibitory neurotransmitter receptor 
subunit Gabra5 and the up-regulation of excitatory neurotransmitter receptor 
subunits Grin2a and Grin2b suggest that ethanol exposure during the third 
trimester-equivalent may lead to general over-excitatory signaling within the 
developing brain.  This would have broad effects on multiple brain regions, given 
that role of NMDA and GABA receptors in the formation, maturation, and pruning 
of synapses has been well-established (BOLTON et al. 2000, COHEN-CORY 2002, LUJAN 
et al. 2005, CSEREP et al. 2012).  Disruption of regulatory control of subunit 
expression by ethanol at this developmental stage has potent consequences for 
neural network connectivity, consequently affecting brain function not only 
acutely but establish an abnormal foundation for adult cellular communication 
and plasticity (MALENKA and BEAR 2004), a crucial impairment associated with 
prenatal alcohol exposure. 
 
4.2.1.4 Hormone signaling and endocrine system development 
The DAVID analyses identified hormone activity and hormone receptor activity as 
biological functions with a significantly over-represented proportion of altered 
transcripts (Table 3.5), most of which were significantly down-regulated 
following ethanol exposure. These genes included Adcyap1 and Pomc, as well as 
Nuclear receptor subfamily 4, group A, member 1 (Nr4a1), Nuclear receptor 
subfamily 0, group B, member 1 (Nrob1) and Retinoid X receptor gamma (Rxrg).   
These genes play varying roles in the development of the brain, most notably in 
the proper function of the HPA axis (VAZQUEZ 1998) including altered stress 
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reactivity, a consistent endophenotype  associated with fetal alcohol spectrum 
disorders (HELLEMANS et al. 2008, WEINBERG et al. 2008, HELLEMANS et al. 2010).   It 
is possible that this period of neural development is critically susceptible to 
molecular changes that affect HPA connectivity and maturation, leading to stress 
vulnerability in prenatally-exposed adolescents and adults (WEINSTOCK 2010).  
The down-regulation of Nr4a1 is interesting given that it is able to mediate both 
pro- and anti-apoptotic effects (LI et al. 2006), as well as mediating thyrotropin-
releasing hormone stimulation within the pituitary (NAKAJIMA et al. 2012).  Also 
relevant to HPA axis function is the reduced expression of Rxrg.  This gene is part 
of the family of retinoic acid receptors that mediate the anti-proliferative effects 
of retinoic acid and act as ligand-dependent transcriptional regulators (DAWSON 
and XIA 2012).  These results follow other studies that have implicated retinoic 
acid signaling in the effects of prenatal alcohol exposure (GRUMMER and ZACHMAN 
1995, KANE et al. 2010, KUMAR et al. 2010), the reduced expression of which can 
delay cellular differentiation and myelination (HUANG et al. 2011), most notably in 
the HPA axis structures but also in the cerebellum and hippocampus, affecting 
developmental and behavioural phenotypes (LU et al. 2001).   
 
4.2.1.5 Gene network interactions highlight the impact of ethanol on 
stress response and neurotransmission 
In addition to functional classification and grouping of the transcripts identified 
as altered following ethanol exposure at P7, the genes were also assessed for 
known interactions to provide further information for how these genes may 
interact to regulate each other, and via which other molecules and pathways.  
Figures 3.17, 3.18 and 3.19 represent significant networks identified by Ingenuity 
Pathway Analysis™ and the findings from these analyses reinforced the 
involvement of the cellular processes identified by the functional annotation 
clustering results in the acute transcriptional response to ethanol.   It is evident 
that ethanol exposure results in a cellular stress response through the up -
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regulation of key effector molecules such as Jun and its interactions with Dusp-
family genes, and the mitochondria-associated apoptosis regulator Bcl2l11 
(Figure 3.17).  These genes are central modulators of oxidative stress-related 
neuronal apoptosis, a process which includes the Wnt and Akt pathways that act 
on downstream effectors such as Forkhead family transcription factors and Bcl-
family genes (CHONG et al. 2005) (Figure 3.17).   This analysis also indicated the 
complex balance of factors that act to direct or halt cell growth and proliferation, 
such as the down-regulation of the tumor suppressor transcription factor Klf6 and 
coincident down-regulation the Etv4, a transcriptional activator that acts to drive 
cell proliferation.  Similarly, cell cycle arrest is indicated by the up-regulation of 
Btg2, an antiproliferation protein that interacts with NGF to regulate G1/S cell 
cycle transition via the down-regulation of cyclin Ccnd1 (MONTAGNOLI et al. 1996, 
GUARDAVACCARO et al. 2000); however, the steroid-thyroid hormone and retinoid 
receptor Nr4a1 can act as a powerful instigator of programmed cell death (MOLL 
et al. 2006), but was found to be down-regulated.  
Network analysis also highlighted the role of factors affecting cellular growth and 
tissue morphology in ethanol response (Figure 3.18), including the up-regulation 
of growth factor Tgfb3, which appears to act as a hub molecule linking other 
altered growth factors such as Vegfa, insulin-like growth factor (Igf) family genes, 
and implicating interleukin and MAP kinase molecules in Jun-associated cellular 
stress response.   We have previously reported that trimester two -equivalent 
ethanol exposure results in an inflammatory response, including an alteration to 
the expression of interleukin genes (MANTHA et al. 2014b).  The expression of 
interleukin 15 has also been implicated as having a role in neural stem cells and 
differentiating neurons, and that down-regulation may increase microtubule-
associated protein 2 (Map2) protein levels to support neurite outgrowth (HUANG 
et al. 2009).    
Also included in this network are genes associated with HPA axis development 
and function, including a down-regulation of Pomc and Adcyap1 (Figure 3.18).  
Pomc is a polypeptide hormonal precursor that yields multiple biologically active 
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peptides such as corticotrophin, α-melanotropin, and β-endorphin, with diverse 
functions.  Early postnatal reductions of Pomc, including those associated with 
ethanol exposure, is associated with apoptosis, altered Circadian regulation, and 
altered stress reactivity in later-life (CHEN et al. 2006a, GREENMAN et al. 2013, 
AGAPITO et al. 2014, LIU et al. 2014).   Adcyap1 is also a secreted peptide that is 
further processed into a number of neurologically active molecules.  Evidence 
from Adcyap1-null mice suggest that reductions in Adcyap1 signaling plays an 
important role in neurodevelopmental-associated psychiatric behaviours such as 
altered psychomotor behaviour, stress response, memory, ethanol sensitivity, and 
circadian rhythm (HASHIMOTO et al. 2006, YAMADA et al. 2010).  The alteration of 
these HPA axis-associated genes by ethanol may be directly related to the altered 
expression of growth factors, cytokines, and interleukins, given that these 
molecules can act to affect HPA axis gene expression and function (DUNN 2000).  
Though the precise impact on long-term phenotype is speculative, it is evident 
that the cellular stress response triggered by a binge-like dose of ethanol has 
consequences for the development of brain regions that are sensitive to cellular 
stress-associated molecules, leading to long-term changes to the architecture of 
brain circuits and setting up the physiological basis for long-term changes to 
behavioural phenotypes. 
Network analysis also highlighted the prominent role of glutamate signaling and 
NMDA receptor expression in the acute response to ethanol at P7 (Figure 3.19).  
Up-regulation of Grin2a and Grin2b may be a response to ethanol’s ability to act 
as a NMDA receptor antagonist, and an attempt to curb the excitotoxic response 
in developing cells in a number of regions within the postnatal brain (IKONOMIDOU 
et al. 1999).  However, this analysis also indicated the interaction between 
glutamate receptor subunit genes and other biological processes.  Of note are the 
interaction of Grin genes with Tubb6, a tubulin isoform, through Dlg4.   Increases 
in Tubb6 expression can profoundly destabilize microtubules and block cell 
proliferation (BHATTACHARYA and CABRAL 2004), suggesting that the down-
regulation may help stabilize microtubule formation that support axonal 
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branching and synapse formation occurring during this developmental stage.  
This is supported by observations that prenatal alcohol exposure increases 
neurite branching in the cerebellar macroneurons (ZOU et al. 1993) and 
disorganized dentritic morphology in the medial prefrontal cortex (LAWRENCE et 
al. 2012).   This network also outlines the potential interaction between glutamate 
receptor up-regulation and the up-regulation of the Circadian rhythm pacemaker 
gene Per1 through huntingtin (Htt) as well as down-regulation of histone 
deacetylase 1 (Hdac1) via survival of motor neuron genes Smn1/Smn2 (Figure 
3.19).    Given that regions of the hypothalamus are extremely vulnerable to 
apoptosis caused by ethanol’s ability to block NMDA receptors during the 
postnatal period (IKONOMIDOU et al. 2000), it is logical ethanol exposure at this time 
may also affect genes expressed within the suprachiasmatic nucleus such as 
Period genes.  However, it is likely that the up-regulation of Per1 is associated with 
its roles in cellular stress and rather than its canonical circadian clock function: 
Per1 mRNA is a target for the unfolded protein stress response, which can be 
induced by ethanol-associated oxidative stress, and increasing its expression is 
associated with increased cell survival and reduced tumorigenesis in certain 
carcinomas (PLUQUET et al. 2013).     
The gene network analysis of genes acutely altered in the brain of mice treated 
with ethanol at P7 further reinforced the findings of the functional annotation 
analysis, and a summary of genes and processes implicated in this ethanol 
response are further highlighted following a merging of these individual gene 
networks (Figure 3.20).   The major gene hubs may be categorized into two main 
functions: stress response and apoptosis, and cellular signaling and interaction.  
These functions are certainly not disparate, as evidenced by the substantial 
interaction between all molecules, and a number of these genes play critical roles 
during synaptogenesis.  The most prominent hub gene appears to be Jun, which 
appears to serve as a mediator between numerous growth factors (such as Gh1, 
Ngf, Tnf, Tgfb, and Vegf), early growth response (EGR) genes, apoptosis-associated 
molecules (such as Bcl2l11), and a variety of developmentally-important 
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transcription factors (such as Sp1 and Foxo3).  Related both to ethanol 
excitotoxicity and synaptic transmission are the marked up-regulation of 
glutamate receptor subunit genes (Grin2a, Grin2b), suggesting that ethanol 
exposure at P7 may alter the balance of excitatory neurotransmission that is 
extremely critical for synaptic stabilization and pruning at this 
neurodevelopmental stage.  Finally, an interesting relationship emerged between 
HPA axis-associated genes Pomc, Adcyap1, and Nr4a1, all of which were down-
regulated.  Given their modulatory roles in HPA axis development and function, 
their responsiveness suggests that the developing HPA axis is particularly 
vulnerable to trimester three-equivalent ethanol exposure. 
 
4.2.2. Effects of ethanol exposure on gene expression in the adult 
brain 
In addition to examining the gene expression profile immediately following 
ethanol exposure during the trimester three-equivalent, an investigation into the 
effects of neurodevelopmental ethanol exposure on adult gene expression became 
intriguing given the observed long-term behavioural effects exhibited by 
adolescent and adult mice.  It is clear that some developing cells succumb to 
ethanol-induced apoptosis (OLNEY et al. 2000); however, some cells encounter 
teratogenic adversity and undergo molecular adaptation, and form the foundation 
for further brain development.  These surviving cells then undergo further 
mitosis, differentiation, migration, and establish synaptic connectivity to form the 
final cellular network of the mature brain.  These cells that survive represent a 
population that must reinitiate neurodevelopment and adjust their 
developmental trajectories to recoup, at least somewhat, the functionality of those 
cells that are lost. These cells must do so within a relatively limited amount of 
time, via alterations to gene expression patterns.  These expression changes may 
represent an adaptive response, involving the reorganization of gene expression 
in surviving cells undergoing development.   These changes set up a pattern of 
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long-lasting genomic dysregulation that can be detected in the adult brain, long 
after the cessation of alcohol exposure.  This analysis was performed to examine 
how this interruption to developmental cues during the third trimester -
equivalent may lead to an altered pattern of gene expression and genomic 
regulation that may be persistent throughout the lifetime of the individual 
(Appendix B). Also, it facilitates the evaluation of those biological processes that 
remain affected in the adult brain of mice exposed to ethanol during 
neurodevelopment that may contribute to the persistence of altered brain 
function, resulting in long-term cognitive and behavioural phenotypes that are 
observed in individuals with FASD.  
 
4.2.2.1 Glutamate-associated synaptic neurotransmission  
The expression differences identified in the adult brain were much more subtle 
than the acute ethanol response and biased heavily towards a significant down-
regulation of transcripts (Appendix B).  Gene ontology functional annotation of 
these transcripts showed some similarities to the short-term analyses, 
particularly with respect to the number of transcripts associated with glutamate-
associated neurotransmission and synaptic function (Table 3.8).  A large number 
of glutamate receptor subunits showed altered expression, including both 
metabotropic and ionotropic type members of the glutamate receptor family.  It is 
interesting that exposure to ethanol during synaptogenesis has such a long-lasting 
effect on glutamate receptor expression, given that regulation of subunit 
expression can greatly impact synaptic function, plasticity, and maintenance 
(AAMODT and CONSTANTINE-PATON 1999, CLINE and HAAS 2008, YASHIRO and PHILPOT 
2008).  This analysis indicates that not only can ethanol alter glutamate-based 
regulation of developing neurons, including during initial synapse establishment, 
but that alterations to this process have long-term repercussions on adult 
glutamate receptor subunit expression and, likely, glutamate neurotransmission. 
Gene ontology, Ingenuity® biological annotation clustering, and Ingenuity® 
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canonical pathway analyses all identified glutamate receptor activity, 
neurotransmission,  and signaling as the most significant biological process over-
represented among altered transcripts (Table 3.8, 3.9, 3.10), suggesting that 
altered glutamate signaling may be among the most pervasive long-term 
consequences of ethanol exposure during synaptogenesis.   The implications of 
this with regard to behavioural phenotypes is likely quite broad given that 
glutamate is the predominant excitatory neurotransmitter in the mammalian 
brain (HAYASHI 1954), and altered glutamate signaling has been implicated in a 
number of cognitive and psychiatric phenotypes.  Reduced brain volume and 
connectivity in cortical and limbic regions, and consequently reduced 
glutamatergic signaling, underlie the “neuroplasticity hypothesis” of anxiety and 
mood disorders (PRICE and DREVETS 2010, DUMAN and AGHAJANIAN 2012).   Given 
that regions such as the prefrontal cortex and the limbic system are vulnerable to 
ethanol-induced apoptosis, particularly during the third trimester-equivalent 
(IKONOMIDOU et al. 2000), the reduction in brain volume and dendritic 
reorganization observed in individuals with FASD could contribute to reduced 
glutamate signaling in the adult brain.  Also, interference with the developmental 
and functional properties of synapse formation is likely to lead to the formation 
of abnormal brain circuits and contribute to complex behavioural phenotypes, as 
has been observed in schizophrenia and autism spectrum disorders (SIGURDSSON 
et al. 2010, CANITANO 2014). 
In addition to reduced brain volume as a potential cause for reduced glutamate 
receptor expression, other molecules that impact the stability of synapse 
formation, maintenance of synaptic strength, and synaptic plasticity were also 
found to be affected in the adult brain of ethanol-exposed mice.  These include 
membrane receptors such as ephrins Ephb1, Efnb2, and Efna5 (Table 3.10), which 
are critical to axon guidance and target recognition during the formation of 
dendritic spines (FLANAGAN and VANDERHAEGHEN 1998), as well as drive NMDA-
type glutamate receptor clustering and enhance NMDA receptor calcium influx 
(DALVA et al. 2000, TAKASU et al. 2002).   Ephrin receptors are therefore important 
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for NMDA-dependent synaptic plasticity and long-term potentiation, and a 
reduction in the expression of these genes may imply reduced dentritic spine 
density and reduced glutamate receptor clustering on remaining synapses.  
Studies have indicated that mice lacking Ephb1 expression also show fewer 
hippocampal neural progenitor cells and abnormal positioning of CA3 
hippocampal pyramidal neurons (CHUMLEY et al. 2007), which has implications for 
performance on learning and memory tasks – a phenotype frequently associated 
with prenatal alcohol exposure and an impairment observed in adult mice treated 
with ethanol within this study.      
Other genes of note associated synaptic function are Cacna1c and the postsynaptic 
density proteins Syngap1 and Syngr1, all of which were also found to be down-
regulated (Table 3.8).   Cacna1c encodes a subunit of a voltage-dependent calcium 
channel that has been identified by unbiased genome-wide association studies as 
a risk gene in multiple psychiatric disorders (BHAT et al. 2012, YOSHIMIZU et al. 
2015).  Animal studies have shown that hippocampal and forebrain-specific 
knock-out of Cacna1c in mice results in a severe impairment of NMDA-receptor-
independent spatial memory and long-term potentiation, leading to a decrease in 
MAP/ERK signaling and a sustained reduction in CREB-dependent transcription 
(MOOSMANG et al. 2005).   CREB signaling has a well-documented role in neuronal 
plasticity and long-term memory formation (SILVA et al. 1998, WON and SILVA 
2008), and was identified by this study as an over-represented canonical pathway 
associated with transcripts altered in the adult brain (Table 3.10).  Consistent with 
this, Cacna1c knockout animals exhibit deficits in hippocampus-dependent spatial 
learning and memory in maze testing paradigms (WHITE et al. 2008).    
Syngap1 is a neuron-specific Ras-GTP activating protein that is expressed in 
glutamatergic neurons and is highly enriched at excitatory synapses where it co -
localizes with postsynaptic density proteins and NMDA receptors to regulate 
excitatory synaptic function and dendritic spine size (KIM et al. 1998, CLEMENT et 
al. 2012).  Altered expression or function of Syngap1 has been identified in 
numerous whole-genome studies evaluating the contribution of DNA variants to 
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neurodevelopmental psychiatric disorders including as autism, schizophrenia, 
and intellectual disability (KREPISCHI et al. 2010, HAMDAN et al. 2011a, HAMDAN et 
al. 2011b, RAUCH et al. 2012, STEFANSSON et al. 2014).  Further, reductions in 
Syngap1 expression has a multitude of pathological consequences on the 
dynamics and structure of postsynaptic structures that guide not only the initial 
development of cortical circuitry, but that also provide the foundation for synaptic 
plasticity associated with learning (ACETI et al. 2015).  Syngap1 was not identified 
as acutely altered following ethanol exposure, raising the question of whether 
changes in its expression in a mature brain can have a significant impact on 
synaptic function, or if the effects of abnormal Syngap1 expression are restricted 
to neurodevelopment. Interestingly, reductions in Syngap1 expression initiated in 
adulthood using a Cre/loxP knockout resulted in disorganized glutamatergic 
receptor localization and a decline in spontaneous excitatory currents.  
Phenotypically, this resulted in impairments in spatial recognition memory and 
elevated spontaneous locomotor activity in an open field assay (MUHIA et al. 2012), 
suggesting that reduced Syngap1 expression in the adult brain of mice exposed to 
ethanol during the third trimester-equivalent may contribute to the observed 
deficits in spatial learning and memory tasks (Figure 3.12, 3.14).    
Similarly, Syngr1 encodes a membrane protein that is abundant in presynaptic 
vesicles (WIEDENMANN and FRANKE 1985) and is a candidate susceptibility gene for 
psychiatric disorders such as schizophrenia and bipolar disorder (VERMA et al. 
2005, IATROPOULOS et al. 2009).  While the specific function of Syngr1 is not 
completely elucidated and it may have a redundant function with other 
synaptogyrin and synaptophysin proteins (MCMAHON et al. 1996), it has been 
linked to impairments in long term potentiation and synaptic plasticity without 
being directly related to the probability of presynaptic neuro transmitter release 
(JANZ et al. 1999).   
It is clear that ethanol exposure during the third trimester-equivalent in mice 
leads to long-term alterations to glutamate neurotransmission systems.  
Alterations to glutamate signaling has profound implications to brain structure 
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and function, particularly within cortical and hippocampal structures, and could 
certainly explain a number of phenotypic observations such as impaired learning 
and memory and changes to locomotor behaviour.  Interestingly, these extensive 
changes to glutamate receptor subunit and associated gene expression seems to 
be specific to third trimester-equivalent exposure as these genes were not 
identified as altered in the adult brain of mice treated during the first or second 
trimester equivalent (KLEIBER et al. 2013).  This suggests that altered glutamate 
neurotransmission and synaptic function is an important consequence of 
exposure at this developmental stage, with long-term and broad consequences to 
neurological function.   
 
4.2.2.2 Retinoic acid signaling 
 A number of gene clustering and functional annotation analyses identified an 
over-representation of transcripts with roles in both retinoic acid and folate -
associated processes.  The importance of vitamin A and its derivative retinoic acid 
to the developing brain is well-established (ROSS et al. 2000), and numerous 
studies have implicated disruptions to retinoic acid signaling in fetal alcohol 
spectrum-associated cognitive and physiological abnormalities (GRUMMER and 
ZACHMAN 1995, KANE et al. 2010, KUMAR et al. 2010).  Retinoid signaling is also 
important for aspects of adult brain function, however, and its disruption may 
impact the regulation of a number of neuronal genes.  Genes known to be 
responsive to retinoic acid include transporters, metabolic enzymes, receptors, 
and signaling molecules associated with acetylcholine, dopamine, glutamate, and 
GABA, as well as oxytocin, nerve growth factor, neural cell adhesion molecule, and 
apolipoprotein E (reviewed in (LANE and BAILEY 2005).   
The genes identified as down-regulated in the adult brain were specifically 
associated with retinoic acid-mediated apoptosis pathways (Table 3.9, 3.10).  The 
pleiotropic actions of retinoic acid are mediated through retino ic acid receptors 
or retinoid X receptors, and both retinoic acid receptor, beta (Rarb) and retinoid X 
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receptor, beta (Rxrb) were found to be down-regulated in the adult brain of mice 
treated with ethanol during synaptogenesis.  These genes are members of the 
steroid/thyroid hormone superfamily of transcriptional activators and act as 
ligand-dependent transcription factors.  Upon binding to retinoic acid, they are 
able to alter the expression of a large number of genes including those associated 
with cell cycle arrest and apoptosis (BASTIEN and ROCHETTE-EGLY 2004).  Retinoic 
acid can trigger apoptosis through the increased expression of interferons and 
TNF-related apoptosis inducing ligands (TRAILs), which bind to their associated 
death receptors leading to the recruitment of Fas (Tnfrsf6)-associated death 
domain (Fadd) that serves as a molecular bridge to Caspase 8, initiating caspase-
mediated mitochondrial apoptotic processes (NOY 2010).   Consistent with 
evidence that ethanol exposure disrupts retinoic acid signaling is the reduced 
expression of a number of genes involved in this pathway in addition to the 
retinoic acid receptors, including interferon regulatory factor 1 (Irf1), Fadd, Tumor 
necrosis factor (ligand) superfamily, member 10 (Tnfsf10) (which, when bound to 
TRAIL protein receptors, can recruit Fadd), and caspase 3 (Casp3).  It is interesting 
to hypothesize how ethanol exposure during the third trimester-equivalent can 
lead to such an extensive footprint on adult retinoic acid signaling pathways, but 
it may be a result of ethanol’s ability to alter neurodevelopmental retinoic acid 
signaling through a variety of mechanisms, including  mobilizing hepatic retinol 
stores, altering enzyme activity including its ability to compete as a substrate for 
alcohol dehydrogenase and acetalydehyde dehydrogenase, changing retinoid -
binding protein expression, or disrupting retinoic acid receptors (GRUMMER and 
ZACHMAN 1995, DUESTER 1996, LIU et al. 2002).  Regardless, adult deficiencies in 
retinoic acid signaling and, specifically, reduced retinoic acid receptor expression, 
is associated with synaptic efficacy including impaired hippocampal long-term 
potentiation and long-term depression of synaptic function (CHIANG et al. 1998).   
Hippocampal long-term potentiation was found to be absent in mice lacking Rarb, 
suggesting a specific role of Rarb-containing receptors in learning and memory 
formation.  Reduced expression of this retinoic acid receptor isoform may have a 
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role in the learning deficits observed in adult mice exposed to ethanol during 
synaptogenesis.   
4.2.2.3 Folate metabolism 
A number of transcripts altered in the adult brain were associated with folate 
metabolism and the ‘one carbon pool by folate’ canonical pathway (Table 3.8, 
3.10).  Folate is a B-vitamin that acts as an enzyme cofactor that chemically 
activate 1-carbons, which are required for the synthesis of purine and thymidine 
nucleotides, and for the remethylation of homocysteine to methionine.  
Methionine can be used for protein synthesis or also adenosylated to S-
adenosylmethionine (SAM) that acts as the major methyl donor for numerous 
processes including the methylation of proteins such as histones and cytosine 
bases within DNA (SELHUB 2002).  The genes identified as altered by 
neurodevelopmental ethanol exposure play a role in the metabolism of folate into 
molecules that are used in both DNA repair and DNA methylation processes. The 
enzyme thymidylate synthetase (Tyms) catalyzes the creation of deoxythymidylate 
using 5,10-methylenyltetrahydrofolate as a cofactor, which maintains the dTMP 
(thymidine-5-prime-monophosphate) pool essential for DNA replication and 
repair (NAZKI et al. 2014).  Also, the enzyme 5,10-methenyltetrahydrofolate 
synthetase (Mthfs) catalyzes tetrahydrofolate to 5,10-methenyltetrahyrofolate, a 
precursor to methionine produced by 5-methyltetrahydrofolate-homocysteine 
methyltransferase (Mtr).   This methionine is then converted to SAM to methylate 
DNA at CpG sites (NAZKI et al. 2014).  Down-regulation of Mthfs nd Mts likely has 
an impact on methionine availability for this process. Further, as a consequence 
of methylation, SAM is converted into homocysteine, a potent neurotoxin that 
must be excreted or drawn back into the methionine cycle by Mts and additional 
folate (NAZKI et al. 2014).  Reduced expression of Mts may result in increased 
concentrations of homocysteine.    
Folate availability is critical during neurodevelopment for DNA replication, repair, 
and appropriate epigenetic patterning.  It has been shown that alcohol 
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consumption during pregnancy can affect the transfer of dietary folate to the 
developing fetus (HUTSON et al. 2012), leading to an array of developmental 
abnormalities (BEAUDIN and STOVER 2009); however, these results suggest that 
neurodevelopmental interruptions to folate metabolism can lead to a long-term 
effect on the expression of a number of genes involved in this process.  It is 
interesting that our lab and others have observed global hypermethylation across 
the genome of mice exposed to ethanol during neurodevelopment (LAUFER et al. 
2013, KHALID et al. 2014), a phenotype that is consistent with a long-term lack of 
dietary methyl donors (POGRIBNY et al. 2008).  This hypermethylation is also 
consistent with the bias towards down-regulation observed in the expression of 
genes in the adult brain observed in this study.   
Phenotypically, there is evidence that impairments in folate metabolism can lead 
to neurological abnormalities including adult cognitive function (SHEA and ROGERS 
2014).  In the adult brain, SAM-dependent histone methylation impacts learning 
and memory (JAROME and LUBIN 2013).  Alterations to histone 
methylation/demethylation cycles that control memory cycles are associated 
with a spectrum of neurological disorders, such as intellectual disability, autism, 
depression, fear and anxiety, and schizophrenia (SHULHA et al. 2012, JAROME and 
LUBIN 2013, ISHII et al. 2014, MORISHITA et al. 2015), suggesting that factors that 
affect methylation-associated processes during neurodevelopment, including 
prenatal alcohol exposure, can set up altered gene expression patterning that 
persists into adulthood and may alter cognition and behaviour.    
 
4.2.2.4 Chromatin organization and histone modification 
In keeping with the hypothesis that alterations to epigenetic regulation of genes 
in the adult brain drive the persistent changes to gene expression, a number of 
genes identified as altered were involved in histone modification and chroma tin 
remodeling (Table 3.8).    These included genes found within the large histone 
gene cluster 1 located on chromosome 13 in mice such as Hist1h2bf, Hist1h2bm, 
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Hist1h3c, and Hist1h4d, which are replication-dependent histones that are 
predominantly expressed during S phase (MARZLUFF et al. 2002).  Also affected 
were histone deacetylase genes Hdac8 and Hdac10 and the histone acetyl 
transferase gene CREB binding protein (Crebbp).  These results support previous 
findings that perinatal alcohol exposure decreases the expression of Crebbp in the 
cerebellum (GUO et al. 2011), which was associated with decreased lysine 
acetylation on histones H3 and H4 with motor activity changes observed in 
individuals with FASD.   Other down-regulated genes critical to epigenetic control 
of gene regulation included DNA methyltransferase 1 associated protein 1 
(Dmap1), a co-repressor that supports the maintenance as well as the de novo 
methylation by DNA methyltransferase 1 (LEE et al.).  The down-regulation of this 
gene is interesting due to the general hypermethylation observed in the genome 
of ethanol-exposed individuals; however, knock-down of Dmap1 has been shown 
to inhibit cellular proliferation via activation (demethylation) of the p16 tumor 
suppressor gene pathway, as well as lead to hypomethylation of regions 
controlling DNA repair products (LEE et al. 2010).  By contrast, methyl-CpG binding 
domain protein 3 (Mbd3) is a strong inducer of demethylation (BROWN et al. 2008) 
and was also identified as down-regulated in the brain of adult ethanol-exposed 
mice.  Down-regulation of Mbd3 was found to be associated with global 
hypermethylation and increased methylation in CpG islands associated with the 
control of cell cycle genes (CUI and IRUDAYARAJ 2015).   Other studies have 
examined the effects of neurodevelopmental alcohol exposure on epigenetic 
patterning in the brain and suggest that ethanol impairs spatiotemporal 
establishment of appropriate epigenetic marks that guide differentiation and 
cellular maturation, and that these changes are correlated with neurobehavioural 
phenotypes associated with FASD such as stress vulnerability, social interaction, 
and learning and memory deficits (CHEN et al. 2013, VEAZEY et al. 2013, BEKDASH et 
al. 2014, SUBBANNA et al. 2015).  Results from our lab also suggest that these 
epigenetic changes are genomically wide-spread and may provide a mechanism 
for long-term gene expression dysregulation (LAUFER et al. 2013).  The 
identification of a number of genes associated with chromatin structure by this 
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study suggests that ethanol may affect the subtle interplay between epigenetic 
control mechanisms, including DNA methylation and histone modifications, 
exerting a global change in regulation of gene transcription.   
4.2.2.5 Gene network interactions highlight alterations to 
neurotransmission  
A gene network analysis was performed on genes identified as altered in the adult 
brain of mice treated with ethanol on P4 and P7 to predict interacting molecules 
and evaluate and predominant biological pathways that may integrate the 
observations gathered by the GO and IPA gene enrichment analyses.  All the genes 
included in these networks were down-regulated, which reflects the bias 
observed from the array results (Appendix B).  Also, the significant networks were 
less intricate than those generated from the short-term analyses and showed a 
number of common molecules (Figures 3.23, 3.24).  Glutamate receptor subunit 
Grin2b appeared as a major hub in all networks, consistent with previous analyses 
suggesting that glutamate neurotransmission may be among the most significant 
processes affected by ethanol exposure during the third trimester -equivalent.  
Interestingly, huntingtin (Htt) appears as a central hub both in the ‘neurological 
disease, psychological disorders, behaviour’ (NPD) network (Figure 3 .23) and in 
the merged network (Figure 3.25).  We have observed that Htt is consistently 
identified as a major hub in gene network analyses of multiple ethanol treatment 
paradigms (KLEIBER et al. 2013).   While the involvement of Htt with regard to 
prenatal ethanol exposure is, as far as we are aware, unreported in prenatal 
alcohol exposure literature, it is known that Htt is widely expressed in the 
developing brain and has roles in cell survival, proliferation, and migration, and it 
is essential for the formation of normal excitatory synapses (TONG et al. 2011, 
MCKINSTRY et al. 2014).  In the adult brain, mouse knock-down models have shown 
that reduced huntingtin levels were associated with neuronal loss and 
degeneration in the subthalamic nucleus and global pallidus, resulting in 
increased motor activity and cognitive deficits (NASIR et al. 1995, O'KUSKY et al. 
1999).  Despite the well-established role of Htt in neuropathology, its relationship 
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with neurodevelopmental alcohol exposure remains an unexplored avenue, 
though its down-regulation and consistent appearance as a ‘hub’ gene in multiple 
treatment paradigms is intriguing.  
Also prominent in the NPD network (Figure 3.23) and in the merged network 
(Figure 3.25) is 5-hydroxytryptamine (serotonin) receptor 1A (Htr1a).  Serotonin 
receptors Htr1a, Htr5b, and Htr1d were all identified as down-regulated in the 
adult brain (Table 3.10).  This is consistent with studies reporting impaired 
serotonin neuron innervation in the forebrain, hypothalamus, frontal and parietal 
cortices, and hippocampus in mice prenatally exposed to alcohol (ZHOU et al. 2001, 
ZHOU et al. 2005).   Reduced expression of human HTR1A is associated with a 
number of psychopathological states such as increased anxiety, stress reactivity, 
and depression (ALBERT 2012).  In mice, Htr1a knock-out results in heightened 
stress reactivity and anxiety-like phenotypes (HEISLER et al. 1998, PARKS et al. 
1998), which can be ameliorated by postnatal handling (ZANETTINI et al. 2010).  
This is consistent with findings that Htra1 and other serotonin receptors may be 
sensitive to gene-environment interactions that result in altered epigenetic marks 
that impact transcriptional control of these genes (ALBERT and FIORI 2014, 
HOLLOWAY and GONZALEZ-MAESO 2015).   Also associated with altered anxiety-
related phenotypes is apolipoprotein E (Apoe), which was identified as down-
regulated in the adult brain of mice exposed to ethanol at P4 and P7, and appears 
within all three gene networks (Figures 3.23, 3.24, 3.25).  Apoe plays an important 
role in the metabolism and redistribution of lipoproteins and cholesterol (HUANG 
and MAHLEY 2014).  Further, Apoe-deficient mice show age-dependent structural 
and functional changes to the cortex and hippocampus (MASLIAH et al. 1995, 
BUTTINI et al. 1999), as well as age-dependent dysregulation of the HPA axis via 
increased levels adrenal corticosterone both at the basal level and following 
restraint stress (RABER et al. 2000).  This was associated with increased anxiety-
related behaviours in the elevated plus maze, reduced activity in a novel open field 
arena, and learning deficits (RABER et al. 2000, GROOTENDORST et al. 2002).  
Persistently reduced expression of Apoe in the adult brain certainly may 
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contribute to the maintenance of anxiety and learning-related phenotypes 
observed in mice exposed to ethanol during the third trimester-equivalent.   Also, 
it is interesting that Apoe and Pomc, which appears in the NPD gene network as 
well as the merged network (Figures 3.23, 3.25), were identified as altered 
following third trimester-equivalent ethanol exposure but not following other 
treatment paradigms (KLEIBER et al. 2013), suggesting that late gestation may be 
a critical window of vulnerability for HPA axis-associated processes.   
Interestingly, there is evidence that ethanol-induced gene expression changes 
associated with HPA axis dysfunction are the result of altered epigenetic 
mechanisms that are malleable and can be corrected (BEKDASH et al. 2013, 
GANGISETTY et al. 2014).     
The genes identified as altered in the adult brain of mice exposed to ethanol 
during neurodevelopment at P4 and P7 suggest changes to critical neural 
processes that are important for behaviours observed in these animals, such as 
altered glutamate neurotransmission, changes to serotonin signaling, and HPA 
axis dysfunction.  These processes are certainly interrelated, and also associated 
with the altered expression of genes related to apoptosis (Casp3), neurotrophic 
signaling (Ntf3), extracellular matrix integrity and signal transduction (Mmp2, 
Map3k10) (Figure 3.25).  While these processes are consistent with the 
behavioural and physiological phenotypes observed in individuals with FASD, it 
remains to be evaluated how the altered expression of these genes may impact 
cellular function and contribute to these phenotypes.   
  
4.2.3 Molecular pathways acutely affected by ethanol exposure during 
synaptogenesis that remain modified into adulthood  
Given the similarities between biological process affected both acutely following 
ethanol exposure during synaptogenesis and those altered in the adult brain, it is 
intriguing to make comparisons between the two gene sets.  Such a comparison is 
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valuable in the understanding of the events that establish long-term neural 
dysfunction resulting from neurodevelopmental ethanol exposure, which 
ultimately manifests as long-lasting cognitive and neurobehavioural phenotypes.   
The results included indicate that binge-like ethanol exposure alters two sets of 
genes: the first represents a rapid cellular stress response that leads to the 
apoptosis of vulnerable cells. Ultimately, this modified expression profile impacts 
the further developmental trajectory of surviving cells, resulting in a ‘molecular 
footprint’ of third trimester-equivalent ethanol exposure observed in adult mice 
that may, in part, account for the behavioural deficits presented by these animals 
(KLEIBER et al. 2013, MANTHA et al. 2013). 
While few transcripts were identified as altered in both analyses (Table 3.11), 
there is a great deal of overlap in the biological processes associated with genes 
altered at P7 and in adulthood at P60 (Table 3.12).   Genes identified as altered 
both acutely following ethanol exposure and within the adult brain suggest that 
third trimester-equivalent ethanol exposure has a significant impact on the 
regulation of synaptic transmission and plasticity, involving the altered 
expression of a number of glutamate receptor subunit genes as well as genes 
involved in synapse formation, organization, and maintenance.  Glutamate 
neurotransmission is essential for the formation of functional neural circuits 
(AAMODT and CONSTANTINE-PATON 1999, BOLTON et al. 2000), and is a major target 
of ethanol, which is able to act as a strong NMDA receptor antago nist (IKONOMIDOU 
et al. 2000).  Altered glutamate neurotransmission also plays a role in an array of 
cognitive and behavioural phenotypes, including those associated with FASD such 
as motor coordination delays, hyperactivity, increased anxiety, and impaired 
learning (KIYAMA et al. 1998, MOHN et al. 1999, JENSEN et al. 2009, BARKUS et al. 2010, 
ARAKAWA et al. 2014).   Important to this study, synaptogenesis seems to be a 
critical period of vulnerability to ethanol-induced changes to glutamate 
neurotransmission (OLNEY et al. 2002a, PUGLIA and VALENZUELA 2010, KLEIBER et al. 
2013), which has led us to the hypothesis that neurodevelopmental processes that 
are active at the time of exposure are most responsive to environmental 
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interference, leading to long-term alterations in sets of genes that are involved in 
these processes (or  the ‘molecular footprint’ of timing of exposure) (KLEIBER et al. 
2014a).   
Also implicated as a consequence of third trimester-equivalent ethanol exposure 
by both short- and long-term gene sets were alterations in steroid hormone 
signaling and potentially abnormal HPA axis development and function in the 
adult brain.  Genes involved have well-established roles in stress response and 
glucocorticoid regulation, including pro-opiomelanocortin (Pomc), apolipoprotein 
E (Apoe), and the steroid-thyroid hormone-retinoid receptor nuclear receptor 
subfamily 4, group A, member 1 (Nr4a1).  Interestingly, this is associated with 
altered Circadian rhythm signaling as identified in both the short-term and long-
term canonical pathways.  We observed altered expression of Period genes Per1 
and Per2, as well as long-term altered expression of pro-opiomelanocortin (Pomc) 
(CHEN et al. 2006a).   Altered sleep-wake cycles have previously been observed in 
human infants and adolescents exposed to alcohol during neurodevelopment 
(CHEN et al. 2006a).  Consistent with this study and others, these effects are most 
pronounced in animal models when exposure occurs during the brain-growth-
spurt period (EARNEST et al. 2001, SAKATA-HAGA et al. 2006).  Altered Circadian 
rhythm, and corresponding altered HPA axis corticosterone signaling, are further 
associated in FASD individuals or models with increased vulnerability to stress, 
depression, hyperactivity, and diminished cognitive function (EARNEST et al. 2001, 
SAKATA-HAGA et al. 2006, GIROTTI et al. 2007, WEINSTOCK 2010).   
A comparison between the biological processes associated with both the short-
term and long-term gene sets also identified thyroid hormone/retinoid X receptor 
signaling (TR/RXR) pathway as affected by trimester three-equivalent ethanol 
exposure (Table 3.12).  Some genes implicated were also associated with altered 
hormonal signaling given that RXRs are nuclear receptors that mediate retinoic 
acid-induced gene expression through the formation of homo or heterodimers 
with other receptors including thyroid hormone receptor (TR), among many 
others (CHAMBON 1996, BASTIEN and ROCHETTE-EGLY 2004).   Again, these processes 
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seem to be affected primarily by ethanol exposure during this developmental 
period as they were not identified by analyses of first or second trimester -
equivalent exposure paradigms (KLEIBER et al. 2013, MANTHA et al. 2014b), 
suggesting that late-gestation may be a critical period for the appropriate 
development and function of systems reliant on retinoic acid receptor signaling.   
Lastly, the PTEN canonical pathway was identified as significantly affected in the 
short-term and long-term effects of ethanol (Table 3.12). Given the broad 
intracellular signaling functions of the PTEN and associated PI3K/AKT/mTOR 
pathway and its ability to respond to nutrient availability, stress, hormones, and 
growth factors to modulate protein synthesis, a comprehensive discussion of this 
pathway with relevance to prenatal alcohol exposure would be assumptive.  The 
pathway is worth attention, however, in light of recent findings implicating that 
this pathway may be a consistent target of neurodevelopmental alcohol exposure 
given its consistent identification in the analysis of brain expression profiles and 
methylation alterations resulting from multiple treatment paradigms (KLEIBER et 
al. 2013, LAUFER et al. 2013).   
 
4.2.4 Maintenance of long-term gene expression changes, altered 
miRNA expression, and epigenetic patterning 
The results included in this study offer an evaluation of potential epigenetic 
mechanisms that may help establish a long-term footprint of altered gene 
expression following ethanol exposure during synaptogenesis.  There has been 
increasing evidence that epigenetic processes established during 
neurodevelopment, such as DNA methylation, chromatin structure, and miRNA 
expression are altered by prenatal ethanol exposure (MIRANDA 2011, BEKDASH et 
al. 2013, VEAZEY et al. 2013).  Histone deacetylases (Hdac1, Hdac9) appear as 
target molecules within multiple canonical pathways identified as altered acutely 
(at P7) following ethanol exposure (Table 3.5).  These genes play an important 
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role in controlling gene expression and cell signaling events via histone 
modifications and chromatin remodeling, and play an established role in a 
number of neurodegenerative disorders including fetal alcohol spectrum 
disorders (BUTLER and BATES 2006, LAUFER et al. 2013, VOGEL-CIERNIA and WOOD 
2013).  These genes act by not only altering chromatin structure but also in 
interacting with tissue-specific transcription factors to control apoptosis and 
differentiation (PARRA and VERDIN 2010, CONWAY et al. 2012).   
Evaluation of miRNA changes in the adult brain of mice exposed to alcohol at P4 
and P7, within the brain “growth spurt” period, identified a number of miRNAs as 
altered at P60 following ethanol exposure at synaptogenesis (Appendix C).  The 
genes identified as potential targets of some of these miRNAs play important roles 
in the function of mature neuronal communication and signaling (Table 3.13).  
Interestingly, many of the biological pathways associated with these miRNAs and 
their targets showed similarities with the pathways affiliated with the modified 
short-term (P7) transcripts and relevance to synaptogenesis.  Further, these 
pathways showed higher relevance to synaptic function and neural function 
rather than cell survival processes, as may be expected given that these results 
highlight the residual effects of exposure at synaptogenesis rather than immediate 
stress response.   Of note are the miRNAs posed to regulate genes associated with 
HPA-associated corticotrophin and retinoic acid signaling such as miR-26b and its 
putative cannabinoid receptor target (Cnr1), miR-184 and its putative target 
Ncor2, miR-721 and its targets Ppargc1a and Ncoa3 (Table 3.13).    The effect of 
ethanol exposure on Cnr1 expression in the developing brain has previously been 
reported.  Subbanna et al. (2013) reported that ethanol exposure at P7 resulted in 
increased Cnr1 expression in the hippocampus and cortex that was associated 
with Erk1/2 phosphorylation and neurodegeneration.  Further, Cnr1 knock-out 
eliminated ethanol-induced neurodegeneration, inhibited Erk1/2 
phosphorylation, and rescued normal adult synaptic plasticity and novel object 
recognition (SUBBANNA et al. 2013).  Nuclear receptor coactivator 3 (Ncoa3) and 
nuclear receptor corepressor 2 (Ncor2) both are thyroid hormone and retinoic acid 
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receptor-associated proteins that act to activate or repress, respectively, 
transcription of certain gene sets.  A recent study suggested that Ncoa3 is itself an 
important regulator of miRNA action by promoting the expression of Argonaute 
proteins, core components of miRNA-induced silencing complex (miRISC), and 
regulates dendritic complexity and spine maturation in the hippocampus 
(STORCHEL et al. 2015).  NCOR proteins have well-established roles in neural 
function and memory, with disruption of NCOR-regulated gene expression 
associated with cognitive and memory impairments in both humans and rodent 
models (XING et al. 2006, HAWK et al. 2012, GILBERT and LASLEY 2013, LYST et al. 
2013).  Ncor2 has been experimentally shown to be regulated by miR-184 (WU et 
al. 2011) and itself regulates gene expression via its interactions with histone 
deacetylases (SUN et al. 2013).    
Correspondingly, the Target Filter™ results suggested that PI3K/AKT/mTOR 
signaling may be altered via aberrant miRNA regulation of the tumor suppressor 
protein Tubular sclerosis 1 (Tsc1) (Table 3.13).  The up-regulation of miR-721 and 
subsequent down-regulation of Tsc1 is significant with relevance to FASD-related 
abnormalities given current evidence that knock-down of Tsc1 or its functional 
partner, huntingtin-associated protein 1 (Hap1), profoundly impairs the 
positioning of pyramidal neurons in the hippocampus (MEJIA et al. 2013), leading 
to long-term neurological impairment including cognitive deficits and learning 
impairments (ORLOVA and CRINO 2010).   
Taken together, these results argue that altered epigenetic mechanisms, including 
histone modifications and miRNA regulatory control, may reflect consequences of 
neurodevelopmental ethanol exposure that do not have a specific relationship to 
cellular stress response but nonetheless exert long-term functional changes 
within the adult brain, and have roles associated with cognitive and behavioural 
phenotypes observed in individuals with FASD.  While these results are 
preliminary in nature and require further functional examination to confirm 
miRNA/mRNA interactions in given cell types and specific consequences on 
cellular function, the findings are interesting and certainly indicate that long-term 
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miRNA regulation is altered as a consequence of neurodevelopmental alcohol 
exposure.  These findings are also consistent with recent literature suggesting that 
miRNAs play multiple roles in both the acute and long-term effects of alcohol in 
the developing and adult brain (SATHYAN et al. 2007, WANG et al. 2009, BALARAMAN 
et al. 2013, IGNACIO et al. 2014, CHEN et al. 2015).    
 
4.3 Caveats to assessing FASD in animal models  
4.3.1 Limitations to the use of mice in modeling FASD 
There are some limitations to the current study which should be noted.  A broad 
observation relevant to many studies that utilize any animal model system to 
assess neurobehavioural or cognitive disorders is that it cannot be ignored tha t 
one is trying to recapitulate a complex human phenotype in an animal model that, 
by its nature, will not be able to fully model all aspects of that disorder as it 
presents in human patients.  In this sense, the validity of the model is reliant on 
its ability to effectively map the etiology, behaviour, and biological mechanisms of 
human psychopathology.   FASD is different from many neurological disorders in 
that it has a clear etiology: exposure to alcohol during neurodevelopment.   This 
known causation provides legitimacy to animal models of FASD in that it is 
relatively simple to treat pregnant dams with ethanol, either via voluntary 
ingestion, gavage, or injection of known ethanol doses, allowing clear relevance of 
the model to human FASD.  Animal models must also focus on the presentation of 
neurobehavioural phenotypes that are relevant to the disorder they are seeking 
to emulate, either cognitive, which in animal models must be inferred, or 
behavioural, which is an observable response to a given assay.  In this study, I 
believed it was important that mice exposed to ethanol during neurodevelopment 
displayed a cluster of endophenotypes that were commonly associated with 
human FASD, namely developmental delay, activity alterations, anxiety-related 
phenotypes, and learning deficits.  A combined behavioural and molecular 
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approach may help define genetic contributions to endophenotypes in mental 
disorders (GOTTESMAN and GOULD 2003).  The presented model successfully 
displayed many endophenotypes that can be compared to human FASD 
behavioural phenotypes, and there was a great deal of consistency with the genes 
and pathways that were implicated as involved in both neonate and adult mice.  
These included pathways that have previously been identified as involved in 
alcohol response and fetal alcohol spectrum effects including glutamate 
neurotransmission and genes associated with synaptic plasticity, cell cycle control 
and stress response, neurotrophic molecules, and genes associated with HPA axis 
function.   
Humans and mice – while genetically and physiologically similar – are certainly 
not identical, and they have different evolutionary histories that cannot be 
discounted.  The neurodevelopmental timeline of mice and humans have been 
well-characterized and well-correlated; however, based on the human 
neurodevelopmental timeline, the developmental processes that occur during the 
third trimester also occur in the mouse from roughly postnatal days 2 to 14 
(DOBBING 1974, DOBBING and SANDS 1979, CLANCY et al. 2001).  Thus, to mimic an 
ethanol exposure during this neurodevelopmental time, ethanol must be 
administered to a neonate pup rather than to an in utero fetus, eliminating 
interactions with maternal genotype and maternal ethanol metabolism.  This 
could be viewed as a potential advantage, given that these maternal confounding 
factors can be avoided and the blood alcohol concentration of the animal can be 
more easily controlled.  In this study, the timing of ethanol exposure also allowed 
us to balance the treatment groups such that we were able to pair each ethanol-
treated pup with a weight and sex-matched littermate control, eliminating the 
potential confounds associated with litter effects.  There are certainly other 
animal models such as non-human primates, other rodent species, and non-
mammalian species (PATTEN et al. 2014), many of which are more precocial at 
birth, that have been successfully used to evaluate behavioural, physiological, or 
molecular phenotypes associated with FASD.   In this study, mice were chosen due 
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to their amenability to ethanol effects, range of well-validated behavioural assays, 
and broad range of available genetic information and tools.  In mice, these 
resources have been shown to be useful when evaluating how molecular 
processes contribute to changes in brain function in neurological disorders, which 
is not possible to assess in humans (CRYAN and HOLMES 2005, NESTLER and HYMAN 
2010a).   
With regards to the model presented here that sought to interrogate the specific 
effects of late-gestational ethanol exposure, it should also be noted that, 
epidemiologically, it is certainly uncommon that a pregnant female would ingest 
a high dose of alcohol during the third trimester only (GLADSTONE et al. 1997, ETHEN 
et al. 2009).  Neurodevelopment is a lengthy and complex process, and without 
controlled models of exposures of specific times, it is difficult to differentiate the 
resulting molecular and, subsequently, the phenotypic effects that result from 
exposures at each stage of development.  The purpose of this third trimester -
equivalent exposure paradigm was to evaluate how exposure during the ‘brain 
growth spurt’ – a period of rapid neural development and synapse formation – 
disrupts certain genes or pathways known to be involved in these processes. Also, 
certain regions of the brain that have relevance to FASD-related phenotypes, such 
as learning, stress reactivity, hyperactivity and attention, and motor coordination, 
show a strong vulnerability to ethanol-induced apoptosis or damage during this 
period of neurodevelopment (IKONOMIDOU et al. 2000, OLNEY 2004, DIKRANIAN et al. 
2005).  Evaluations of third trimester-equivalent models of FASD are becoming 
increasingly prevalent in the literature due to the brain’s vulnerability at this 
stage.  Studies have established that ethanol exposure at P7 results in robust 
phenotypic consequences, such as profound learning deficits, altered stress-
reactivity and altered Circadian rhythm dysfunction (EARNEST et al. 2001, WOZNIAK 
et al. 2004, BROCARDO et al. 2012).  This is also why we have employed various 
treatment paradigms in our research, including ‘binge’-like exposures at distinct 
neurodevelopmental times and a moderate chronic exposure paradigm that 
exposes the developing pup to ethanol throughout gestation via voluntary 
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maternal consumption of a 10% ethanol solution (KLEIBER et al. 2011, MANTHA et 
al. 2013).  While it is clear that there is no one exposure time that is independently 
responsible for the range of behaviours associated with FASD, it is important to 
discern the mechanisms that may underlie the subtle differences in behavioural 
and molecular phenotypes generated from each treatment paradigm.   
 
4.3.2 Technical considerations 
Aside from considerations regarding the model itself, there are other cavea ts to 
this research that should be noted that were associated with technical aspects of 
the methodology.   First, the gene expression changes identified in this study were 
evaluated using whole-brain homogenates.  It is recognized that the developing 
and adult brain are complex tissues with a number of regions that undergo 
neurodevelopmental processes at a varying timeframes.  While synapse formation 
may the predominant process occurring during the first two weeks of postnatal 
mouse development (corresponding to the processes occurring during the third 
trimester equivalent), there are also a number of other critical processes 
occurring at this time depending on region, including neurogenesis, glial 
development, apoptotic pruning, and myelination (DOBBING and SANDS 1973).  The 
results we have generated have relevance to synapse-related processes, 
particularly in regions such as the corpus callosum, the limbic system, the HPA 
axis, the cerebellum, and the cortices.  Coincidentally, these are the regions that 
are particularly vulnerable to ethanol-induced neurodegeneration and show 
altered developmental trajectories following trimester three-equivalent ethanol 
exposure (BONTHIUS and WEST 1990, IKONOMIDOU et al. 2000, OLNEY 2004, DIAZ et 
al. 2014a).  We hypothesize that the brain regions most vulnerable to ethanol will 
be those cells that are actively undergoing developmental processes and are 
particularly sensitive to intracellular and extracellular cues, such as ethanol.  As 
such, the results generated in this study can only be interpreted on a broad scale, 
perhaps suggesting that common alterations to neurodevelopmental trajectories 
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may happen in some varying brain regions that have a similar developmental 
timeline.   Regardless, future studies examining region-specific changes in gene 
expression, protein expression, and physiological structure would be extremely 
useful and will provide a more detailed perspective of those genes and pathways 
that may be affected by ethanol within those regions.   
Secondly, experimenters using microarrays as investigative tools have attempted 
to achieve a standardization of data quality with the suggestion of requirements, 
known as the ‘minimum information about a microarray experiment’ (MIAME) 
that may be needed to interpret the results of the experiment and potentially 
reproduce its findings (BRAZMA et al. 2001).  Currently, many journals and funding 
agencies require that microarray experiments adhere to MIAME guidelines, 
though there has been criticism (GALBRAITH 2006, SHIELDS 2006).  While the array 
experiments included in this study have attempted to meet MIAME standards and 
the information regarding all experiments have been curated to NCBI’s Gene 
Expression Omnibus (GEO) database , I acknowledge that the sample sizes used 
by the microarray studies were low, resulting in less than ideal statistical power 
to identify low-fold gene expression changes.  The use of an FDR-corrected p-value 
in the identification of differentially expressed genes certainly assisted in 
reducing array noise, though it cannot be discounted that a proportion of the 
genes identified were false positives, and equally importantly, a number of genes 
affected were likely not identified by this study (false negatives).   It has been 
reported that the use of inbred animals, as in this study, reduces the need for a 
greater number of array replicates (WEI et al. 2004).  Also, I had success in 
confirming three of four genes identified by the short-term array, and four of four 
genes identified by the long-term analysis, which may speak to the reliability of 
the array results using qPCR, though the confirmation of more genes would 
certainly add to confidence in the array results.   Further, the cost of arrays since 
2001 has substantially decreased and continues to decline, allowing current 
studies to employ more arrays or even make use of next-generation technology, 
such as RNA-seq (MARIONI et al. 2008, MORTAZAVI et al. 2008).   
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Lastly, while behavioural analyses used both male and female cohorts, all samples 
used for RNA and miRNA expression analysis were derived from male mice.  Sex-
specific differences in certain behaviours, such as activity in a novel open field 
arena (Figure 3.2) and anxiety-related behaviours (Figures 3.8, 3.9, 3.10, 3.11) 
were identified by this study.   As mentioned, these findings are consistent with 
other studies suggesting that prenatal alcohol exposure may affect individuals in 
a sexually-dimorphic manner, particularly with regard to stress vulnerability, 
HPA axis function, serotonin response, and hippocampal function (GABRIEL et al. 
2006, HOFMANN et al. 2007, MCMURRAY et al. 2008, HELLEMANS et al. 2010, 
PRZYBYCIEN-SZYMANSKA et al. 2010, ZAJAC et al. 2010).  It would be prudent to 
evaluate sex-specific differences in gene expression, particularly with regard to 
genes that were identified and are critical to HPA axis development and function 
such as pro-opiomelanocortin (Pomc) and apolipoprotein E (Apoe), and to further 
assess how ethanol affects neurodevelopment in conjunction with sex -specific 
hormonal signaling (HELLEMANS et al. 2008, WEINBERG et al. 2008, KUDWA et al. 
2014).   
 
4.4 Evaluation of behavioural and gene expression changes 
across treatment paradigms 
Upon the initiation of this study, there were few models of FASD that were being 
utilized to evaluate the molecular effects of prenatal alcohol exposure in the brain.  
These models varied in treatment dose, timing, treatment method, and model 
system, making comparisons between them difficult.  A major goal of this research 
was to develop a comprehensive animal model that evaluated the behavioural and 
genetic effects of ethanol exposure during neurodevelopment using controlled 
dosage paradigms across multiple trimester equivalents.  These studies have 
provided a mechanism to compare the behaviours and genes that may be affected 
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by alcohol consumption at specific stages of human neurodevelopment (KLEIBER 
et al. 2013, MANTHA et al. 2013, KLEIBER et al. 2014b, MANTHA et al. 2014a).    
 
4.4.1 Behavioural changes and timing of exposure 
The results included in this thesis focus on findings resulting from a heavy binge-
like exposure during early postnatal period, disrupting neurodevelopmental 
processes that are roughly equivalent to those occurring in the human brain 
during the third trimester.  The first goal of this research was to establish a battery 
of behavioural assays that was relevant to major behavioural and cognitive 
phenotypes observed in human FASD and that could be used to test the 
development of these features as they emerged throughout the course of the 
maturation from neonate to adult.  The behavioural battery, while certainly not 
an exhaustive evaluation of all FASD-relevant behaviours, was able to successfully 
identify changes to early neuromuscular coordination, activity levels, anxiety-
related traits, and learning ability, strategy, and spatial memory retention 
resulting from early postnatal ethanol exposure.   
This battery was also able to identify behavioural differences between treatment 
paradigms that used an equivalent ethanol dose administered at the trimester 
one, trimester two, or trimester three-equivalent (MANTHA et al. 2013).  Findings 
across treatment paradigms were intriguing, and while similar behaviours were 
observed within all models, there were distinctive differences in the subset or 
severity of the phenotypes observed.  For example, while differences in nocturnal 
overnight activity were observed in all paradigms, the pattern varied considerably 
with very little difference observed following trimester one-equivalent exposure, 
an intermediate phenotype observed following trimester two-equivalent 
exposure, and a pronounced difference – specifically during the early period of the 
light/dark cycle - following third trimester-equivalent ethanol exposure.  Further, 
the emergence of anxiety-related traits seemed to be specific to late-gestational 
(trimester two and three-equivalents) ethanol exposure.  Lastly, the pattern of 
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spatial learning was interestingly variable between treatment times, with 
trimester one-equivalent-treated mice showing a pronounced difference in 
latency to locate the target of the Barnes maze between control and ethanol-
treated mice only during the latter testing days.  Conversely, trimester two -
equivalent-treated mice showed differences in latency during the first day of 
training, but appeared to ‘catch up’ to their control counterparts – eliminating 
differences in latency to locate the target - by testing days two to four.    As 
presented within this thesis, ethanol treatment during the third trimester -
equivalent resulted in the most severe spatial learning deficits as tested by the 
Barnes maze, which were more pronounced when postnatal day 7 was included 
as a treatment day.  These findings suggest that there may be windows of 
vulnerability for the later emergence of certain phenotypes that may be 
dependent on the sensitivity of certain neural regions that govern these 
behaviours.  This would also imply that certain behaviours are likely to appear co -
morbidly given that brain regions interact to influence multiple cognitive 
behaviours, such as the hippocampus and its role in learning and memory and the 
influence of HPA axis-associated stress reactivity on learning behaviour (MCEWEN 
2003, WINGENFELD and WOLF 2014).  The sensitivity of particular brain regions to 
ethanol at varying neurodevelopmental times also may speak to the phenotypic 
heterogeneity of FASD.  Its classification as a “spectrum” disorder certainly 
reflects the broad range and severity of phenotypes that are associated with 
prenatal alcohol exposure, and factors including (though not limited to) timing 
and dose of ethanol may contribute to this variability.  Finally, as early gestational 
exposure has been biologically associated with distinctive craniofacial and other 
physiological abnormalities that categorize FAS (SULIK 2005), the appearance of a 
subset of abnormal behaviours in an infant, child, or adolescent with prenatal 
alcohol exposure may offer a modest estimate of the timing and/or dosage of 
ethanol exposure, though this hypothesis certainly would require a much more 
thorough evaluation at both the animal model and clinical level given the complex 
socio-economic factors that influence outcome in humans.   
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4.4.2 Genome-wide gene expression changes as an indicator of altered 
neurodevelopmental and adult neural processes 
Many studies have examined the ability of ethanol to elicit excitotoxic cell death 
in immature brain regions depending on timing and dosage (IKONOMIDOU et al. 
2000, GOODLETT and HORN 2001, DIKRANIAN et al. 2005, NOWOSLAWSKI et al. 2005).  
Fewer studies, however, have examined the long-term molecular effects of 
ethanol exposure – those effects that do not lead to apoptosis but to an 
interruption of normal neurodevelopmental processes that causes the cell to 
respond, adapt, and continue on a developmental trajectory towards maturation.   
Analysis of gene expression changes acutely (4 hours) following ethanol exposure 
at P7 suggested that a number of cellular stress-associated mechanisms underlie 
the response of developing neural cells to a binge-like ethanol insult.   While a 
number of genes associated with apoptotic cell death were upregulated, a number 
of biological processes were identified that were consistent with optimizing cell 
survival, such as the down-regulation of molecules involved in energetically costly 
processes such as ribosome synthesis, cell cycle transition, and a number of 
transcription factors involved in developmental processes, and the upregulation 
of molecules integral to cell membrane integrity (Table 3.5). These findings are 
consistent with results from ethanol treatments administered during the first and 
second trimester equivalent, which identified the down-regulation of genes 
associated with ribosomal biosynthesis, cell cycle progression, cellular migration, 
and neuronal maturation, and the upregulation of genes involved in cellular 
integrity and adhesion (GREEN et al. 2007, MANTHA et al. 2014a).  What seems to be 
integral to ethanol exposure during the third trimester-equivalent is the changes 
in expression of a number of genes associated with neurotransmitter systems 
such as glutamate, GABA, dopamine and serotonin, as well as steroid hormone 
signaling including retinoic acid and metabolic derivatives of pro-
opiomelanocortin (Pomc) (Tables 3.5, 3.6, 3.8. 3.9. 3.10).  This may be related to 
the timing of exposure and the sensitivity of predominant biological processes 
that are occurring during this ‘brain growth spurt’ to external molecular cues, 
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including the maturation of neural circuitry, maintenance of synaptic connections, 
and apoptotic synaptic pruning (COHEN-CORY 2002, LUJAN et al. 2005, AKERMAN and 
CLINE 2007).  Interestingly, we have found that ethanol exposure during the first 
trimester equivalent alters the expression of a number of genes associated with 
cellular survival, neurulation, and extracellular matrix remodeling, while 
exposure during the second trimester-equivalent disrupts processes associated 
with cellular migration and differentiation (KLEIBER et al. 2013, KLEIBER et al. 
2014a). This has reinforced our hypothesis that ethanol may target cells that are 
particularly sensitive to intra- and extracellular cues, as is the case with cells 
undergoing neurodevelopmental processes that rely heavily on cellular 
communication, signaling, and appropriate and timely gene expression.  
A novel goal of this study was to not only assess the changes to the brain 
transcriptome acutely following ethanol exposure, but to also evaluate if 
neurodevelopmental ethanol exposure resulted in long-term changes to brain 
gene expression that are present in adulthood, potentially driving or at least 
contributing to the behavioural phenotypes that emerge and persevere in 
individuals with FASD.  Given that long-term gene expression changes were 
identified regardless of treatment paradigm (KLEIBER et al. 2012, KLEIBER et al. 
2013), the question of what may initiate and maintain these gene expression 
changes over time naturally arises.   A clear answer to these questions is not 
straight-forward and may involve some combination of the primary (acute) and 
secondary effects of ethanol exposure.    
Factors that instigate these changes in gene expression may include ethanol-
induced apoptosis of susceptible cell types, leading to an overall change in the 
cellular composition of the brain and, subsequently, the overall pattern of brain 
gene expression (IKONOMIDOU et al. 2000, OLNEY et al. 2002a).  Given that this study 
utilized whole brain tissue as a source of RNA, this may certainly contribute to 
some of the gene expression changes identified.  Another contributing mechanism 
may be the ability of ethanol to disrupt developmental processes that are highly 
reliant on external cues such as cell proliferation, migration, differentiation, and 
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communication (GUERRI 1998, RICE and BARONE 2000, CAMARILLO and MIRANDA 
2008).  The disruption of these processes would represent residual effects of the 
ability of alcohol to alter cellular identity, structure, or connectivity in a way that 
alters the physiology of the brain such that the appropriate balance of adult gene 
expression is not maintained.  This hypothesis has been suggested for a number 
of spectrum disorders, and has been referred to as a neurodevelopmental 
“footprint” of teratogen exposure (DEMJAHA et al. 2011, DUFOUR-RAINFRAY et al. 
2011, KLEIBER et al. 2012).  We have observed distinct (though related) patterns 
of altered gene expression depending on timing and dose of ethanol exposure, 
supporting that neurodevelopmental ethanol exposure may leave a ‘molecular 
footprint’ that is somewhat specific to the timing of exposure and involves altered 
gene expression and epigenetic patterning (KLEIBER et al. 2012, KLEIBER et al. 2013, 
LAUFER et al. 2013).  
There is increasing evidence that developmental ethanol exposure can affect 
epigenetic patterning including DNA methylation, histone modifications, and 
microRNA expression, which can produce long-term and relatively stable changes 
to the expression of a number of genes (SATHYAN et al. 2007, WANG et al. 2008, LIU 
et al. 2009, KAMINEN-AHOLA et al. 2010, MIRANDA 2011).  Results presented within 
this thesis support research reporting ethanol’s ability to alter the expression of 
proteins involved in histone modifications (ie, HDACs), proteins involved in one-
carbon metabolism and DNA methylation, and a number of microRNAs, 
suggesting that ethanol exposure during the third trimester equivalent is able to 
interfere with processes that establish appropriate neural epigenetic 
programming.  This is consistent with results from other treatment paradigms 
used within our lab; indeed, all treatment methods (binge or voluntary maternal 
consumption) that we have utilized have been associated with changes to 
epigenetic programming (LAUFER et al. 2013, KLEIBER et al. 2014b, MANTHA et al. 
2014b).  This avenue of fetal alcohol research is relatively new but gaining in 
attention given that it has implications towards the persistence of FASD 
phenotypes throughout the lifetime of an individual.  Developmentally-
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established epigenetic programming can often be rendered extremely stable (REIK 
et al. 2001, HAYCOCK 2009, O'SULLIVAN et al. 2012); however, reprogramming can 
take place at several points throughout the lifespan in response to changes in 
environmental conditions, suggesting that if epigenetic factors strongly underlie 
the behavioural and cognitive consequences of fetal alcohol exposure, they may 
be amenable to treatment by environmental interventions. 
 
4.4.3 Future directions: understanding FASD etiology and potential for 
developing diagnostic and treatment strategies 
The ultimate goal of any animal model of a human genetic disorder is the 
utilization of that model to understand the pathogenesis of the disease and assess 
potential treatment strategies.   The mouse model developed in this study, along 
with other models developed by our lab, interrogate the effects of ethanol dosage 
and timing on behaviour, brain gene expression, and epigenetic patterning 
(KLEIBER et al. 2012, KLEIBER et al. 2013, LAUFER et al. 2013, MANTHA et al. 2013, 
KLEIBER et al. 2014b).  Given that the ultimate purpose of these models is to 
examine the biological underpinnings of human FASD, future studies examining 
how the findings from this study may translate diagnostically or prognostically to 
humans would be useful and, importantly, evaluate if similar mechanisms, either 
genetic or epigenetic, contribute to the development of this disorder in humans.  
The results submitted as part of this thesis are hopefully an initial step to facilitate 
these studies and there are some findings included that may direct future research 
with these goals in mind.  As with other array studies involving complex traits and 
disorders, a large number of gene transcripts – both mRNA and miRNA – were 
identified including those affected acutely following ethanol exposure (short-term 
effects) and those that remain altered in the adult brain (long-term effects).  This 
indicates that multiple mechanisms and pathways are involved, and certainly, 
many have been implicated in FASD not only by this study but also within the 
expanding FASD-associated literature.  This raises the question of how to reduce 
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this biological complexity and how to most effectively identify candidate target 
molecules or processes that may aid in diagnosis or treatment.   
To explore the molecular relationships between the genes identified within this 
study and to identify core molecules that could unify the somewhat distinct 
biological processes associated with them, the transcripts were organized into 
interconnected gene networks. This approach is a key feature of ‘network 
medicine’ that has been applied to the analysis of other complex diseases and is a 
promising approach to identify potential diagnostic and prognostic biomarkers or 
pharmaceutical targets from large array-based studies (BENSON and BREITLING 
2006, BARABASI et al. 2011).   Indeed, the results from this study and other research 
investigating the molecular consequences of neurodevelopmental alcohol 
exposure demonstrate that while various genes or gene sets may be identified 
depending on factors such as timing of exposure or ethanol dosage administered, 
there is some consistency with regard to the biological pathways and ‘hub’ 
molecules that appear following network analyses associated with those gene sets 
(KLEIBER et al. 2013).  Evaluating the role of these specific genes in the developing 
and adult brain with regard to the influence of alcohol on their expression or 
function may be a promising initial step to unravelling the complexity of FASD -
associated neural dysfunction.   
In addition to identifying core molecules that may be key biological effectors of 
FASD, it is also important to consider that FASDs do not occur in isolation of social, 
economic, and other environmental factors.  FASD prevalence is often 
considerably higher in populations with low socioeconomic and educational 
status, increasing the likelihood of factors that exacerbate the severity of FASD 
phenotypes both prenatally and postnatally, including nutritional deficiencies, 
comorbid exposure to other teratogenic substances, and a suboptimal early-life 
environment  (LIEBER 2003, SECKL and MEANEY 2004, STREISSGUTH et al. 2004, 
DWYER et al. 2009, ESPER and FURTADO 2014).  While these factors contribute to 
how FASD phenotypes may present, they are also potential targets to mitigate the 
effects of prenatal alcohol exposure.   Improving the nature of early postnatal care 
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has been shown to improve a number of phenotypic impairments associated with 
prenatal alcohol exposure (CHIODO et al. 2009, ORNOY and ERGAZ 2010).  Children 
that have a strong, interdisciplinary support system including parents, teachers, 
and health care professionals show improved social and learning skills (KALBERG 
and BUCKLEY 2007).  Additionally, these improvements may have a molecular basis 
including epigenetic reprogramming of genes associated with cognition and 
stress reactivity (WEAVER et al. 2004).  Given that epigenetic alterations appear to 
be a prominent consequence of prenatal alcohol exposure, the malleability of 
these features by postnatal environment suggests that positive and enriched early 
life experiences may ameliorate some prenatal alcohol effects in a stable and long-
term manner.  There are also pharmaceutical epigenetic treatment opportunities 
that have proven successful for enhancing learning and memory following 
traumatic brain injury and within some models of neurodegenerative conditions 
(HOCKLY et al. 2003, CHEN et al. 2006b, DASH et al. 2009), though the transient 
effects and non-specific alterations to the epigenome limit this avenue.  
Technologies such as CRISPR-Cas9-mediated alteration of epigenetic marks are 
promising in that they may be able to specifically target and alter acetylation or 
methylation at specific locations throughout the genome (DOUDNA and 
CHARPENTIER 2014, HILTON et al. 2015).  This technology is still being developed, 
but it has proven effective and may, in the future, facilitate new treatments to 
improve some phenotypes associated with neurodevelopmental disorders such 
as FASD. 
Finally, while mouse models can be extremely useful in identifying molecular 
pathways that underlie neurodevelopmental disorders, it must be confirmed that 
those models reliably and consistently reflect the processes that occur during 
human neurodevelopment and contribute to the manifestation of any 
neurological disorder.   As an initial step towards translating this research to 
human FASD, our lab has performed some investigative studies examining if the 
altered epigenetic patterning that we observed in mice following prenatal alcohol 
exposure may be present in peripheral human tissues and may be used as a 
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diagnostic measure in children.  Indeed, similar to results obtained from mouse 
brain tissue, we have observed a great deal of consistency between the 
methylation patterns of buccal DNA obtained from children with FASD that were 
distinct from non-exposed children, suggesting that analysis of DNA methylation 
or other epigenetic marks may provide a novel diagnostic strategy (LAUFER et al. 
2015).   
 
4.5 Conclusions 
4.5.1 Contributions to FASD research 
Neurodevelopmental ethanol exposure results in a complex array of behavioural, 
genetic and epigenetic changes in the brain.  It is remarkable that so little attention 
was given to such a detrimental, prevalent, and entirely preventable set of 
disorders by the scientific and medical community until the early 1970s (LEMOINE 
et al. 1968, JONES and SMITH 1973).  Since its recognition, however, literature 
examining the behavioural, cognitive, physiological, cellular, and genetic effects 
on the developing brain has steadily grown.   The results from these studies are 
varied as are the strategies used by researchers, but consistent themes are 
emerging.  The results included in this thesis present several contributions to 
extant FASD literature that, along with other research I have previously published, 
have hopefully progressed our understanding of the biological mechanisms that 
contribute to these disorders.   
First, a goal of this research was to generate a mouse model that recapitulated a 
number of phenotypes consistent with FASD that could be assessed at throughout 
the maturation of the mouse from neonate to adult.  To assess this, I developed a 
behavioural battery designed to follow the maturation of the mouse from neonate 
to adult to somewhat parallel the emergence of behaviours in children and young 
adults affected by prenatal alcohol exposure. Further, the battery could be used 
on cohorts of mice exposed to alcohol using varying treatment paradigms.  While 
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this thesis focuses on a third trimester-equivalent ‘binge’-like exposure, we have 
also used the same battery on mice treated with binge doses at other trimester 
equivalents as well as by voluntary maternal consumption throughout gestation.  
This has allowed for the validation of these models in that they do show FASD-
relevant behavioural and cognitive phenotypes but also allowed for the 
comparison of the effects of ethanol exposure at different developmental times 
and doses.  The results from these studies have suggested that there are temporal 
windows during neurodevelopment that affect the presence or severity of certain 
behaviours as they appear later in life.  The results also suggest that the third 
trimester-equivalent is an extremely sensitive period for the disruption of brain 
regions or pathways associated with spatial learning and stress reactivity.  These 
data are consistent with FASD as a ‘spectrum’ disorder and support that alcohol 
timing and dose are key factors that contribute to the range of neurobehavioural 
phenotypes associated with prenatal alcohol exposure.   
Second, this study is the first to examine genome-wide changes in gene expression 
resulting from ethanol exposure during synaptogenesis.   Gene expression was 
examined at two time points: acutely (4 hours) following ethanol exposure to gain 
insight into how ethanol may alter neurodevelopmental processes, and during 
adulthood (postnatal day 60) to evaluate how neurodevelopmental alcohol 
exposure may cause long-lasting changes within the adult brain and how these 
changes relate to the persistent FASD-associated phenotypes.  The acute response 
was characterized by cellular stress response and the down-regulation of 
energetically costly cellular processes, consistent with the current literature; 
however, there were a subset of genes identified associated with glutamate 
neurotransmission and synaptic formation that were not over-represented in 
other treatment paradigms.  This ability to compare altered gene sets across 
different treatments has been informative, and has led to our hypothesis that 
ethanol may most effectively disrupt neurodevelopmental processes that are 
active at the time of exposure, perhaps due to their sensitivity to environmental 
cues.  Also, while few transcripts were identified as altered in both the short-term 
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and long-term analyses, there was considerable consistency between the 
biological processes and pathway associated with them including synaptic 
plasticity, neurotransmission, and HPA axis function.  These processes were 
consistent with the learning and anxiety-related phenotypes I observed in these 
animals, particularly with regard to their severity compared to animals treated 
using other paradigms.   
Finally, given that epigenetic mechanisms have been implicated in maintaining 
the long-term effects of prenatal alcohol exposure, miRNA expression in the adult 
brain was analyzed to evaluate any correlations between altered miRNA levels 
and the expression of their putative mRNA targets.  A number of miRNAs were 
identified and showed an inverse direction of expression change as compared to 
their mRNA target(s).  While this analysis requires further confirmation, the 
processes associated with the mRNA targets again showed an over-
representation of a number of processes identified by both mRNA array 
experiments.    
It is important to note that all of these analyses are exploratory and designed 
toward establishing and testing the utility of a novel animal model strategy in 
assessing the molecular changes in the brain associated with FASD.  The model 
has proven effective in identifying molecular features of ethanol exposure at 
different developmental times, and comparing those changes with differences in 
observed behaviours.  Also, there is consistency and a logical agreement between 
the results from multiple lines of analyses including behaviour, biological 
functions associated with the short and long-term transcript changes, and miRNA 
target processes that may point to lucrative avenues for future investigation.  This 
process, while essential and valuable, is an initial step towards understanding the 
complexity associated with how ethanol can affect the developing brain and lead 
to a lifetime of behavioural and cognitive changes.  These studies leave many more 
questions regarding the role of these genes in altering the function of cells, brain 
regions, and the neural interactions that ultimately dictate behaviour, as well as 
which mechanisms may be effective diagnostic or therapeutic targets.  There 
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likely will be no ‘smoking gun’ mechanism or course of obvious  treatment; 
however, this research has facilitated ongoing studies that use the models and 
findings established within this thesis to more deeply explore biological 
mechanisms that contribute to FASD including epigenetic alterations such as the 
involvement of DNA methylation and histone modification, how alcohol exposure 
may interact with postnatal environment to affect behaviour, and translational 
work involving potential diagnostic strategies in humans.  
 
4.5.2 A working model of FASD  
This study was initiated to provide a holistic investigation into the effects of 
ethanol exposure during neurodevelopment on behaviour, gene expression, and 
epigenetic patterning.   The model allows for the proposal of FASD as a continuum 
of molecular events that ultimately manifests as long-term cognitive and 
behavioural phenotypes (Figure 4.1).  Ethanol exposure represents an 
interruption in normal neurodevelopmental processes.  Depending on the timing 
of exposure, certain populations of cells will succumb to cellular stress response 
and undergo apoptosis, while surviving cells must suspend their normal 
developmental trajectories and utilize molecular adaptations that include 
changes in gene expression and epigenetic patterning.  These epigenetic 
alterations likely involve the interaction of DNA methylation, histone 
modification, and ncRNA regulation.  Many of these epigenetic changes are 
expected to be stably inherited following subsequent neurogenesis, 
differentiation, and maturation, resulting in not only altered brain str ucture and 
neuronal connectivity but also a distinctive pattern of altered gene expression in 
the mature brain.  These transcriptomic and epigenetic changes represent an 
enduring molecular “footprint” that reflects the timing, dose, and pattern of 
alcohol exposure as well as their interactions with maternal and fetal genotype 
and the prenatal environment.  This reprogramming of neurogenomic patterning 
may be further compounded by subsequent ontogenetic factors such as postnatal 
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environment, which may further exacerbate or ameliorate epigenetic signatures 
and subsequent gene expression.  Postnatal environment is therefore a potential 
avenue for early-life mitigation of FASD phenotypes.  Also, these epigenetic   
signatures may—if shared by peripheral tissue sources—offer a source of early 
diagnosis of prenatal alcohol exposure.  Given the unlikelihood of total abstinence 
from alcohol consumption during pregnancy, particularly within Western 
cultures, evidence that the effects of prenatal alcohol exposure may be  amended 
or reversed at the molecular and, subsequently, at the phenotypic level would 
represent a significant step towards improving the prognosis of individuals with 
FASD.   
Not even half a century after the recognition that alcohol consumption during 
pregnancy leads to a set of characteristic physiological and cognitive phenotypes 
that led Jones and Smith to coin the term ‘fetal alcohol syndrome’ (JONES et al. 
1973), we are making leaps in our understanding of the myriad of effects of 
alcohol on neurodevelopment, including its eventual manifestation as increased 
risk for behavioural and cognitive phenotypes that ultimately impair the ability of 
an ethanol-exposed child to thrive.  In addition to contributing to our 
understanding of the biological etiology of FASD, it is hoped that this work 
facilitates the development of novel therapeutic and treatment approaches to 
improve the outcome of individuals with this pervasive and costly disorder.  Given 
the increase in prevalence of disorders of neurodevelopmental origin, this work 
also provides a model to assist in our understanding of how adverse prenatal 
environments, including exposure to teratogens such as alcohol, can lead to 
adverse effects on brain development that contributes to the emergence of later -
life psychopathologies.   
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FIGURE 4.1.  A working model of FASD as a continuum of genetic and epigenetic events.  (A)  Ethanol exposure results in cellular 
stress response leading to the apoptosis of vulnerable cell types. (B)  These changes are followed by molecular adaptation in 
surviving cells that include changes to gene expression, driven in part by changes to epigenetic programming including altered DNA 
methylation, histone modifications, and ncRNA regulation.  (C) These changes may be inherited and maintained throughout further 
developmental processes such as cellular differentiation and maturation.  Additionally, following parturition, epigenetic control of 
gene expression is vulnerable to exacerbation or amelioration by postnatal environmental experiences.  (D) Adverse (red) or 
positive (green) outcomes likely depend on the interaction of these factors and contribute to the ontogeny of FASD phenotypes.  
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Appendix A.  mRNA transcripts identified as altered in the brain of neonate mice (postnatal day 7) four hours following ethanol 
treatment (fold cutoff ≥ ±1.2, FDR-corrected p-value < 0.05). Genes are listed alphabetically by gene symbol.  
 
Transcript 
ID 
Gene 
symbol 
Gene name RefSeq ID Chra Fold change p-valueb 
10539766 Aak1 AP2 associated kinase 1 NM_001040106 6 1.22 0.012 
10392484 Abca8b ATP-binding cassette, sub-family A (ABC1), member 8b NM_013851 11 1.36 0.009 
10443730 Abcg1 ATP-binding cassette, sub-family G (WHITE), member 1 NM_009593 17 1.21 0.024 
10485241 Accs 1-aminocyclopropane-1-carboxylate synthase (non-functional) NM_183220 2 1.36 0.002 
10505779 Acer2 alkaline ceramidase 2 NM_139306 4 1.31 0.003 
10397172 Acot6 acyl-CoA thioesterase 6 NM_172580 12 1.25 0.005 
10554074 Adamts17 a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 17 
NM_001033877 7 1.21 0.007 
10531195 Adamts3 a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 3 
NM_177872 5 1.20 0.038 
10351551 Adamts4 a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 4 
NM_172845 1 1.21 0.002 
10447502 Adcyap1 adenylate cyclase activating polypeptide 1 NM_009625 17 -1.31 0.014 
10479351 Adrm1 adhesion regulating molecule 1 NM_019822 2 -1.21 0.012 
10523647 Aff1 AF4/FMR2 family, member 1 NM_001080798 5 1.22 0.005 
10534889 Agfg2 ArfGAP with FG repeats 2 NM_178162 5 -1.21 0.009 
10582658 Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) NM_007428 8 1.23 0.038 
10472923 Ak4 adenylate kinase 4 NM_001177602 4 -1.22 0.024 
10446214 Alkbh7 alkB, alkylation repair homolog 7 (E. coli) NM_025538 17 -1.25 0.049 
10459389 Amd1 S-adenosylmethionine decarboxylase 1 NM_009665 10 -1.21 0.014 
10595668 Ankrd34c ankyrin repeat domain 34C NM_207260 9 -1.40 0.022 
10583834 Anln anillin, actin binding protein NM_028390 9 1.23 0.010 
10594631 Aph1b anterior pharynx defective 1b homolog (C. elegans) NM_177583 9 1.22 0.003 
10604375 Apln apelin NM_013912 X -1.29 0.042 
10450796 Armcx5 armadillo repeat containing, X-linked 5 NM_001009575 X 1.40 0.037 
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10406407 Arrdc3 arrestin domain containing 3 NM_001042591 13 2.22 0.000 
10564507 Arrdc4 arrestin domain containing 4 NM_001042592 7 1.65 0.001 
10499666 Atp8b2 ATPase, class I, type 8B, member 2 NM_001081182 3 1.29 0.029 
10490104 Aurka aurora kinase A NM_011497 2 -1.24 0.007 
10406456 AY512938 cDNA sequence AY512938 AY512938 UN 1.25 0.003 
10437191 B3galt5 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 NM_033149 16 1.31 0.008 
10434291 B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 NM_001159407 16 1.23 0.040 
10439854 Bbx bobby sox homolog (Drosophila) NM_027444 16 1.23 0.001 
10587085 BC031353 family with sequence similarity 214, member A NM_001113283 9 1.21 0.019 
10439409 BC031361 cDNA sequence BC031361 NR_033221 16 1.20 0.042 
10475866 Bcl2l11 BCL2-like 11 (apoptosis facilitator) NM_207680 2 1.46 0.002 
10357875 Btg2 B cell translocation gene 2, anti-proliferative NM_007570 1 1.48 0.001 
10440419 Btg3 B cell translocation gene 3 NM_009770 16 1.25 0.004 
10515026 Cc2d1b coiled-coil and C2 domain containing 1B NM_177045 4 1.23 0.011 
10578557 Ccdc111 primase and polymerase (DNA-directed) NM_001001184 8 1.29 0.025 
10368083 Ccdc28a coiled-coil domain containing 28A NM_144820 10 1.30 0.021 
10569646 Ccnd1 cyclin D1 NM_007631 7 -1.34 0.003 
10349442 Ccnt2 cyclin T2 NM_028399 1 -1.20 0.024 
10474229 Cd59a CD59a antigen NM_001111060 2 1.24 0.037 
10564573 Chd2 chromodomain helicase DNA binding protein 2 NM_001081345 7 1.34 0.006 
10583347 Chordc1 cysteine and histidine-rich domain (CHORD)-containing, zinc-binding 
protein 1 
NM_025844 9 -1.28 0.008 
10507726 Cited4 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal 
domain, 4 
NM_019563 4 -1.26 0.013 
10438769 Cldn1 claudin 1 NM_016674 16 1.29 0.018 
10547674 Clec4e C-type lectin domain family 4, member e AB024717 6 1.20 0.007 
10597564 Cmc1 COX assembly mitochondrial protein 1 NM_026442 9 -1.20 0.028 
10364593 Cnn2 calponin 2 NM_007725 10 -1.21 0.010 
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10346298 Coq10b coenzyme Q10 homolog B (S. cerevisiae) NM_001039710 1 -1.26 0.014 
10565089 Cpeb1 cytoplasmic polyadenylation element binding protein 1 NM_007755 7 1.31 0.011 
10388996 Crlf3 cytokine receptor-like factor 3 NM_018776 11 1.21 0.024 
10371400 Cry1 cryptochrome 1 (photolyase-like) NM_007771 10 -1.24 0.001 
10428453 Csmd3 CUB and Sushi multiple domains 3 NM_001081391 15 1.21 0.007 
10472408 Csrnp3 cysteine-serine-rich nuclear protein 3 NM_153409 2 1.25 0.012 
10485580 Cstf3 cleavage stimulation factor, 3' pre-RNA, subunit 3 NM_145529 2 1.31 0.011 
10515943 Ctps cytidine 5'-triphosphate synthase NM_016748 4 -1.22 0.003 
10453057 Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 NM_009994 17 1.25 0.011 
10514520 Cyp2j9 cytochrome P450, family 2, subfamily j, polypeptide 9 NM_028979 4 1.29 0.001 
10489498 Dbndd2 dysbindin (dystrobrevin binding protein 1) domain containing 2 NM_001048227 2 -1.22 0.041 
10369290 Ddit4 DNA-damage-inducible transcript 4 NM_029083 10 1.24 0.023 
10369630 Ddx21 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 NM_019553 10 -1.27 0.001 
10470628 Ddx31 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 NM_001033294 2 -1.20 0.004 
10525751 Ddx55 DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 NM_026409 5 -1.21 0.036 
10437664 Dexi dexamethasone-induced transcript NM_021428 16 1.21 0.011 
10401841 Dio2 deiodinase, iodothyronine, type II NM_010050 12 -1.21 0.023 
10449284 Dusp1 dual specificity phosphatase 1 NM_013642 17 1.65 0.001 
10548735 Dusp16 dual specificity phosphatase 16 NM_130447 6 1.27 0.004 
10571312 Dusp4 dual specificity phosphatase 4 NM_176933 8 -1.35 0.035 
10366043 Dusp6 dual specificity phosphatase 6 NM_026268 10 -1.73 0.000 
10588495 Dusp7 dual specificity phosphatase 7 NM_153459 9 -1.21 0.002 
10569280 Dusp8 dual specificity phosphatase 8 NM_008748 7 1.21 0.011 
10574682 E2f4 E2F transcription factor 4 NM_148952 8 -1.29 0.046 
10404783 Edn1 endothelin 1 NM_010104 13 1.29 0.019 
10603768 Efhc2 EF-hand domain (C-terminal) containing 2 NM_028916 X 1.23 0.007 
10518069 Efhd2 EF hand domain containing 2 NM_025994 4 -1.28 0.007 
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10416251 Egr3 early growth response 3 NM_018781 14 -1.26 0.003 
10545859 Egr4 early growth response 4 NM_020596 6 -1.25 0.040 
10368317 Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 NM_134005 10 1.22 0.047 
10357164 Epb41l5 erythrocyte membrane protein band 4.1 like 5 NM_145506 1 -1.20 0.027 
10391490 Etv4 ets variant 4 NM_008815 11 -1.27 0.016 
10438626 Etv5 ets variant 5 NM_023794 16 -1.73 0.000 
10545045 Fam13a family with sequence similarity 13, member A NM_153574 6 1.30 0.004 
10368638 Fam26e family with sequence similarity 26, member E NM_178908 10 1.31 0.018 
10597088 Fbxw26 F-box and WD-40 domain protein 26 NM_198674 9 1.22 0.049 
10524052 Fgfrl1 fibroblast growth factor receptor-like 1 NM_054071 5 -1.26 0.013 
10505044 Fktn fukutin NM_139309 4 1.25 0.005 
10565401 Folh1 folate hydrolase 1 NM_016770 7 1.44 0.003 
10368886 Foxo3 forkhead box O3 ENSMUST00000
105502 
10 1.27 0.000 
10553769 Gabra5 gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 NM_176942 7 -1.23 0.024 
10404702 Gcnt2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme NM_023887 13 1.22 0.014 
10418480 Gnl3 guanine nucleotide binding protein-like 3 (nucleolar) NM_153547 14 -1.21 0.002 
10493120 Gpatch4 G patch domain containing 4 NM_025663 3 -1.23 0.014 
10414278 Gpr137c G protein-coupled receptor 137C NM_027518 14 1.32 0.000 
10567361 Gpr139 G protein-coupled receptor 139 NM_001024138 7 1.30 0.002 
10368780 Gpr6 G protein-coupled receptor 6 NM_199058 10 1.40 0.007 
10433101 Gpr84 G protein-coupled receptor 84 NM_030720 15 -1.22 0.029 
10437629 Grin2a glutamate receptor, ionotropic, NMDA2A (epsilon 1) NM_008170 16 1.25 0.049 
10548791 Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) NM_008171 6 1.25 0.018 
10407543 Gtpbp4 GTP binding protein 4 NM_027000 13 -1.27 0.002 
10444802 H2-Q2 histocompatibility 2, Q region locus 2 NM_010392 17 -1.23 0.037 
10447004 Hdac1 histone deacetylase 1 NM_008228 4 -1.25 0.000 
10399973 Hdac9 histone deacetylase 9 NM_024124 12 -1.22 0.008 
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10403511 Heatr1 HEAT repeat containing 1 NM_144835 13 -1.31 0.001 
10560329 Hif3a hypoxia inducible factor 3, alpha subunit NM_001162950 7 1.23 0.003 
10358609 Hmcn1 hemicentin 1 NM_001024720 1 -1.20 0.039 
10435443 Hspbap1 Hspb associated protein 1 NM_175111 16 -1.23 0.004 
10509238 Htr1d 5-hydroxytryptamine (serotonin) receptor 1D NM_008309 4 1.23 0.038 
10520355 Htr5a 5-hydroxytryptamine (serotonin) receptor 5A NM_008314 5 1.22 0.009 
10400095 Ifrd1 interferon-related developmental regulator 1 NM_013562 12 -1.29 0.035 
10554094 Igf1r insulin-like growth factor I receptor NM_010513 7 1.21 0.043 
10384223 Igfbp3 insulin-like growth factor binding protein 3 NM_008343 11 1.26 0.013 
10498386 Igsf10 immunoglobulin superfamily, member 10 NM_001162884 3 1.34 0.002 
10579958 Il15 interleukin 15 NM_008357 8 -1.23 0.005 
10413398 Il17rd interleukin 17 receptor D NM_134437 14 -1.21 0.043 
10465861 Incenp inner centromere protein NM_016692 19 -1.21 0.040 
10403743 Inhba inhibin beta-A NM_008380 13 -1.23 0.006 
10389421 Ints2 integrator complex subunit 2 NM_027421 11 1.26 0.013 
10557925 Itgad integrin, alpha D ENSMUST00000
106237 
7 -1.25 0.039 
10567297 Itpripl2 inositol 1,4,5-triphosphate receptor interacting protein-like 2 NM_001033380 7 1.24 0.025 
10544148 Jhdm1d lysine (K)-specific demethylase 7A NM_001033430 6 1.24 0.043 
10411126 Jmy junction-mediating and regulatory protein NM_021310 13 1.25 0.006 
10514466 Jun jun proto-oncogene NM_010591 4 2.60 0.000 
10382321 Kcnj2 potassium inwardly-rectifying channel, subfamily J, member 2 NM_008425 11 -1.40 0.008 
10561702 Kcnk6 potassium inwardly-rectifying channel, subfamily K, member 6 NM_001033525 7 1.36 0.043 
10412650 Kctd6 potassium channel tetramerisation domain containing 6 NM_027782 14 1.27 0.035 
10403352 Klf6 Kruppel-like factor 6 NM_011803 13 -1.26 0.011 
10396079 Klhdc1 kelch domain containing 1 NM_178253 12 1.25 0.012 
10434302 Klhl24 kelch-like 24 NM_029436 16 1.28 0.024 
10400572 Klhl28 kelch-like 28 NM_025707 12 1.21 0.025 
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10519392 Krit1 KRIT1, ankyrin repeat containing NR_033173 5 -1.21 0.036 
10603254 Larp4 La ribonucleoprotein domain family, member 4 NM_001024526 15 -1.31 0.015 
10583732 Ldlr low density lipoprotein receptor NM_010700 9 -1.26 0.020 
10422822 Lifr leukemia inhibitory factor receptor NM_013584 15 1.23 0.025 
10467139 Lipa lysosomal acid lipase A NM_021460 19 1.25 0.024 
10578207 Lonrf1 LON peptidase N-terminal domain and ring finger 1 NM_001081150 8 -1.22 0.035 
10367931 Ltv1 LTV1 homolog (S. cerevisiae) NM_181470 10 -1.48 0.005 
10521555 Lyar Ly1 antibody reactive clone NM_025281 5 -1.28 0.023 
10510464 Lzic leucine zipper and CTNNBIP1 domain containing NM_026963 4 -1.28 0.032 
10465244 Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding 
RNA) 
NR_002847 19 1.53 0.004 
10568780 Mapk1ip1 mitogen-activated protein kinase 1 interacting protein 1 NM_001045483 7 1.20 0.001 
10425507 Mchr1 melanin-concentrating hormone receptor 1 NM_145132 15 1.37 0.006 
10546163 Mcm2 minichromosome maintenance deficient 2 mitotin (S. cerevisiae) NM_008564 6 -1.22 0.011 
10470696 Med27 mediator complex subunit 27 NM_026896 2 -1.26 0.027 
10455826 Megf10 multiple EGF-like-domains 10 NM_001001979 18 1.22 0.020 
10475890 Mertk c-mer proto-oncogene tyrosine kinase NM_008587 2 1.56 0.001 
10382852 Mfsd11 major facilitator superfamily domain containing 11 NM_178620 11 1.23 0.044 
10378568 Mir22 microRNA 22 NR_029739 11 -1.36 0.006 
10398442 Mir410 microRNA 410 NR_029914 12 -1.47 0.003 
10398394 Mir494 microRNA 494 NR_030269 12 -1.22 0.041 
10469239 Mir669c microRNA 669c NR_030473 2 -1.33 0.029 
10433656 Mkl2 MKL/myocardin-like 2 NM_153588 16 1.28 0.029 
10401616 Mlh3 mutL homolog 3 (E coli) NM_175337 12 1.24 0.034 
10564313 Mphosph10 M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) NM_026483 7 -1.34 0.030 
10566514 Mrps36 mitochondrial ribosomal protein S36 NM_025369 13 -1.22 0.043 
10574027 Mt1 metallothionein 1 NM_013602 8 1.25 0.004 
10574023 Mt2 metallothionein 2 NM_008630 8 1.37 0.015 
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10605421 Mtcp1 mature T cell proliferation 1 NM_001039373 X 1.27 0.000 
10545672 Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), 
methenyltetrahydrofolate cyclohydrolase 
NM_008638 6 -1.27 0.012 
10361366 Mtrf1l mitochondrial translational release factor 1-like NM_175374 10 -1.20 0.022 
10601980 Mum1l1 melanoma associated antigen (mutated) 1-like 1 NM_001164630 X 1.25 0.011 
10503643 Ndufaf4 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 
4 
NM_026742 4 -1.29 0.005 
10488771 Necab3 N-terminal EF-hand calcium binding protein 3 NM_021546 2 -1.20 0.015 
10408850 Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 NM_001111324 13 1.20 0.018 
10577492 Nek3 NIMA (never in mitosis gene a)-related expressed kinase 3 NM_001162947 8 1.21 0.046 
10493114 Nes nestin NM_016701 3 -1.22 0.032 
10492598 Nmd3 NMD3 homolog (S. cerevisiae) NM_133787 3 -1.26 0.003 
10404827 Nol7 nucleolar protein 7 NM_023554 13 -1.20 0.035 
10463535 Nolc1 nucleolar and coiled-body phosphoprotein 1 NM_053086 19 -1.26 0.018 
10541845 Nop2 NOP2 nucleolar protein NM_138747 6 -1.21 0.002 
10600707 Nr0b1 nuclear receptor subfamily 0, group B, member 1 NM_007430 X -1.30 0.025 
10427035 Nr4a1 nuclear receptor subfamily 4, group A, member 1 NM_010444 15 -1.40 0.015 
10522192 Nsun7 NOL1/NOP2/Sun domain family, member 7 NM_027602 5 1.20 0.032 
10479397 Ntsr1 neurotensin receptor 1 NM_018766 2 1.21 0.012 
10598236 Nudt11 nudix (nucleoside diphosphate linked moiety X)-type motif 11 NM_021431 X 1.33 0.004 
10416510 Nufip1 nuclear fragile X mental retardation protein interacting protein 1 NM_013745 14 -1.22 0.009 
10361651 Nup43 nucleoporin 43 NM_145706 10 -1.21 0.014 
10466268 Olfr1418 olfactory receptor 1418 NM_001011524 19 -1.24 0.017 
10436823 Olig2 oligodendrocyte transcription factor 2 NM_016967 16 -1.30 0.009 
10360454 Opn3 opsin 3 NM_010098 1 -1.21 0.035 
10346260 Osgepl1 O-sialoglycoprotein endopeptidase-like 1 NM_028091 1 1.29 0.008 
10427471 Osmr oncostatin M receptor NM_011019 15 1.23 0.033 
10498367 P2ry13 purinergic receptor P2Y, G-protein coupled 13 NM_028808 3 -1.20 0.012 
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10363350 P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), alpha 1 polypeptide 
NM_011030 10 -1.26 0.017 
10586347 Parp16 poly (ADP-ribose) polymerase family, member 16 NM_177460 9 1.21 0.035 
10455118 Pcdhb18 protocadherin beta 18 NM_053143 18 1.21 0.018 
10455135 Pcdhb21 protocadherin beta 21 NM_053146 18 1.22 0.015 
10479726 Pcmtd2 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain 
containing 2 
NM_153594 2 1.30 0.005 
10414417 Peli2 pellino 2 NM_033602 14 1.21 0.023 
10377439 Per1 period circadian clock 1 NM_001159367 11 1.20 0.000 
10356601 Per2 period circadian clock 2 NM_011066 1 -1.26 0.037 
10361887 Perp PERP, TP53 apoptosis effector NM_022032 10 1.25 0.030 
10470959 Phyhd1 phytanoyl-CoA dioxygenase domain containing 1 NM_172267 2 1.22 0.033 
10351788 Pigm phosphatidylinositol glycan anchor biosynthesis, class M NM_026234 1 1.25 0.040 
10441055 Pigp phosphatidylinositol glycan anchor biosynthesis, class P NM_001159617 16 -1.21 0.041 
10517083 Pigv phosphatidylinositol glycan anchor biosynthesis, class V NM_178698 4 1.21 0.008 
10373740 Pik3ip1 phosphoinositide-3-kinase interacting protein 1 NM_178149 11 1.51 0.002 
10411782 Pik3r1 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 
alpha) 
NM_001077495 13 1.21 0.005 
10515399 Plk3 polo-like kinase 3 NM_013807 4 -1.23 0.006 
10499366 Pmf1 polyamine-modulated factor 1 NM_025928 3 -1.21 0.033 
10384474 Pno1 partner of NOB1 homolog (S. cerevisiae) NM_025443 11 -1.28 0.037 
10421351 Polr3d polymerase (RNA) III (DNA directed) polypeptide D NM_025945 14 -1.27 0.018 
10394240 Pomc pro-opiomelanocortin-alpha NM_008895 12 -1.21 0.013 
10543471 Pot1a protection of telomeres 1A NM_133931 6 1.24 0.000 
10545001 Ppm1k protein phosphatase 1K (PP2C domain containing) NM_175523 6 1.30 0.020 
10525374 Pptc7 PTC7 protein phosphatase homolog (S. cerevisiae) NM_177242 5 -1.20 0.013 
10485624 Prrg4 proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) NM_178695 2 1.27 0.006 
10587616 Prss35 protease, serine 35 NM_178738 9 1.41 0.010 
10578986 Psd3 pleckstrin and Sec7 domain containing 3 NM_030263 8 1.28 0.021 
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10535637 Ptcd1 pentatricopeptide repeat domain 1 NM_133735 5 1.20 0.026 
10357191 Ptpn4 protein tyrosine phosphatase, non-receptor type 4 NM_019933 1 1.23 0.010 
10376163 Rapgef6 Rap guanine nucleotide exchange factor (GEF) 6 NM_175258 11 1.66 0.000 
10522467 Rasl11b RAS-like, family 11, member B NM_026878 5 1.45 0.003 
10558840 Rassf7 Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 NM_025886 7 -1.21 0.025 
10453867 Rbbp8 retinoblastoma binding protein 8 NM_001081223 18 -1.32 0.001 
10410709 Rfesd Rieske (Fe-S) domain containing NM_178916 13 1.23 0.003 
10359908 Rgs4 regulator of G-protein signaling 4 NM_009062 1 -1.30 0.000 
10466935 Rln1 relaxin 1 NM_011272 19 1.22 0.027 
10350742 Rnasel ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) NM_011882 1 1.28 0.003 
10404965 Rnf144b ring finger protein 144B NM_146042 13 1.30 0.009 
10565852 Rnf169 ring finger protein 169 NM_175388 7 1.20 0.020 
10381395 Rundc1 RUN domain containing 1 NM_172566 11 -1.22 0.043 
10351430 Rxrg retinoid X receptor gamma NM_009107 1 -1.24 0.022 
10402512 Scarna13 small Cajal body-specific RNA 1 NR_028576 12 1.27 0.012 
10514219 Scarna8 small Cajal body-specific RNA 8 NR_028545 4 1.21 0.015 
10483326 Scn9a sodium channel, voltage-gated, type IX, alpha NM_018852 2 1.29 0.012 
10489484 Sdc4 syndecan 4 NM_011521 2 1.31 0.004 
10357072 Serpinb3a serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A NM_009126 1 1.20 0.041 
10362811 Sesn1 sestrin 1 NM_001162908 10 1.29 0.001 
10469167 Sfmbt2 Scm-like with four mbt domains 2 NM_177386 2 1.29 0.033 
10457959 Sft2d3 SFT2 domain containing 3 NM_026006 18 -1.23 0.009 
10471505 Sh2d3c SH2 domain containing 3C NM_013781 2 1.39 0.000 
10393866 Sirt7 sirtuin 7 NM_153056 11 -1.33 0.021 
10356240 Slc16a14 solute carrier family 16 (monocarboxylic acid transporters), member 14 NM_027921 1 1.33 0.003 
10392440 Slc16a6 solute carrier family 16 (monocarboxylic acid transporters), member 6 NM_001029842 11 1.35 0.006 
10363860 Slc16a9 solute carrier family 16 (monocarboxylic acid transporters), member 9 NM_025807 10 1.36 0.010 
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10397835 Slc24a4 solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 NM_172152 12 1.34 0.000 
10495405 Slc25a24 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 
24 
NM_172685 3 1.28 0.015 
10507594 Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 NM_011400 4 1.30 0.003 
10378649 Slc43a2 solute carrier family 43, member 2 NM_173388 11 1.28 0.001 
10496975 Slc44a5 solute carrier family 44, member 5 NM_001081263 3 1.41 0.002 
10386683 Slc47a1 solute carrier family 47, member 1 NM_026183 11 -1.23 0.020 
10605986 Slc7a3 solute carrier family 7 (cationic amino acid transporter, y+ system), 
member 3 
NM_007515 X 1.21 0.049 
10396936 Smoc1 SPARC related  modular calcium binding 1 NM_001146217 12 1.21 0.010 
10383731 Smtn smoothelin NM_001159284 11 -1.22 0.030 
10396442 Snapc1 small nuclear RNA activating complex, polypeptide 1 NM_178392 12 -1.22 0.047 
10576216 Snord68 small nucleolar RNA, C/D box 68 NR_028128 8 -1.21 0.010 
10582874 Sp110 Sp110 nuclear body protein NM_175397 1 1.23 0.018 
10347933 Sp140 Sp140 nuclear body protein NM_001013817 1 -1.21 0.046 
10387936 Spag7 sperm associated antigen 7 NM_172561 11 -1.22 0.025 
10561673 Spred3 sprouty-related, EVH1 domain containing 3 NM_182927 7 -1.35 0.008 
10458555 Spry4 sprouty homolog 4 (Drosophila) NM_011898 18 -1.69 0.001 
10393395 Srsf2 serine/arginine-rich splicing factor 2 NM_011358 11 -1.21 0.000 
10453102 Srsf7 serine/arginine-rich splicing factor 7 NR_036615 17 -1.20 0.013 
10434758 St6gal1 beta galactoside alpha 2,6 sialyltransferase 1 NM_145933 16 1.21 0.020 
10549162 St8sia1 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 NM_011374 6 1.22 0.013 
10519484 Steap2 six transmembrane epithelial antigen of prostate 2 AK141701 5 1.56 0.004 
10554863 Sytl2 synaptotagmin-like 2 NM_001040085 7 1.25 0.040 
10515706 Szt2 seizure threshold 2 NM_198170 4 -1.22 0.047 
10448707 Tbl3 transducin (beta)-like 3 NM_145396 17 -1.21 0.025 
10365098 Tbxa2r thromboxane A2 receptor NM_009325 10 -1.23 0.022 
10365344 Tcp11l2 t-complex 11 (mouse) like 2 NM_146008 10 1.22 0.047 
10369688 Tet1 tet methylcytosine dioxygenase 1 NM_027384 10 1.22 0.041 
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10401673 Tgfb3 transforming growth factor, beta 3 NM_009368 12 1.32 0.000 
10567316 Tmc7 transmembrane channel-like gene family 7 NM_172476 7 1.25 0.000 
10572318 Tmem161a transmembrane protein 161A NM_145597 8 -1.24 0.045 
10458314 Tmem173 transmembrane protein 173 NM_028261 18 -1.23 0.039 
10346224 Tmem194b transmembrane protein 194B NM_001142647 1 1.23 0.026 
10461214 Tmem223 transmembrane protein 223 NM_025791 19 -1.20 0.040 
10572747 Tpm4 tropomyosin 4 NM_001001491 8 -1.20 0.004 
10438621 Tra2b transformer 2 beta homolog (Drosophila) NM_009186 16 -1.30 0.020 
10503259 Trp53inp1 transformation related protein 53 inducible nuclear protein 1 NM_021897 4 1.32 0.001 
10353221 Trpa1 transient receptor potential cation channel, subfamily A, member 1 NM_177781 1 -1.20 0.017 
10428534 Trps1 trichorhinophalangeal syndrome I (human) NM_032000 15 1.31 0.011 
10483819 Ttc30b tetratricopeptide repeat domain 30B NM_028235 2 1.27 0.000 
10456400 Tubb6 tubulin, beta 6 class V NM_026473 18 -1.26 0.009 
10494428 Txnip thioredoxin interacting protein NM_001009935 3 2.63 0.000 
10599222 Ube2a ubiquitin-conjugating enzyme E2A NM_019668 X -1.27 0.046 
10416793 Uchl3 ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) NM_016723 14 -1.22 0.039 
10469083 Upf2 UPF2 regulator of nonsense transcripts homolog (yeast) NM_001081132 2 1.32 0.004 
10440800 Urb1 URB1 ribosome biogenesis 1 homolog (S. cerevisiae) NM_029497 16 -1.26 0.011 
10516229 Utp11l UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast) NM_026031 4 -1.27 0.004 
10389842 Utp18 UTP18, small subunit (SSU) processome component, homolog (yeast) NM_001013375 11 -1.27 0.010 
10451198 Vegfa vascular endothelial growth factor A NM_001025250 17 -1.24 0.000 
10547682 Vmn2r22 vomeronasal 2, receptor 22 NM_001104637 6 1.20 0.007 
10559880 Vmn2r33 vomeronasal 2, receptor 33 NM_001105065 7 1.29 0.045 
10549904 Vmn2r37 vomeronasal 2, receptor 37 NM_009489 7 1.24 0.034 
10559890 Vmn2r43 vomeronasal 2, receptor 43 NM_198961 7 1.28 0.011 
10405879 Vmn2r85 vomeronasal 2, receptor 85 NM_001102602 10 1.24 0.026 
10552425 Vsig10l V-set and immunoglobulin domain containing 10 like BC112410 7 -1.21 0.045 
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10444098 Wdr46 WD repeat domain 46 NM_020603 17 -1.21 0.005 
10346074 Wdr75 WD repeat domain 75 NM_028599 1 -1.21 0.004 
10373000 Xrcc6bp1 XRCC6 binding protein 1 NM_026858 10 -1.20 0.020 
10433904 Yars2 tyrosyl-tRNA synthetase 2 (mitochondrial) NM_198246 16 -1.20 0.048 
10473349 Ypel4 yippee-like 4 (Drosophila) NM_001005342 2 1.49 0.018 
10446756 Ypel5 yippee-like 5 (Drosophila) NM_027166 17 1.23 0.006 
10406733 Zbed3 zinc finger, BED type containing 3 NM_028106 13 1.30 0.003 
10490826 Zbtb10 zinc finger and BTB domain containing 10 NM_177660 3 1.38 0.002 
10509998 Zbtb17 zinc finger and BTB domain containing 17 NM_009541 4 -1.25 0.010 
10480027 Zbtb2 zinc finger and BTB domain containing 2 NM_001033466 10 -1.28 0.043 
10359377 Zbtb37 zinc finger and BTB domain containing 37 NM_173424 1 1.22 0.001 
10475946 Zc3h6 zinc finger CCCH type containing 6 NM_178404 2 1.24 0.016 
10550029 Zfp110 zinc finger protein 110 NM_022981 7 1.24 0.004 
10556246 Zfp143 zinc finger protein 143 NM_009281 7 -1.23 0.015 
10591161 Zfp558 zinc finger protein 558 NM_028935 9 1.47 0.006 
10547282 Zfp9 zinc finger protein 9 NM_011763 6 1.25 0.008 
 
a Chromosomal location of transcript-encoding gene 
b p-values < 0.001 are shown as 0.000 
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APPENDIX B.  mRNA transcripts identified as altered in the adult brain (P60) of mice exposed to ethanol during synaptogenesis (P4+7) 
(fold cutoff ≥ ±1.2, FDR-corrected p-value < 0.05). Genes are listed alphabetically by gene symbol.  
 
Transcript 
ID 
Gene symbol Gene name RefSeq Chra Fold-change p-valueb 
10389269 Aatf apoptosis antagonizing transcription factor NM_019816 11 -1.32 0.001 
10546432 Adamts9 a disintegrin-like and metallopeptidase (reprolysin type) with 
thrombospondin type 1 motif, 9 
NM_175314 6 -1.23 0.000 
10496438 Adh1 alcohol dehydrogenase 1 (class I) NM_007409 3 -1.35 0.000 
10532630 Adrbk2 adrenergic receptor kinase, beta 2 NM_177078 5 -1.28 0.000 
10554233 Aen apoptosis enhancing nuclease NM_026531 7 -1.35 0.000 
10371332 Aldh1l2 aldehyde dehydrogenase 1 family, member L2 NM_153543 10 -1.32 0.000 
10452734 Alk anaplastic lymphoma kinase NM_007439 17 -1.37 0.000 
10586744 Anxa2 annexin A2 NM_007585 9 -1.42 0.000 
10419977 Ap1g2 adaptor protein complex AP-1, gamma 2 subunit NM_007455 14 -1.36 0.000 
10462113 Apba1 amyloid beta (A4) precursor protein binding, family  A, member 1 NM_177034 19 -1.25 0.000 
10560624 Apoe apolipoprotein E NM_009696 7 -1.26 0.000 
10430190 Apol10b apolipoprotein L 10B NM_177820 15 -1.27 0.000 
10490221 Atp5e ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon 
subunit 
NM_025983 2 -1.35 0.000 
10587892 Atr ataxia telangiectasia and Rad3 related NM_019864 9 -1.37 0.000 
10402249 Atxn3 ataxin 3 NM_029705 12 -1.34 0.001 
10485700 Bbox1 butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-
butyrobetaine hydroxylase) 
NM_130452 2 -1.42 0.000 
10400030 Bzw2 basic leucine zipper and W2 domains 2 NM_025840 12 -1.24 0.000 
10547322 Cacna1c calcium channel, voltage-dependent, L type, alpha 1C subunit NM_001159533 6 -1.24 0.000 
10579691 Calr3 calreticulin 3 NM_028500 8 -1.27 0.000 
10475144 Capn3 calpain 3 NM_007601 2 -1.25 0.000 
10571696 Casp3 caspase 3 NM_009810 8 -1.31 0.001 
10457106 Cbln2 cerebellin 2 precursor protein NM_172633 18 -1.27 0.001 
10348999 Cdh20 cadherin 20 NM_011800 1 -1.31 0.000 
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10513824 Cdk5rap2 CDK5 regulatory subunit associated protein 2 NM_145990 4 -1.26 0.000 
10468974 Cdnf cerebral dopamine neurotrophic factor NM_177647 2 -1.55 0.000 
10466423 Cep78 centrosomal protein 78 NM_198019 19 -1.37 0.000 
10470775 Cercam cerebral endothelial cell adhesion molecule NM_207298 2 -1.41 0.001 
10560063 Chmp2a charged multivesicular body protein 2A NM_026885 7 -1.27 0.000 
10461143 Chrm1 cholinergic receptor, muscarinic 1, CNS NM_001112697 19 -1.24 0.000 
10542129 Clec2g C-type lectin domain family 2, member g NM_027562 6 -1.24 0.000 
10402473 Clmn calmin NM_053155 12 -1.49 0.000 
10416843 Cln5 ceroid-lipofuscinosis, neuronal 5 NM_001033242 14 -1.36 0.001 
10484457 Clp1 CLP1, cleavage and polyadenylation factor I subunit NM_133840 2 -1.20 0.000 
10545874 Cml5 camello-like 5 NM_023493 6 -1.47 0.001 
10581049 Cmtm2a CKLF-like MARVEL transmembrane domain containing 2A NM_027022 8 -1.36 0.000 
10503902 Cnr1 cannabinoid receptor 1 (brain) NM_007726 4 -1.30 0.000 
10467216 Cpeb3 cytoplasmic polyadenylation element binding protein 3 NM_198300 19 -1.37 0.000 
10437330 Crebbp CREB binding protein ENSMUST00000
100216 
16 -1.25 0.000 
10526931 Cyp2w1 cytochrome P450, family 2, subfamily w, polypeptide 1 NM_001160265 5 -1.27 0.000 
10399732 Dcdc2c doublecortin domain containing 2C NM_001177964 12 -1.38 0.000 
10560983 Dedd2 death effector domain-containing DNA binding protein 2 NM_207677 7 -1.39 0.000 
10577441 Defb9 defensin beta 9 NM_139219 8 -1.41 0.000 
10438245 Dgcr14 DiGeorge syndrome critical region gene 14 NM_022408 16 -1.24 0.000 
10515481 Dmap1 DNA methyltransferase 1-associated protein 1 NM_023178 4 -1.38 0.001 
10600604 Dmd dystrophin, muscular dystrophy NM_007868 X -1.30 0.000 
10596231 Dnajc13 DnaJ (Hsp40) homolog, subfamily C, member 13 NM_001163026 9 -1.21 0.001 
10417034 Dnajc3 DnaJ (Hsp40) homolog, subfamily C, member 3 NM_008929 14 -1.38 0.000 
10345241 Dst dystonin NM_134448 1 -1.24 0.000 
10506170 Efcab7 EF-hand calcium binding domain 7 NM_145549 4 -1.43 0.000 
10452419 Efna5 ephrin A5 NM_207654 17 -1.33 0.000 
10576911 Efnb2 ephrin B2 NM_010111 8 -1.30 0.000 
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10374366 Egfr epidermal growth factor receptor NM_207655 11 -1.27 0.000 
10400304 Egln3 egl-9 family hypoxia-inducible factor 3 NM_028133 12 1.41 0.001 
10349752 Elk4 ELK4, member of ETS oncogene family NM_007923 1 -1.31 0.000 
10596115 Ephb1 Eph receptor B1 AK082061 9 -1.49 0.000 
10389990 Epn3 epsin 3 NM_027984 11 -1.41 0.000 
10562064 Etv2 ets variant 2 NM_007959 7 -1.23 0.000 
10569611 Fadd Fas (TNFRSF6)-associated via death domain NM_010175 7 -1.24 0.001 
10470298 Fam69b family with sequence similarity 69, member B NM_019833 2 -1.28 0.000 
10460726 Fau Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously 
expressed (fox derived) 
NM_007990 19 -1.24 0.001 
10540085 Fbln2 fibulin 2 NM_007992 6 -1.33 0.000 
10557742 Fbxl19 F-box and leucine-rich repeat protein 19 NM_172748 7 -1.38 0.000 
10492755 Fga fibrinogen alpha chain NM_001111048 3 -1.23 0.000 
10415651 Fgf9 fibroblast growth factor 9 NM_013518 14 -1.30 0.000 
10481566 Fibcd1 fibrinogen C domain containing 1 NM_178887 2 -1.28 0.000 
10603099 Figf c-fos induced growth factor NM_010216 X -1.23 0.001 
10565401 Folh1 folate hydrolase 1 NM_016770 7 -1.28 0.000 
10576046 Foxf1a forkhead box F1 NM_010426 8 -1.36 0.000 
10504534 Frmpd1 FERM and PDZ domain containing 1 NM_001081172 4 -1.65 0.000 
10495596 Frrs1 ferric-chelate reductase 1 NM_001113478 3 -1.24 0.000 
10445710 Frs3 fibroblast growth factor receptor substrate 3 NM_144939 17 -1.41 0.000 
10530563 Fryl furry homolog-like (Drosophila) NM_028194 5 -1.28 0.000 
10552964 Ftl1 ferritin light chain 1 NM_010240 7 -1.51 0.000 
10581702 Fuk fucokinase NM_172283 8 -1.49 0.001 
10571233 Fut10 fucosyltransferase 10 NM_134161 8 -1.58 0.000 
10376230 G3bp1 GTPase activating protein (SH3 domain) binding protein 1 NM_013716 11 -1.33 0.001 
10575616 Gabarapl2 gamma-aminobutyric acid (GABA) A receptor-associated protein-like 
2 
ENSMUST00000
034428 
8 -1.51 0.043 
10436416 Gabrr3 gamma-aminobutyric acid (GABA) receptor, rho 3 NM_001081190 16 -1.21 0.012 
10487190 Galk2 galactokinase 2 NM_175154 2 -1.32 0.000 
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10578786 Galntl6 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like 6 
NM_175032 8 1.29 0.001 
10526055 Gbas glioblastoma amplified sequence NM_008095 5 -1.32 0.001 
10406777 Gcnt4 glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-
acetylglucosaminyltransferase) 
NM_001166065 13 -1.44 0.001 
10375614 Gfpt2 glutamine fructose-6-phosphate transaminase 2 NM_013529 11 -1.26 0.000 
10544588 Gimap3 GTPase, IMAP family member 3 NM_031247 6 -1.23 0.001 
10372410 Glipr1 GLI pathogenesis-related 1 (glioma) NM_028608 10 -1.26 0.000 
10558454 Glrx3 glutaredoxin 3 NM_023140 7 -1.87 0.000 
10560202 Gltscr1 glioma tumor suppressor candidate region gene 1 NM_001081418 7 -1.30 0.000 
10560181 Gltscr2 glioma tumor suppressor candidate region gene 2 NM_133831 7 -1.30 0.001 
10490653 Gmeb2 glucocorticoid modulatory element binding protein 2 NM_198169 2 -1.31 0.000 
10547858 Gnb3 guanine nucleotide binding protein (G protein), beta 3 NM_013530 6 -1.41 0.000 
10458547 Gnpda1 glucosamine-6-phosphate deaminase 1 NM_011937 18 -1.48 0.000 
10419216 Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 NM_019425 14 -1.25 0.000 
10526838 Got2 glutamatic-oxaloacetic transaminase 2, mitochondrial NM_010325 8 -1.34 0.000 
10598381 Gpkow G patch domain and KOW motifs  NM_173747 X 1.35 0.000 
10560237 Gpr77 G protein-coupled receptor 77 NM_176912 7 -1.28 0.001 
10414137 Grid1 glutamate receptor, ionotropic, delta 1 NM_008166 14 -1.31 0.001 
10508052 Grik3 glutamate receptor, ionotropic, kainate 3 NM_001081097 4 -1.29 0.002 
10548791 Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) NM_008171 6 -1.27 0.000 
10392863 Grin2c glutamate receptor, ionotropic, NMDA2C (epsilon 3) NM_010350 11 -1.26 0.002 
10563421 Grin2d glutamate receptor, ionotropic, NMDA2D (epsilon 4) NM_008172 7 -1.54 0.000 
10364583 Grin3b glutamate receptor, ionotropic, NMDA3B NM_130455 10 -1.31 0.001 
10449343 Grm4 glutamate receptor, metabotropic 4 NM_001013385 17 -1.38 0.004 
10521461 Grpel1 GrpE-like 1, mitochondrial NM_024478 5 -1.38 0.000 
10527562 Gsx1 GS homeobox 1 NM_008178 5 -1.37 0.000 
10420268 Gzme granzyme E NM_010373 14 -1.21 0.027 
10391084 Hap1 huntingtin-associated protein 1 NM_010404 11 1.50 0.000 
10514201 Haus6 HAUS augmin-like complex, subunit 6 NM_173400 4 -1.42 0.000 
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10585851 Hcn4 hyperpolarization-activated, cyclic nucleotide-gated K+ 4 NM_001081192 9 -1.53 0.000 
10431371 Hdac10 histone deacetylase 10 NM_199198 15 -1.25 0.001 
10606088 Hdac8 histone deacetylase 8 NM_027382 X -1.38 0.000 
10403511 Heatr1 HEAT repeat containing 1 NM_144835 13 -1.33 0.001 
10507394 Hectd3 HECT domain containing 3 NM_175244 4 -1.32 0.000 
10435266 Heg1 HEG homolog 1 (zebrafish) NM_175256 16 -1.55 0.000 
10382152 Helz helicase with zinc finger domain NM_198298 11 -1.26 0.000 
10542917 Hepacam2 HEPACAM family member 2 NM_178899 6 -1.32 0.000 
10585874 Hexa hexosaminidase A NM_010421 9 -1.39 0.000 
10408210 Hist1h2bf histone cluster 1, H2bf NM_178195 13 -1.33 0.000 
10403943 Hist1h2bm histone cluster 1, H2bm NM_178200 13 -1.53 0.001 
10408239 Hist1h3c histone cluster 1, H3c NM_175653 13 -1.30 0.001 
10404051 Hist1h4d histone cluster 1, H4d NM_175654 13 -1.26 0.000 
10500333 Hist2h4 histone cluster 2, H4 NM_033596 3 -1.27 0.000 
10491014 Hltf helicase-like transcription factor NM_009210 3 -1.33 0.000 
10358557 Hmcn1 hemicentin 1 NM_001024720 1 -1.28 0.001 
10424909 Hsf1 heat shock factor 1 NM_008296 15 -1.22 0.013 
10407034 Htr1a 5-hydroxytryptamine (serotonin) receptor 1A NM_008308 13 -1.25 0.001 
10509238 Htr1d 5-hydroxytryptamine (serotonin) receptor 1D NM_008309 4 -1.28 0.009 
10357288 Htr5b 5-hydroxytryptamine (serotonin) receptor 5B NM_010483 1 1.30 0.012 
10521261 Htt huntingtin NM_010414 5 -1.23 0.001 
10569014 Ifitm2 interferon induced transmembrane protein 2 NM_030694 7 -1.43 0.000 
10588707 Ifrd2 interferon-related developmental regulator 2 NM_025903 9 -1.21 0.000 
10390209 Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 NM_009951 11 -1.56 0.000 
10540679 Il17re interleukin 17 receptor E NM_145826 6 -1.28 0.000 
10581664 Il34 interleukin 34 NM_029646 8 -1.44 0.000 
10372730 Iltifb interleukin 10-related T cell-derived inducible factor beta NM_054079 10 -2.20 0.000 
10555574 Inppl1 inositol polyphosphate phosphatase-like 1 NM_010567 7 -1.27 0.000 
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10576696 Insr insulin receptor NM_010568 8 -1.30 0.000 
10535247 Iqce IQ motif containing E NM_028833 5 -1.34 0.000 
10385870 Irf1 interferon regulatory factor 1 NM_008390 11 -1.25 0.001 
10536898 Irf5 interferon regulatory factor 5 NM_012057 6 -1.25 0.000 
10573910 Irx5 Iroquois related homeobox 5 (Drosophila) NM_018826 8 -1.54 0.000 
10554240 Isg20 interferon-stimulated protein NM_020583 7 -1.51 0.001 
10557862 Itgam integrin alpha M NM_001082960 7 -1.29 0.001 
10435305 Itgb5 integrin beta 5 NM_001145884 16 1.37 0.001 
10485340 Itpa inosine triphosphatase (nucleoside triphosphate pyrophosphatase) NM_025922 2 -1.25 0.001 
10436892 Itsn1 intersectin 1 (SH3 domain protein 1A) NM_010587 16 -1.23 0.000 
10352798 Kcnh1 potassium voltage-gated channel, subfamily H (eag-related), member 
1 
NM_010600 1 -1.27 0.000 
10401987 Kcnk10 potassium channel, subfamily K, member 10 NM_029911 12 -1.32 0.000 
10541216 Kdm5a lysine (K)-specific demethylase 5A NM_145997 6 -1.34 0.000 
10377547 Kdm6b KDM1 lysine (K)-specific demethylase 6B NM_001017426 11 -1.35 0.000 
10594251 Kif23 kinesin family member 23 NM_024245 9 -1.41 0.000 
10398814 Kif26a kinesin family member 26A NM_001097621 12 -1.22 0.000 
10561942 Kirrel2 kin of IRRE like 2 (Drosophila) NM_172898 7 -1.41 0.000 
10366052 Kitl kit ligand NM_013598 10 1.33 0.000 
10514319 Klhl9 kelch-like 9 NM_172871 4 -1.31 0.000 
10552594 Klk1b22 kallikrein 1-related peptidase b22 NM_010114 7 -1.26 0.000 
10548450 Klra5 killer cell lectin-like receptor, subfamily A, member 5 NM_008463 6 -1.28 0.001 
10379260 Ksr1 kinase suppressor of ras 1 NM_013571 11 -1.26 0.000 
10565479 l7Rn6 lethal, Chr 7, Rinchik 6 NM_026304 7 1.32 0.000 
10362538 Lama4 laminin, alpha 4 NM_010681 10 -1.25 0.000 
10571005 Letm2 leucine zipper-EF-hand containing transmembrane protein 2 NM_173012 8 -1.28 0.000 
10502774 Lphn2 latrophilin 2 NM_001081298 3 -1.32 0.000 
10445816 Lrfn2 leucine rich repeat and fibronectin type III domain containing 2 NM_027452 17 -1.23 0.001 
10537123 Lrguk leucine-rich repeats and guanylate kinase domain containing NM_028886 6 -1.32 0.000 
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10396314 Lrrc9 leucine rich repeat containing 9 NM_001142728 12 -1.41 0.000 
10463457 Lzts2 leucine zipper, putative tumor suppressor 2 NM_145503 19 -1.44 0.000 
10581992 Maf avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene 
homolog 
NM_001025577 8 -1.30 0.000 
10412100 Map3k1 mitogen-activated protein kinase kinase kinase 1 NM_011945 13 -1.50 0.000 
10561323 Map3k10 mitogen-activated protein kinase kinase kinase 10 NM_001081292 7 -1.25 0.001 
10551666 Map4k1 mitogen-activated protein kinase kinase kinase kinase 1 NM_008279 7 -1.21 0.000 
10346328 Mars2 methionine-tRNA synthetase 2 (mitochondrial) BC132343 1 -1.62 0.000 
10480432 Mastl microtubule associated serine/threonine kinase-like NM_025979 2 -1.43 0.000 
10370824 Mbd3 methyl-CpG binding domain protein 3 NM_013595 10 -1.41 0.000 
10536472 Mdfic MyoD family inhibitor domain containing NM_175088 6 -1.48 0.000 
10503723 Mdn1 midasin homolog (yeast) NM_001081392 4 -1.38 0.000 
10420080 Mdp1 magnesium-dependent phosphatase 1 NM_023397 14 -1.37 0.000 
10554819 Me3 malic enzyme 3, NADP(+)-dependent, mitochondrial NM_181407 7 -1.33 0.000 
10508686 Mecr mitochondrial trans-2-enoyl-CoA reductase NM_025297 4 -1.39 0.000 
10493189 Mef2d myocyte enhancer factor 2D ENSMUST00000
001455 
3 -1.26 0.000 
10398326 Meg3 maternally expressed 3 NR_003633 12 -1.22 0.001 
10378482 Mett10d methyltransferase like 16 NM_026197 11 -1.34 0.000 
10584589 Mir100 microRNA 100 NR_029790 9 -1.37 0.000 
10472982 Mir10b microRNA 10b NR_029566 2 -1.42 0.000 
10470296 Mir126 microRNA 126a NR_029541 2 -1.24 0.000 
10543680 Mir182 microRNA 182 NR_029569 6 -1.26 0.000 
10352499 Mir194-1 microRNA 194-1 NR_029580 1 1.50 0.000 
10398812 Mir203 microRNA 203 NR_029590 12 -1.32 0.000 
10345028 Mir206 microRNA 206 NR_029593 1 -1.41 0.001 
10375214 Mir218-2 microRNA 218-2 NR_029799 11 -1.22 0.000 
10603807 Mir222 microRNA 222 NR_029807 X -1.35 0.000 
10398382 Mir379 microRNA 379 NR_029880 12 -1.58 0.000 
10379028 Mir451 microRNA 451a NR_029971 11 -1.33 0.001 
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10604585 Mir717 microRNA 717 NR_030497 X -1.26 0.000 
10507218 Mknk1 MAP kinase-interacting serine/threonine kinase 1 NM_021461 4 -1.21 0.001 
10492469 Mlf1 myeloid leukemia factor 1 NM_001039543 3 -1.54 0.000 
10515363 Mmachc methylmalonic aciduria cblC type, with homocystinuria NM_025962 4 -1.22 0.000 
10482486 Mmadhc methylmalonic aciduria (cobalamin deficiency) cblD type, with 
homocystinuria 
NM_133839 2 -1.27 0.000 
10590781 Mmp1b matrix metallopeptidase 1b (interstitial collagenase) NM_032007 9 -1.24 0.001 
10573924 Mmp2 matrix metallopeptidase 2 NM_008610 8 -1.30 0.001 
10553330 Mrgprb13 MAS-related GPR, member B13 XM_003086592 7 -1.62 0.000 
10563760 Mrgprb2 MAS-related GPR, member B2 NM_175531 7 -1.43 0.000 
10523161 Mthfd2l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like NM_026788 5 -1.47 0.001 
10587695 Mthfs 5, 10-methenyltetrahydrofolate synthetase NM_026829 9 -1.37 0.000 
10407709 Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase NM_001081128 13 -1.29 0.001 
10399421 Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma 
derived (avian) 
NM_008709 12 -1.35 0.000 
10557831 Myst1 MYST histone acetyltransferase 1 NM_026370 7 -1.36 0.001 
10395074 Myt1l myelin transcription factor 1-like NM_001093775 12 -1.27 0.000 
10480901 Nacc2 nucleus accumbens associated 2, BEN and BTB (POZ) domain 
containing 
NM_001037098 2 -1.24 0.000 
10411595 Naip2 NLR family, apoptosis inhibitory protein 2 NM_010872 13 -1.45 0.000 
10545041 Nap1l5 nucleosome assembly protein 1-like 5 NM_021432 6 -1.21 0.000 
10517677 Nbl1 neuroblastoma, suppression of tumorigenicity 1 NM_008675 4 -1.47 0.000 
10503431 Nbn nibrin NM_013752 4 -1.33 0.000 
10480652 Ndor1 NADPH dependent diflavin oxidoreductase 1 NM_001082476 2 -1.44 0.000 
10456254 Nedd4l neural precursor cell expressed, developmentally down-regulated 
gene 4-like 
NM_001114386 18 -1.20 0.000 
10407420 Net1 neuroepithelial cell transforming gene 1 NM_019671 13 -1.52 0.000 
10459944 Nfatc1 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 
1 
NM_001164109 18 -1.26 0.000 
10553635 Nipa1 non imprinted in Prader-Willi/Angelman syndrome 1 homolog 
(human) 
NM_153578 7 -1.22 0.000 
10599232 Nkap NFKB activating protein NM_025937 X -1.21 0.001 
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10408037 Nkapl NFKB activating protein-like NM_025719 13 -1.43 0.001 
10491066 Nlgn1 neuroligin 1 NM_138666 3 -1.26 0.000 
10494595 Notch2 notch 2 NM_010928 3 -1.24 0.000 
10395719 Npas3 neuronal PAS domain protein 3 NM_013780 12 -1.32 0.000 
10401519 Npc2 Niemann-Pick type C2 NM_023409 12 -1.27 0.000 
10363492 Npffr1 neuropeptide FF receptor 1 NM_001177511 10 -1.30 0.000 
10548038 Ntf3 neurotrophin 3 NM_001164035 6 -1.58 0.000 
10481349 Ntng2 netrin G2 NM_133501 2 -1.25 0.000 
10520111 Nupl2 nucleoporin like 2 NM_153092 5 -1.36 0.000 
10351491 Olfml2b olfactomedin-like 2B NM_177068 1 -1.26 0.000 
10592391 Olfr937 olfactory receptor 937 NM_146439 9 -1.34 0.000 
10484514 Olfr993 olfactory receptor 993 NM_146435 2 -1.41 0.000 
10479833 Optn optineurin NM_181848 2 -1.46 0.000 
10484486 P2rx3 purinergic receptor P2X, ligand-gated ion channel, 3 NM_145526.2 2 -1.28 0.000 
10378319 P2rx5 purinergic receptor P2X, ligand-gated ion channel, 5 NM_033321 11 -1.29 0.000 
10492330 P2ry1 purinergic receptor P2Y, G-protein coupled 1 NM_008772 3 -1.37 0.000 
10590983 Panx1 pannexin 1 NM_019482 9 -1.39 0.000 
10592355 Panx3 pannexin 3 NM_172454 9 -1.24 0.000 
10587871 Paqr9 progestin and adipoQ receptor family member IX NM_198414 9 -1.40 0.001 
10355916 Pax3 paired box 3 NM_008781 1 -1.24 0.000 
10363921 Pcdh15 protocadherin 15 NM_023115 10 -1.32 0.000 
10455088 Pcdhb11 protocadherin beta 11 NM_053136 18 -1.34 0.000 
10455108 Pcdhb16 protocadherin beta 16 NM_053141 18 -1.30 0.000 
10455118 Pcdhb18 protocadherin beta 18 NM_053143 18 -1.43 0.000 
10455071 Pcdhb7 protocadherin beta 7 NM_053132 18 -1.47 0.000 
10418247 Pde12 phosphodiesterase 12 NM_178668 14 1.25 0.000 
10497713 Pex5l peroxisomal biogenesis factor 5-like NM_021483 3 -1.30 0.000 
10445607 Pex6 peroxisomal biogenesis factor 6 NM_145488 17 -1.49 0.000 
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10550509 Pglyrp1 peptidoglycan recognition protein 1 NM_009402 7 -1.31 0.000 
10439710 Phldb2 pleckstrin homology-like domain, family B, member 2 NM_153412 16 -1.26 0.001 
10452030 Plin3 perilipin 3 NM_025836 17 -1.23 0.000 
10497253 Pmp2 peripheral myelin protein 2 NM_001030305 3 -1.30 0.000 
10454478 Polr2d polymerase (RNA) II (DNA directed) polypeptide D NM_027002 18 -1.57 0.000 
10394240 Pomc pro-opiomelanocortin-alpha NM_008895 12 -1.57 0.000 
10542983 Pon1 paraoxonase 1 NM_011134 6 -1.25 0.000 
10357948 Ppp1r12b protein phosphatase 1, regulatory (inhibitor) subunit 12B NM_001081307 1 -1.29 0.001 
10607475 Prdx4 peroxiredoxin 4 NM_016764 X -1.39 0.000 
10408412 Prl7b1 prolactin family 7, subfamily b, member 1 NM_029355 13 -1.28 0.000 
10408436 Prl7d1 prolactin family 7, subfamily d, member 1 NM_011120 13 -1.22 0.000 
10423049 Prlr prolactin receptor NM_011169 15 -1.57 0.000 
10542239 Prp2 proline rich protein 2 NM_031499 6 3.30 0.000 
10407390 Ptbp1 polypyrimidine tract binding protein 1 NM_001077363 10 1.61 0.000 
10471411 Ptges2 prostaglandin E synthase 2 NM_133783 2 -1.28 0.001 
10367100 Ptges3 prostaglandin E synthase 3 (cytosolic) NM_019766 10 1.68 0.000 
10567034 Pth parathyroid hormone NM_020623 7 -1.20 0.000 
10513154 Ptpn3 protein tyrosine phosphatase, non-receptor type 3 NM_011207 4 -1.25 0.000 
10409414 Rab24 RAB24, member RAS oncogene family NM_009000 13 -1.26 0.000 
10423068 Rad1 RAD1 checkpoint DNA exonuclease NM_011232 15 -1.55 0.000 
10535312 Radil Ras association and DIL domains NM_178702 5 -1.35 0.000 
10525983 Ran RAN, member RAS oncogene family NM_009391 5 -1.26 0.000 
10417713 Rarb retinoic acid receptor, beta NM_011243 14 -1.44 0.000 
10544573 Rarres2 retinoic acid receptor responder (tazarotene induced) 2 NM_027852 6 -1.54 0.000 
10526459 Rasa4 RAS p21 protein activator 4 NM_133914 5 -1.24 0.000 
10359235 Rasal2 RAS protein activator like 2 NM_177644 1 -1.25 0.000 
10464819 Rbm14 RNA binding motif protein 14 NM_019869 19 -1.41 0.000 
10440993 Rcan1 regulator of calcineurin 1 NM_001081549 16 -1.27 0.001 
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10373588 Rdh5 retinol dehydrogenase 5 NM_134006 10 -1.32 0.001 
10490736 Rgs19 regulator of G-protein signaling 19 NM_026446 2 -1.37 0.000 
10428124 Rgs22 regulator of G-protein signalling 22 NM_001195748 15 -1.47 0.000 
10566132 Rhog ras homolog gene family, member G NM_019566 7 -1.48 0.001 
10449071 Rhot2 ras homolog gene family, member T2 NM_145999 17 -1.23 0.000 
10423855 Rims2 regulating synaptic membrane exocytosis 2 NM_053271 15 -1.22 0.001 
10507731 Rims3 regulating synaptic membrane exocytosis 3 NM_182929 4 -1.23 0.000 
10383200 Rnf213 ring finger protein 213 ENSMUST00000
131035 
11 -1.37 0.000 
10445061 Rnf39 ring finger protein 39 NM_001099632 17 -1.30 0.000 
10533106 Rnft2 ring finger protein, transmembrane 2 NM_172998 5 -1.34 0.001 
10378768 Rnmtl1 RNA methyltransferase like 1 NM_183263 11 -1.38 0.000 
10438564 Rps10 ribosomal protein S10 NM_025963 17 -1.29 0.000 
10385034 Rpsa ribosomal protein SA NM_011029 9 -1.36 0.000 
10383245 Rptor regulatory associated protein of MTOR, complex 1 NM_028898 11 -1.27 0.001 
10444137 Rxrb retinoid X receptor beta NM_011306 17 -1.41 0.000 
10402428 Serpina12 serine (or cysteine) peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 12 
NM_026535 12 -1.26 0.000 
10574404 Setd6 SET domain containing 6 NM_001035123 8 -1.51 0.000 
10344750 Sgk3 serum/glucocorticoid regulated kinase 3 NM_133220 1 -1.26 0.000 
10502224 Sgms2 sphingomyelin synthase 2 NM_028943 3 -1.40 0.000 
10400971 Six4 sine oculis-related homeobox 4 NM_011382 12 -1.26 0.000 
10360173 Slamf7 SLAM family member 7 NM_144539 1 -1.25 0.000 
10531887 Slc10a6 solute carrier family 10 (sodium/bile acid cotransporter family), 
member 6 
NM_029415 5 -1.21 0.000 
10474545 Slc12a6 solute carrier family 12, member 6 NM_133649 2 -1.28 0.000 
10377790 Slc16a11 solute carrier family 16 (monocarboxylic acid transporters), member 
11 
NM_153081 11 -1.50 0.000 
10392440 Slc16a6 solute carrier family 16 (monocarboxylic acid transporters), member 6 NM_001029842 11 -1.45 0.000 
10481634 Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), 
member 25 
NM_146118 2 -1.35 0.001 
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10421172 Slc25a37 solute carrier family 25, member 37 NM_026331 14 -1.29 0.001 
10451123 Slc29a1 solute carrier family 29 (nucleoside transporters), member 1 NM_022880 17 -1.28 0.000 
10510516 Slc2a5 solute carrier family 2 (facilitated glucose transporter), member 5 NM_019741 4 -1.34 0.001 
10352548 Slc30a10 solute carrier family 30, member 10 NM_001033286 1 -1.35 0.000 
10496324 Slc39a8 solute carrier family 39 (metal ion transporter), member 8 NM_001135149 3 -1.24 0.000 
10435993 Slc9a10 solute carrier family 9, subfamily C (Na+-transporting carboxylic acid 
decarboxylase), member 1 
NM_198106 16 -1.31 0.000 
10532275 Smndc1 survival motor neuron domain containing 1 NM_172429 19 -1.22 0.000 
10368806 Smpd2 sphingomyelin phosphodiesterase 2, neutral NM_009213 10 -1.35 0.001 
10508723 Snora61 small nucleolar RNA, H/ACA box 61 NR_034046 4 -1.34 0.000 
10564017 Snord115 small nucleolar RNA, C/D Box 115 cluster AF357427 7 1.71 0.000 
10375499 Snord96a small nucleolar RNA, C/D box 96A NR_028563 11 -1.26 0.001 
10529515 Sorcs2 sortilin-related VPS10 domain containing receptor 2 NM_030889 5 -1.27 0.000 
10570189 Sox1 SRY (sex determining region Y)-box 1 NM_009233 8 -1.57 0.001 
10491721 Spry1 sprouty homolog 1 (Drosophila) NM_011896 3 -1.50 0.000 
10541721 Spsb2 splA/ryanodine receptor domain and SOCS box containing 2 NM_013539 6 -1.37 0.000 
10390430 Srcin1 SRC kinase signaling inhibitor 1 NM_018873 11 -1.29 0.000 
10411274 Sv2c synaptic vesicle glycoprotein 2c NM_029210 13 -1.34 0.000 
10595604 Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein NM_019796 9 -1.24 0.000 
10361381 Syne1 spectrin repeat containing, nuclear envelope 1 NM_001079686 10 -1.32 0.001 
10443080 Syngap1 synaptic Ras GTPase activating protein 1 homolog (rat) XM_985548 17 -1.25 0.000 
10425335 Syngr1 synaptogyrin 1 NM_207708 15 -1.23 0.001 
10515708 Szt2 seizure threshold 2 NM_198170 4 -1.24 0.000 
10472240 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 NM_198294 2 -1.39 0.000 
10548677 Tas2r140 taste receptor, type 2, member 140 NM_021562 6 -1.39 0.001 
10359701 Tbx19 T-box 19 NM_032005 1 -1.27 0.000 
10380887 Tcap titin-cap NM_011540 11 -1.22 0.000 
10548146 Tead4 TEA domain family member 4 NM_011567 6 -1.34 0.000 
10557960 Tgfb1i1 transforming growth factor beta 1 induced transcript 1 NM_009365 7 -1.30 0.000 
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10606548 Tgif2lx1 TGFB-induced factor homeobox 2-like, X-linked 1 NM_153109 X -1.39 0.000 
10385518 Tgtp1 T cell specific GTPase 1 NM_011579 11 -1.25 0.000 
10516296 Thrap3 thyroid hormone receptor associated protein 3 NM_146153 4 -1.60 0.000 
10565081 Timm17a translocase of inner mitochondrial membrane 17a NM_011590 1 -1.35 0.000 
10512514 Tln1 talin 1 NM_011602 4 -1.25 0.000 
10530145 Tlr1 toll-like receptor 1 NM_030682 5 -1.47 0.000 
10518714 Tmem201 transmembrane protein 201 NM_001025106 4 -1.38 0.000 
10581917 Tmem231 transmembrane protein 231 NM_001033321 8 -1.37 0.000 
10491091 Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 NM_009425 3 -1.37 0.001 
10576951 Tnfsf13b tumor necrosis factor (ligand) superfamily, member 13b NM_033622 8 -1.23 0.001 
10580522 Tox3 TOX high mobility group box family member 3 NM_172913 8 -1.22 0.000 
10348600 Traf3ip1 TRAF3 interacting protein 1 NM_028718 1 -1.42 0.000 
10437311 Trap1 TNF receptor-associated protein 1 NM_026508 16 -1.35 0.000 
10362442 Trdn triadin NM_029726 10 -2.21 0.000 
10356194 Trip12 thyroid hormone receptor interactor 12 NM_133975 1 -1.22 0.001 
10534718 Trip6 thyroid hormone receptor interactor 6 NM_011639 5 -1.52 0.000 
10424331 Trmt12 tRNA methyltranferase 12 NM_026642 15 -1.28 0.000 
10486722 Trp53bp1 transformation related protein 53 binding protein 1 NM_013735 2 -1.25 0.000 
10503520 Ttpa tocopherol (alpha) transfer protein NM_015767 4 -1.27 0.000 
10548163 Tulp3 tubby-like protein 3 NM_011657 6 -1.66 0.000 
10591446 Tyk2 tyrosine kinase 2 NM_018793 9 -1.28 0.000 
10528915 Tyms thymidylate synthase NM_021288 5 -1.57 0.000 
10525885 Ubc ubiquitin C BC025894 5 -1.34 0.000 
10463185 Ubtd1 ubiquitin domain containing 1 NM_145500 19 -1.30 0.000 
10436561 Usp25 ubiquitin specific peptidase 25 NM_013918 16 -1.25 0.000 
10367843 Utrn utrophin NM_011682 10 -1.26 0.000 
10495416 Vav3 vav 3 oncogene NM_020505 3 -1.63 0.000 
10432032 Vdr vitamin D receptor NM_009504 15 -1.22 0.000 
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10571788 Vegfc vascular endothelial growth factor C NM_009506 8 -1.54 0.000 
10559970 Vmn1r69 vomeronasal 1 receptor 69 NM_145842 7 -1.33 0.000 
10532285 Vmn2r15 vomeronasal 2, receptor 15 NM_001104626 5 -1.44 0.000 
10565373 Vmn2r76 vomeronasal 2, receptor 76 NM_001102580 7 -1.34 0.000 
10345546 Vwa3b von Willebrand factor A domain containing 3B XM_003086154 1 -1.34 0.000 
10526193 Wbscr16 Williams-Beuren syndrome chromosome region 16 homolog (human) NM_033572 5 -1.36 0.000 
10419296 Wdhd1 WD repeat and HMG-box DNA binding protein 1 NM_172598 14 -1.37 0.000 
10386376 Wnt3a wingless-type MMTV integration site family, member 3A NM_009522 11 -1.25 0.000 
10562323 Wtip WT1-interacting protein NM_207212 7 1.26 0.000 
10468489 Xpnpep1 X-prolyl aminopeptidase (aminopeptidase P) 1, soluble NM_133216 19 -1.26 0.000 
10347232 Xrcc5 X-ray repair complementing defective repair in Chinese hamster cells 
5 
NM_009533 1 -1.28 0.000 
10373000 Xrcc6bp1 XRCC6 binding protein 1 NM_026858 10 -1.36 0.000 
10434313 Yeats2 YEATS domain containing 2 NM_001145930 16 -1.25 0.001 
10458755 Ythdc2 YTH domain containing 2 NM_001163013 18 -1.23 0.001 
10490826 Zbtb10 zinc finger and BTB domain containing 10 NM_177660 3 -1.30 0.000 
10350377 Zbtb41 zinc finger and BTB domain containing 41 homolog NM_172643 1 -1.32 0.001 
10551426 Zfp59 zinc finger protein 59 NM_011762 7 -1.20 0.000 
10547282 Zfp9 zinc finger protein 9 NM_011763 6 -1.29 0.003 
 
a Chromosomal location of transcript-encoding gene 
b p-values < 0.001 are shown as 0.000 
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APPENDIX C.  microRNAs identified as differentially expressed in the adult (P60) brain of 
mice treated with ethanol during synaptogenesis (fold cutoff ≥ ±1.2, FDR-corrected p<0.05).  
miRNAs are listed in order of fold change relative to control. 
 
Mature miRNA Gene ID Chra Fold Change p-value 
mmu-miR-704 Mir704 6 -4.169 0.003 
mmu-miR-1903 Mir1903 8 -2.701 0.035 
mmu-miR-10b Mir10b 2 -2.276 0.036 
mmu-miR-1196 Mir1196 14 -2.046 0.019 
mmu-miR-335-3p Mir335 6 -1.930 0.003 
mmu-let-7g Mirlet7g 9 -1.914 0.016 
mmu-let-7b Mirlet7b 15 -1.892 0.022 
mmu-miR-297a  ml -1.880 0.002 
mmu-miR-1947 Mir1947 16 -1.755 0.008 
mmu-miR-376b Mir376b 12 -1.702 0.043 
mmu-miR-1970 Mir1970 X -1.694 0.034 
mmu-let-7i Mirlet7i 10 -1.589 0.040 
mmu-miR-590-5p Mir590 unk -1.562 0.003 
mmu-miR-223 Mir223 X -1.491 0.001 
mmu-miR-503* Mir503 X -1.479 0.029 
mmu-miR-1953 Mir1953 2 -1.401 0.031 
mmu-miR-343 Mir343 7 -1.317 0.037 
mmu-miR-467a-1 Mir467a-1 2 -1.313 0.037 
mmu-miR-34b-5p Mir34b 9 -1.292 0.006 
mmu-miR-1927 Mir1927 1 -1.287 0.029 
mmu-miR-544 Mir544 12 -1.256 0.022 
mmu-miR-2182 Mir2182 unk -1.256 0.048 
mmu-miR-466i Mir466i 13 -1.252 0.017 
mmu-miR-696 Mir696 unk -1.231 0.008 
mmu-miR-15b Mir15b 3 -1.214 0.022 
mmu-miR-665 Mir665 12 -1.207 0.032 
mmu-miR-715 Mir715 unk 1.238 0.042 
mmu-miR-878-3p Mir878 X 1.242 0.013 
mmu-miR-467b Mir467b 2 1.246 0.038 
mmu-miR-1195 Mir1195 17 1.272 0.033 
mmu-miR-26b Mir26b 1 1.284 0.036 
mmu-miR-93 Mir93 5 1.311 0.006 
mmu-miR-184 Mir184 9 1.485 0.035 
mmu-miR-1941-5p Mir1941 15 1.688 0.037 
mmu-miR-669a  ml 1.876 0.025 
mmu-miR-721 Mir721 5 2.437 0.004 
 
a Chromosomal location of miRNA gene; ml: multiple loci; unk: unknown 
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APPENDIX D.  Animal use protocols approval obtained from the Animal Use Subcommittee at 
the University of Western Ontario in compliance with the ethical standards established by 
the Canadian Council on Animal Care. 
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